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Summary 
 
 
Marine sponges (Porifera) harbor diverse microbial communities within their mesohyl, 
among them representatives of the phylum Actinobacteria, commonly known as 
actinomycetes.  Actinomycetes are prolific producers of pharmacologically important 
compounds and are responsible for producing the majority of antibiotics. The main aim of 
this Ph.D. study was to investigate the metabolic potential of the sponge-associated 
actinomycetes to produce novel anti-infective agents. 
 
The first aim was to cultivate actinomycetes derived from different marine sponges. 16S 
rDNA sequencing revealed that the strains belonged to diverse actinomycete genera 
such as Gordonia, Isoptericola, Micromonospora, Nocardiopsis, Saccharopolyspora and 
Streptomyces. Phylogenetic analyses and polyphasic characterization further revealed 
that two of these strains represent new species, namely Saccharopolyspora cebuensis 
strain SPE 10-1T (Pimentel-Elardo et al. 2008a) and Streptomyces axinellae strain 
Pol001T (Pimentel-Elardo et al. 2008b). 
 
Furthermore, secondary metabolite production of the actinomycete strains was 
investigated.  The metabolites were isolated using a bioassay-guided purification scheme 
followed by structure elucidation using spectroscopic methods and subjected to an 
elaborate anti-infective screening panel. Several interesting compounds were isolated 
namely, the novel polyketides cebulactam A1 and A2 (Pimentel-Elardo et al. 2008c), a 
family of tetromycin compounds including novel derivatives, cyclodepsipeptide 
valinomycin, indolocarbazole staurosporine, diketopiperazine cycloisoleucylprolyl and 
butenolide. These compounds exhibited significant anti-parasitic as well as protease 
inhibitory activities. 
 
The third aim of this Ph.D. study was to identify biosynthetic gene clusters encoding for 
nonribosomal peptide synthetases (NRPS) and polyketide synthases (PKS) present in the 
actinomycete strains. Genomic library construction and sequencing revealed insights into 
the metabolic potential and biosynthetic pathways of selected strains. An interesting 
NRPS system detected in Streptomyces sp. strain Aer003 was found to be widely 
distributed in several sponge species, in an ascidian and in seawater and is postulated to 
encode for a large peptide molecule. Sequencing of the PKS gene cluster of 
Saccharopolyspora cebuensis strain SPE 10-1T allowed the prediction of the cebulactam 
biosynthetic pathway which utilizes 3-amino-5-hydroxybenzoic acid as the starter unit 
Summary 
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followed by successive condensation steps involving methylmalonyl extender units and 
auxiliary domains responsible for the polyketide assembly. 
 
In conclusion, this Ph.D. study has shown that diverse actinomycete genera are 
associated with marine sponges. The strains, two of them novel species, produced 
diverse chemical structures with interesting anti-infective properties. Lastly, the presence 
of biosynthetic gene clusters identified in this study substantiates the biosynthetic 
potential of actinomycetes to produce exploitable natural products and hopefully provides 
a sustainable supply of anti-infective compounds. 
 
 
 
                                                                                                            Zusammenfassung 
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Zusammenfassung 
 
Zahlreiche marine Schwämme (Phylum: Porifera) beherbergen eine phylogenetisch 
diverse mikrobielle Gemeinschaft in der Mesohyl-Matrix, darunter auch viele Vertreter des 
bakteriellen Phylums Actinobacteria, die umgangssprachlich als Actinomyceten bekannt 
sind. Actinomyceten sind wichtige Produzenten vieler Antibiotika und von weiteren 
pharmazeutisch relevanten Substanzen. Das Hauptziel dieser Promotionsarbeit war die 
Untersuchung des Potentials Schwamm-assoziierter Actinomyceten zur Produktion neuer 
Infektions-hemmender Substanzen.  
 
Ein erstes Ziel dieser Doktorarbeit war die Kultivierung von Actinomyceten aus 
verschiedenen marinen Schwammarten. Die Sequenzierung der respektiven 16S rRNA 
Gene zeigte eine phylogenetische Zugehörigkeit der Isolate zu verschiedenen 
Actinomyceten-Familien, wie Gordonia, Isoptericola, Micromonospora, Nocardiopsis, 
Saccharopolyspora und Streptomyces. Durch phylogenetische Analysen und 
umfangreiche taxonomische Charakterisierungen konnten zwei neue Actinomyceten-
Arten, Saccharopolyspora cebuensis strain SPE 10-1T (Pimentel-Elardo et al. 2008a) und 
Streptomyces axinellae strain Pol001T (Pimentel-Elardo et al. 2008b) beschrieben 
werden.  
 
Des Weiteren sollten die Actinomyceten-Isolate auf die Produktion von Sekundär-
Metaboliten hin untersucht werden. Die Substanzen wurden „bioassay-guided“ 
aufgereinigt und isoliert sowie deren Struktur mittels spektroskopischer Methoden 
aufgeklärt. Anschließend wurden die Substanzen ausführlichen Screening-Methoden 
unterzogen, um sie auf anti-infektive Wirkungen hin zu untersuchen. Zahlreiche 
interessante Verbindungen konnten so isoliert werden, u. a. die neuen Polyketide 
Cebulactam A1 und A2 (Pimentel-Elardo et al. 2008c); eine Familie von Tetromycin-
Substanzen inklusive neuartiger Derivative; das Cyclodepsipeptid Valinomycin, 
Indolocarbazole Staurosporine, Diketopiperazine Cycloisoleucylprolyl und Butenolide. Die 
Verbindungen zeigten signifikante anti-parasitische und Protease-hemmende Aktivitäten.  
 
Das dritte Ziel dieser Arbeit war es, die für nicht-ribosomale Peptidsynthetasen (NRPS) 
und Polyketidsynthasen (PKS) kodierenden, biosynthetischen Gen-Cluster in den 
Actinomyceten-Isolaten zu identifizieren. Die Konstruktion von Genbanken sowie die 
Sequenzierung ausgewählter Cosmidklone lieferte erste Einblicke in das Stoffwechsel- 
und Biosynthesepotential ausgewählter Isolate. Beispielsweise konnte ein interessantes 
NRPS-System in Streptomyces sp. Stamm Aer003 identifiziert werden, welches in 
                                                                                                            Zusammenfassung 
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verschiedenen Schwammarten, einer Ascidienart sowie im Meerwasser gefunden wurde. 
Die Sequenzierung eines PKS-Genclusters aus Saccharopolyspora cebuensis strain SPE 
10-1T ermöglicht die Voraussage des Cebulactam-Biosynthesewegs in dem 3-Amino-5-
Hydroxybenzoesäure als Ausgangsprodukt dient, welches durch sukzessive 
Kondensationsschritte sowie Verlängerungen durch Methylmalonyl- und Zusatzdomänen 
zum endgültigen Polyketid führen.  
 
Zusammenfassend konnte in dieser Promotionsarbeit gezeigt werden, dass marine 
Schwämme mit diversen Vertretern aus verschiedenen Familien der Actinomyceten 
assoziiert sind. Die Bakterienisolate, von denen zwei neue Arten repräsentieren, 
produzierten mehrere chemische Substanzen mit interessanten anti-infektiven 
Eigenschaften. Des Weiteren konnte mit dieser Arbeit durch die Identifizierung von 
Biosynthese-Genclustern das Potential von Actinomyceten zur Produktion verwertbarer 
bioaktiver Substanzen bekräftigt und somit ein Beitrag zur Entdeckung neuer anti-
infektiver Substanzen erbracht werden. 
Chapter 1 
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Chapter 1 
Introduction 
 
1.1 Marine sponges (Porifera) 
1.1.1 Biology and microbial diversity 
Marine sponges (Porifera) are ancient metazoans dating back to the Precambrian era (Li 
et al. 1998). The phylum Porifera is divided into three classes: Hexactinellida (glass 
sponges), Calcarea (calcareous sponges) and Demospongiae (demosponges), with the 
last group containing an estimated 85% of the formally described living species (Hooper 
and van Soest 2002). These sessile invertebrates inhabit a wide variety of marine and 
freshwater systems and are found throughout tropical, temperate and polar regions 
(Hooper and van Soest 2002). The growth habits of sponges encompass various shapes, 
colors and sizes (Fig.1.1) (Brusca and Brusca 1990). Furthermore, sponges are 
comprised of a basic body plan (Bergquist 1978; Simpson 1984; Brusca and Brusca 
1990). The outer surface, pinacoderm consists of pores called ostia which extend along 
interior canals that permeate through the sponge. Specialized flagellated cells called 
choanocytes form a series of choanoderm chambers where the choanocytes beat to 
pump water in through the ostia as well as through the aquiferous systems within the 
sponge body. These flagellated choanocytes also filter out food particles from the 
surrounding water, including bacteria and microalgae which are then transferred to the 
mesohyl and digested by archaeocytes through phagocytosis. After water is filtered 
through the choanocytes, it is then expelled from the sponge via the osculum rendering 
the effluent essentially sterile. Sponges are capable of turning over large volumes of 
water through its aquiferous canal system equaling to several thousands of liters for a 1-
kg sponge per day (Vogel 1977). 
 
Dense communities of microorganisms are present in the mesohyl of most sponges 
(Vacelet and Donadey 1977; Wilkinson 1978; Friedrich et al. 1999). These types of 
sponges have been termed ‘bacteriosponges’ or ‘high-microbial-abundance sponges’ 
(Vacelet and Donadey 1977; Hentschel et al. 2003) where bacterial densities may reach 
up to 108-1010 bacteria per gram of sponge wet weight (Hentschel et al. 2006), exceeding 
that of seawater by several orders of magnitude (Friedrich et al. 2001) and accounting to 
up to 40% of the sponge biomass (Vacelet and Donadey 1977). On the other hand, the 
mesohyl of other sponges that co-exist in the same habitat are essentially devoid of 
microorganisms, hence these are termed as ‘low-microbial-abundance sponges’ with 105-
Chapter 1 
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106 bacteria per gram of sponge wet weight which are within the range of natural 
seawater (Hentschel et al. 2006) (Fig. 1.2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1.1 Demosponges: (A): Agelas clathrodes; (B): Amphimedon compressa; 
(C): Aplysina fistularis; (D): Callyspongia plicifera; (E): Niphates digitalis; 
(F): Pseudoceratina crassa; (G): Mycale laxissima; (H): Xestospongia muta 
(underwater photography by H. Angermeier, University of Würzburg) 
 
A B C
D E F
G H
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Fig. 1.2 Transmission electron micrographs of (A) Xestospongia muta (high-microbial-abundance 
sponge) and (B) Callyspongia vaginalis (low-microbial-abundance sponge) (Hentschel et al. 2006) 
 
 
The associations between sponges and microorganisms are maintained such that 
microbial symbionts are passed on from the parent sponge through reproductive stages 
through vertical transmission (Usher et al. 2001; Ereskovsky et al. 2005; Schmitt et al. 
2007; Schmitt et al. 2008a). These symbionts are stable populations which are 
phylogenetically distinct from transient bacteria and which are filtered out of the 
surrounding seawater during the feeding process of the sponge. Symbiotic functions that 
have been attributed include nutrient acquisition, sponge skeleton stabilization, metabolic 
waste processing and metabolite production (Wilkinson 1992; Unson et al. 1994; Bewley 
et al. 1996; Schmidt et al. 2000; Hentschel et al. 2006).  
 
Furthermore, the microbial communities of sponges have been documented by electron 
microscopy studies indicating high morphological diversity as well as the presence of 
unusual microorganisms (Vacelet and Donadey 1977; Wilkinson 1978). Several studies 
have been reported on the diversity of the microbial consortia of sponges using 
cultivation-dependent approaches (Santavy et al. 1990; Webster and Hill 2001). With the 
advent of molecular tools such as 16S rRNA gene library construction, fluorescence in 
situ hybridization (FISH) and denaturing gradient gel electrophoresis (DGGE), it is now 
possible to gain insights into the complex microbial consortia of sponges, including those 
that have eluded cultivation efforts (Head et al. 1998; Juretschko et al. 1998; Schmid et 
al. 2000; Webster et al. 2001; Hentschel et al. 2002; Olson and McCarthy 2005; Hill et al. 
2006). 
 
 
 
1.5 μm 5 μm
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Fig. 1.3 Phylogenetic tree of prokaryotes indicating microbial groups recovered from marine 
sponges (highlighted in colored boxes) by cultivation-independent (pink boxes) and cultivation-
dependent approaches (blue boxes). Members of Actinobacteria have been recovered using both 
approaches (violet box). Modified from Hugenholtz et al. (1998) and Schmitt et al. (2008b) 
 
 
For instance, 16S rRNA gene library construction using universal bacterial PCR primers 
revealed a uniform, yet phylogenetically complex microbial population in sponges from 
different oceans (Hentschel et al. 2002; Hentschel et al. 2006). These 16S rRNA gene 
phylotypes are affiliated with the phyla Chloroflexi, Actinobacteria, Proteobacteria, 
Nitrospira, Cyanobacteria, and Bacteroidetes. A novel eubacterial candidate phylum 
Poribacteria was also discovered in Verongid sponges (Fieseler et al. 2004). In addition, 
Actinobacteria, Bacteroidetes, Cyanobacteria, Firmicutes, Planctomycetes, 
Proteobacteria, and Verrucomicrobia have also been isolated in pure culture from marine 
sponges (Burja and Hill 2001; Hentschel et al. 2001; Webster and Hill 2001; Olson et al. 
2002; Pimentel-Elardo et al. 2003; Dieckmann et al. 2005; Kim et al. 2005; Montalvo et al. 
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2005; Enticknap et al. 2006; Kim and Fuerst 2006; Scheuermayer et al. 2006; Zhang et 
al. 2006; Jiang et al. 2007; Sertan-de Guzman et al. 2007). In contrast, freshwater 
sponge species have much lower bacterial diversity and abundance and only 
representatives of Actinobacteria, Chloroflexi, Alpha- and Betaproteobacteria were 
recovered (Gernert et al. 2005). Archaeal members have been detected from the phylum 
Crenarchaeota such as the well-studied sponge archaeon “Candidatus Cenarchaeum 
symbiosum” (Preston et al. 1996; Taylor et al. 2007).  Fungal strains have also been 
recovered in several sponges such as Penicillium and Aspergillus, which are ubiquitous in 
terrestrial habitats (Höller et al. 2000). 
 
The identification of Actinobacteria in marine sponges is interesting as members of this 
group are known to be prolific producers of pharmacologically important natural products 
(Munro et al. 1999; Fiedler et al. 2005; Fenical and Jensen 2006; Newman and Hill 2006). 
For example, the presence of Actinobacteria was detected in the sponge Rhopaloeides 
odorabile by culture-independent methods such as FISH and culture-dependent 
approaches (Webster et al. 2001). Furthermore, sponge-specific actinobacterial clusters 
were also recovered from Theonella swinhoei and Aplysina aerophoba (Hentschel et al. 
2002; Montalvo et al. 2005). Actinobacteria exclusively within the sub-class 
Acidimicrobidae were shown to be the major components of the bacterial community of 
two Xestospongia species, namely X. muta and X. testudinari (Montalvo et al. 2005).  
Initial culturing attempts of the sponges also yielded different genera such as Gordonia, 
Micrococcus and Brachybacterium. Furthermore, over a hundred of actinomycete strains 
were cultivated from the marine sponge Hymeniacidon perleve and by phylogenetic 
analysis of the 16S rDNA gene sequences, these isolates belonged to the genera 
Actinoalloteichus, Micromonospora, Nocardia, Nocardiopsis, Pseudonocardia, 
Rhodococcus and Streptomyces, with the latter accounting for 74% of the isolates (Zhang 
et al. 2006). Using the same culture-dependent approach, several actinomycetes were 
isolated from the sponge Haliclona sp., such as Streptomyces, Nocardiopsis, 
Micromonospora and Verrucosispora (Jiang et al. 2007). Interestingly, marine 
actinomycetes related to the Salinispora group previously reported only from marine 
sediments were isolated from the Great Barrier Reef marine sponge Pseudoceratina 
clavata (Kim et al. 2005).  Salinispora, the first seawater-requiring marine actinomycete 
discovered, produce secondary metabolites in a species-specific pattern (Jensen et al. 
2007). Interestingly, genome sequencing revealed that Salinispora tropica dedicates a 
large percentage of its genome to natural product assembly, greater than previous 
Streptomyces species and other actinomycetes (Udwary et al. 2007). 
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1.2 Secondary metabolites 
1.2.1 Natural products from marine sponges 
Marine organisms produce novel secondary metabolites with a wide array of biological 
and pharmacological activities. Out of the 194,000 natural compounds listed in the first 
volume of the 2006 Chapman and Hall Dictionary of Natural Products, approximately 
18,000 are derived from marine sources (Singh and Pelaez 2008). The number of marine 
natural products continues to rise with sponges as the most prolific producers of novel 
compounds, with more than 200 new metabolites reported annually (Blunt et al. 2003; 
Blunt et al. 2004; Blunt et al. 2005; Blunt et al. 2006; Blunt et al. 2007; Taylor et al. 2007; 
Blunt et al. 2008). These compounds have shown promise in treating inflammation, 
cancer as well as microbial and viral infections (Newman and Cragg 2004b; Fenical 2006; 
Newman 2008). The wealth of the bioactive compounds isolated especially from soft-
bodied, sessile marine organisms such as sponges that lack morphological defense 
structures stresses the ecological importance of the compounds for these invertebrates 
(Thoms et al. 2004; Gross and König 2006; Paul et al. 2006; Thoms et al. 2006). Marine 
sponges accumulate structurally diverse secondary metabolites which have been found 
to be deterrent to potential fish predators (Pawlik et al. 1995), exhibit anti-fouling activity 
(Martin and Uriz 1993) and prevent the growth of competing invertebrates (Porter and 
Targett 1988; Paul et al. 2006).  
 
The majority of the natural products currently in clinical and pre-clinical trials are 
produced by invertebrates, including marine sponges (Proksch et al. 2002; Haefner 2003; 
Newman and Cragg 2004a; Fenical 2006). One example is discodermolide, a 
polyhydroxylated lactone isolated from the sponge Discodermia dissoluta (Gunasekera et 
al. 1991) which is now under phase I clinical trial for pancreatic cancer.  The compound 
KRN7000 from the sponge Agelas mauritianus (Kikuchi et al. 2001) and HTI-286, a 
hemiasterlin derivative from the South African sponge Hemiasterella minor, are 
anticancer drugs under phase II clinical trial (Newman and Cragg 2004b). The 
contignasterol derivative, IPL-576,092 isolated from the sponge Petrosia contignata 
(Coulson and O'Donnell 2000) is under phase II clinical trial for oral asthma therapy.  
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Fig. 1.4 Examples of natural products from sponges in clinical trials 
 
 
Furthermore, there are several antitumour compounds from marine sponges in preclinical 
status (Newman and Cragg 2004a) such as laulimalide and isolaulimalide from the Pacific 
Ocean sponge Cacospongia mycofijiensis (Mooberry et al. 1999); peloruside A from the 
New Zealand sponge Mycale hentscheli (West et al. 2000); salicylihalimides A and B from 
the Western Australian sponge Haliclona sp. (Erickson et al. 1987); and the variolins from 
the Antarctic sponge Kirckpatrickia variolosa  (Perry et al. 1994; Trimurtulu et al. 1994). 
 
Despite the large number of novel bioactive metabolites reported from marine sponges 
over the years, not a single compound has been approved as a drug, whether isolated or 
from total synthesis. A couple of exceptions are the nucleoside analogues Ara-A and Ara-
C, now commercialized as antiviral and anticancer agents but these were not directly 
isolated from sponges but are synthetic derivatives of compounds from the Caribbean 
sponge Cryptotethia crypta (Bergmann and Feeney 1951). A major problem to the 
ultimate development of these compounds undergoing clinical or pre-clinical trials is the 
problem of supply. The concentrations of these bioactive compounds in marine 
invertebrates are minute, accounting typically less than 10-6 % of the wet weight (Proksch 
et al. 2002). This already causes considerable difficulties in clinical studies where gram 
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quantities of compounds are required. Such is the case of the potent antitumor 
halichondrins originally isolated from the Japanese sponge Halichondria okadai (Hirata 
and Uemura 1986). Although these macrolides have also been subsequently isolated 
from a number of other sponges such as Axinella sp. from the Western Pacific (Pettit et 
al. 1991), Phakellia carteri from the Eastern Indian Ocean (Pettit et al. 1993), and from 
Lissondendoryx sp. off the East Coast of South Island, New Zealand (Munro et al. 1999), 
still the demand for clinical trials and annual requirement as a commercial drug is not 
sufficient (Hart et al. 2000). The synthetic analogue of halichondrin B, E7389 having the 
same biological properties circumvented the supply problem and is now under phase II 
clinical trial (Choi et al. 2003; Sipkema et al. 2005). 
 
1.2.2 Metabolites from associated microorganisms 
The majority of secondary metabolites that have been isolated from marine sponges are 
hypothesized to be produced by bacterial symbionts (Piel 2004). This speculation was 
based on the striking structural similarities with bacterial natural products (Table 1.1) 
belonging to substance classes that are typical for these microorganisms such as 
polyketides and nonribosomal peptides.  
 
 
Table 1.1 Natural products from marine sponges that resemble bacterial metabolites (Piel 2004) 
 
Sponge   
metabolite 
Sponge 
Source 
Bacterial 
metabolite 
Bacterial 
Source  
Arenastatin A Dysidea arenaria Cryptophycin Nostoc sp. 
Discodermide Discodermia dissoluta Alteramide A Alteromonas sp. 
  Ikarugamycin Streptomyces sp. 
Jaspamide Jaspis spp. Chondramide D Chondromyces crocatus 
Keramamide A Theonella sp. Ferintoic acid A Microcystis aeruginosa 
Mimosamycin Petrosia sp. Mimosamycin Streptomyces lavendulae 
Motuporin Theonella swinhoei Nodularin Nodularia spumigena 
Renieramycin E Reniera sp. Safracin B Pseudomonas fluorescens 
  Saframycin A Streptomyces lavendulae 
  Saframycin Mx1 Myxococcus xanthus 
Salicylihalamide A Haliclona sp. Apicularen A Chondromyces sp. 
Swinholide A Theonella swinhoei Tolytoxin Tolypothrix sp.  
Misakinolide A Theonella sp. Scytophycin C Scytonema sp. 
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Despite structural complexity, the majority of these compounds exhibits only slight 
differences in the substitution patterns. Examples are renieramycin from Reniera sp. 
sponge (He and Faulkner 1989) and saframycin A from Streptomyces lavendulae (Arai et 
al. 1977), discodermide from the marine sponge Discodermia dissoluta (Gunasekera et 
al. 1980; Gunasekera et al. 1991) and ikarugamycin from Streptomyces sp. (Ito and 
Hirata 1972). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1.5 Examples of sponge metabolites structurally similar to bacterial metabolites 
 
 
Secondary metabolites found in the tropical sponges Dysidea herbacea and Theonella 
swinhoei provide additional evidence to the involvement of microorganisms in natural 
product synthesis (Proksch et al. 2002). The Great Barrier reef sponge Dysidea herbacea 
was found to contain the sesquiterpenes spirodysin and herbadysidolide as well as the 
chlorinated amino acid derivative (Unson and Faulkner 1993). These compounds were 
also found in their cyanobacterial symbiont  Oscillatoria spongeliae (Berthold et al. 1982) 
after disruption of the sponge tissue and separation of the cyanobacterial cells. The 
sponge Theonella swinhoei collected from the Philippines and Micronesia produces the 
cyclic peptide theopalaumide and the macrolide swinholide and these compounds were 
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detected in cellular fractions containing filamentous bacteria as well as unicellular 
bacteria, respectively (Bewley et al. 1996; Piel 2004). Using 16S rDNA sequencing, the 
theopalaumide-containing symbiont was assigned as a novel δ-proteobacterium 
“Candidatus Entotheonella palauensis” (Schmidt et al. 2000).   
 
1.2.3 Metabolites from marine actinomycetes 
The class Actinobacteria, specifically bacteria belonging to the order Actinomycetales, 
accounts for approximately 7000 of compounds reported in the Dictionary of Natural 
Products (Jensen et al. 2005). Actinomycetes are responsible for the production of about 
half of the discovered bioactive secondary metabolites such as antibiotics. Remarkably, 
the genus Streptomyces accounts for 80% of actinomycete natural products reported 
(Berdy 2005), mostly producing phenazone and lactone amide type of compounds with 
antibiotic properties (Kelecom 2002). Although the majority of the actinomycetes were 
previously isolated from terrestrial sources, these bacteria have also been recovered from 
marine sediments, and even from deepest ocean trenches (Grein and Meyers 1958; 
Mincer et al. 2002; Maldonado et al. 2005b; Fenical and Jensen 2006; Pathom-Aree et al. 
2006; Bredholdt et al. 2007). The isolation of these marine actinomycetes could be 
accounted for by the cultivation of spores that may have originated from soil-inhabiting 
strains that were washed into the marine environment. The first marine actinomycete 
described taxonomically was Rhodococcus marinonascens (Helmke and Weyland 1984) 
and quite recently, new genera have been described including Salinispora, the first 
obligate marine actinomycete isolated from ocean sediments (Han et al. 2003; Yi et al. 
2004; Maldonado et al. 2005a).  Furthermore, Mincer et al. (2005) demonstrated that 
Salinispora strains are actively growing in sediment samples indicating that these bacteria 
are metabolically active in the natural marine environment, addressing the question 
whether actinomycetes only exist as dormant spores. The discovery of numerous new 
marine actinomycete taxa, their demonstrated metabolic activity, and their ability to form 
stable populations in different habitats clearly illustrate that indigenous marine 
actinomycetes exist in the oceans (Lam 2006).  
 
Numerous novel secondary metabolites have been isolated from marine actinomycetes, 
although exploitation of this group is still at its infancy. Example is the novel β-lactone-γ-
lactam, salinisporamide A isolated from Salinispora tropica now undergoing phase I 
clinical trial as proteasome inhibitor for treating multiple myeloma cells (Feling et al. 2003; 
Chauhan et al. 2005). Another example is abyssomicin C, a novel polyketide antibiotic 
produced by the marine Verrucosispora strain (Riedlinger et al. 2004), is a potent inhibitor 
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of para-aminobenzoic acid biosynthesis inhibiting folic acid biosynthesis at an earlier 
stage compared to the well-known sulfa drugs (Bister et al. 2004). Diazepinomicin, 
produced by a Micromonospora strain, is another example (Charan et al. 2004). This 
unique farnesylated dibenzodiazepenone is now under preclinical development as an 
anticancer agent.   
 
 
Table 1.2 Novel metabolites produced by marine actinomycetes during the period 2003-2005 
(Lam 2006) 
 
Compound Source Activity 
Abyssomicins Verrucosispora Antibacterial 
Aureoverticillilactam Streptomyces aureoverticillatus Anticancer 
Bonactin Streptomyces sp. Antimicrobial 
Caprolactones Streptomyces sp. Anticancer 
Chandrananimycins Actinomadura sp. Antimicrobial; anticancer 
Chinikomycins Streptomyces sp. Anticancer 
Diazepinomicin Micromonospora sp. Antibacterial; anticancer; 
antiinflammatory 
3,6-disubstituted indoles Streptomyces sp. Anticancer 
Frigocyclinone Streptomyces griseus Antibacterial 
Glaciapyrroles Streptomyces sp. Antibacterial 
Gutingimycin Streptomyces sp. Antibacterial 
Helquinoline Janibacter limosus Antibacterial 
Himalomycins Streptomyces sp. Antibacterial 
IB-00208 Actinomadura sp. Anticancer 
Komodoquinone A Streptomyces sp. Neuritogenic 
Lajollamycin Streptomyces nodosus Antibacterial 
Marinomycins Marinispora sp. Antibacterial; anticancer 
Mechercharmycins Thermoactinomyces sp. Anticancer 
Salinosporamide A Salinispora tropica Anticancer 
Sporolides Salinispora tropica Unknown biological activity 
Trioxacarcins Streptomyces sp. Antibacterial; anticancer; 
antimalarial 
 
 
1.3 Biosynthetic gene clusters 
 
A growing number of novel, bioactive secondary metabolites produced by marine 
invertebrates as well as marine bacteria appear to be structurally biosynthesized by 
polyketide synthases (PKS) and/or nonribosomal peptide synthetases (NRPS). These 
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enzymes are organized in a modular fashion utilizing specific domains to sequentially 
catalyze the condensation of simple carboxylic acids for PKS systems or amino acid 
building blocks for NRPS systems into a growing chain. Each module is a cluster 
responsible for chain elongation through the recognition, activation and incorporation of 
specific substrates and structural diversity is introduced through various combinations of 
the integral and auxiliary domains (Schwarzer and Marahiel 2001; Salomon et al. 2004).  
 
Nonribosomally produced peptides exhibit a remarkable spectrum of biological and 
pharmacological activities such as the antibiotics vancomycin and penicillin, 
immunosuppressive agent cyclosporine and the antitumor compound bleomycin.  
Actinomycetes are known to produce these pharmacologically important peptides. PCR 
screening efforts for genes associated with secondary metabolism such as NRPS have 
been used to evaluate the biosynthetic potential of actinomycetes (Ayuso-Sacido and 
Genilloud 2005; Ayuso et al. 2005). PCR primers tested on a large collection of 210 
reference strains encompassing major families and genera in actinomycetes revealed the 
wide distribution of these genes in Streptomyces species as well as in other minor 
lineages where in some cases only a few compounds have been isolated. The NRPS 
systems occur more frequently in strains of the main antibiotic producers from the families 
Micromonosporaceae, Pseudonocardiaceae, and Actinosynnemataceae. Furthermore, 
NRPS genes were also detected by PCR amplification in cultivated actinobacteria from 
the South China Sea sponge Haliclona sp. belonging to the genera Streptomyces, 
Nocardiopsis, Micromonospora and Verrucosispora (Jiang et al. 2007). Biosynthetic 
genes have also been recovered from marine invertebrates. However, in another study by 
Kennedy et al. (2008), NRPS genes were not detected  from the microbial metagenome 
of the sponge Haliclona simulans. A remarkable discovery on biosynthetic pathways for 
investigating marine invertebrate-bacteria associations is the isolation of the peptides 
patellamide A and C (Schmidt 2005; Schmidt et al. 2005). These cyclic peptides were 
thought to be synthesized by the cyanobacterial symbiont Prochloron didemni of the 
ascidian Lissoclinum patella. Schmidt et al. identified these NRPS genes and confirmed 
their function by heterologous expression of the whole pathway. This work represents the 
potential of functional expression of a marine natural product pathway from an obligate 
symbiont, thus alleviating the problem of supply by genetic manipulation. 
 
Polyketides are classified as aromatic, polyenes and polyethers including macrolides 
(Rawlings 1997). The PKSs are responsible for the synthesis of several 
pharmacologically important bacterial polyketides such as antibiotics (i.e. erythromycin, 
tetracycline), antitumor, immunosuppressive and cholesterol-lowering agents. 
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Remarkably, a number of important natural products isolated from sponges such as 
discodermolide, laulimalide and peloruside are of polyketide biosynthetic origin (Fortman 
and Sherman 2005). Piel et al. (2004) made a milestone discovery on polyketide genes 
from a marine sponge confirming the long-suspected role of symbiotic bacteria in the 
production of natural products such as polyketides. Using metagenomics, production of 
the antitumor onnamide was studied in the marine sponge Theonella swinhoei by first 
investigating the production of pederin subsequently linked to a beetle symbiont closely 
related to Pseudomonas aeruginosa (Piel 2002). The sponge metagenome strongly 
indicated bacterial origin for the genome fragment corresponding to the entire onnamide 
polyketide region. PKS systems have also been studied in other sponges by 
metagenomics. PCR amplification of ketosynthase domains from the microbial consortia 
of the Caribbean sponge Discodermia dissoluta revealed great diversity and a novel 
group of sponge-specific KS domains (Schirmer et al. 2005). The most abundant modular 
PKS appeared to be encoded by a bacterial symbiont that made up <1% of the sponge 
community. Fieseler et al. (2007) systematically investigated 20 demosponge species in 
different oceans and found that the sponge microbial metagenomes were dominated by 
an evolutionary distinct and highly sponge-specific group of polyketide synthases. In 
another study by Kim and Fuerst (2006), direct amplification of KS domains in the Great 
Barrier reef sponge Pseudoceratina clavata using fosmid library construction yielded KS 
domains falling into a sponge-specific cluster. Quite interestingly, cultivated bacteria from 
the sponge were also screened for KS domains and these were detected in 
representatives of Actinobacteria, Alphaproteobacteria and Firmicutes. This is not 
surprising since members of the Actinobacteria, in particular are known to produce 
important natural products with polyketide biosynthetic origin. An example is the rifamycin 
polyketide, known to be produced by the soil actinomycete Amycolatopsis mediterranei 
(August et al. 1998) was also found to be produced by the marine actinomycete 
Salinispora sp. isolated from the sponge Pseudoceratina clavata.  Phylogenetic analysis 
of the KS gene sequences revealed that these are closely related to rifamycin B synthase 
of A. mediterranei (Kim et al. 2006).  Additional examples of PKS gene clusters identified 
from marine actinomycetes are enterocin PKS from Streptomyces maritimus (Piel et al. 
2000) and the aromatic polyketide griseorhodin from Streptomyces sp. (Li and Piel 2002).   
 
Marine bacterial gene clusters that have been so far identified have demonstrated that 
while PKS and NRPS biosynthetic routes are conserved between terrestrial and marine 
systems, interestingly, there are additional novel catalytic enzymes responsible for the 
unique functional groups found solely in marine natural products (Piel et al. 2000; Chang 
et al. 2002; Li and Piel 2002; Salomon et al. 2004). Furthermore, recent investigations 
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focusing on marine actinomycetes have yielded numerous novel biologically active 
compounds, and more importantly, a surprisingly much more improved rate of discovery 
of new compounds in contrast to their terrestrial counterparts (Bernan et al. 1997). Thus, 
given the promising potential of marine actinomycetes, different strategies (Fig.1.6) were 
employed in this Ph.D. study to fully exploit the capacity of actinomycetes, specifically 
those associated with marine sponges, to produce bioactive secondary metabolites. 
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Fig. 1.6 Stategies to access the potential of sponge-associated microorganisms to produce anti-infective metabolites
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1.4 Aims 
Marine sponges, particularly ‘high-microbial-abundance sponges’ are known to harbour 
huge amounts of microorganisms which include members of the order Actinomycetales. 
Actinomycetes are known as prolific producers of pharmacologically important 
compounds such as antibiotics. The main aim of this Ph.D. study was to investigate the 
potential of actinomycetes associated with marine sponges to produce novel anti-infective 
agents.   
 
The first aim of this Ph.D. study (Chapter 2) was to cultivate actinomycetes derived from 
different marine sponges with a particular focus on strains belonging to novel taxa. The 
strains were identified by 16S rRNA gene sequence analysis and further characterized 
using polyphasic techniques.  
 
The second aim of this Ph.D. study (Chapter 3) was to investigate the secondary 
metabolites produced by the sponge-associated actinomycetes.  The metabolites were 
isolated using a bioassay-guided purification scheme followed by structure elucidation 
using spectroscopic methods. These compounds were subjected to an elaborate anti-
infective screening panel to determine various activities, namely antibacterial, antifungal, 
antiparasitic, cytotoxic as well as inhibition against different cysteine proteases. 
 
The third aim of this Ph.D. study (Chapter 4) was to identify biosynthetic gene clusters 
encoding for nonribosomal peptide synthetases (NRPS) and polyketide synthases (PKS) 
present in the actinomycete strains. Genomic library construction and sequencing were 
carried out in order to provide insights into the metabolic potential and biosynthetic 
pathways of selected strains.  
 
Finally, a general discussion (Chapter 5) of the association of actinomycetes with marine 
sponges and their biosynthetic potential as well as future perspectives is provided.  
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Chapter 2 
Isolation and identification of sponge-associated actinomycetes 
 
2.1 Materials and methods 
2.1.1 Sponge collection and cultivation  
The sponge Haliclona sp. was collected by SCUBA diving off Maribago waters (10° 17’ 
0.97” N, 124° 00’ 01.8” E), Cebu, Philippines in February 2003. Axinella polypoides was 
collected offshore Banyuls-sur-mer, France (42° 29’ N 03° 08’ E) in May 2003. The 
sponges Aplysina aerophoba, Chondrosia reniformis, Dysidea avara, Tedania sp. and 
Tethya sp. were also collected by SCUBA diving offshore Rovinj, Croatia (45° 05′ N, 13° 
38′ E) in May 2006. 
 
Sponge tissues were excised from the center of individual sponge samples (ca. thumb-
sized pieces) using flame-sterilized scalpel. The tissues (2-3 pieces per sponge sample) 
were rinsed with sterile natural or artificial seawater (ASW) (Lyman and Fleming 1940) 
and homogenized in seawater. The homogenates were diluted (10-1 to 10-3) in seawater 
and plated out on different actinomycete-selective media: M1 (Mincer et al. 2002), M2 
(Mincer et al. 2002), ISP medium 2 (Shirling and Gottlieb 1966), M7 (Webster et al. 2001) 
and NaSt21Cx (Magarvey et al. 2004). Media formulations are provided in detail in the 
Annex section. These media were supplemented with the following antibiotics: 
cycloheximide (100 μg/ml), nystatin (25 μg/ml) and nalidixic acid (25 μg/ml). Undiluted 
sponge homogenates (in duplicates) were heated at 90°C for 15 min to enrich for spore-
forming actinomycetes and likewise plated out. The plates were incubated at 30°C for 
about 6-8 weeks and inspected regularly for growth. Colonies were picked up and 
transferred to fresh media for pure culture isolation and glycerol stocks were prepared for 
long-term storage at -80°C.  
 
2.1.2 Cloning, sequencing and phylogenetic analysis  
DNA was extracted from growing cultures either by boiling cells at 95°C for 10 min or 
using the FastDNA® spin kit for soil (Q-Biogene) following manufacturer’s instructions. 
The broth cultures were centrifuged at 8000 rpm for 5 min and the supernatant was 
discarded. The resulting pellet was resuspended in 978 μl sodium phosphate buffer and 
122 μl MT buffer. The solution was transferred to lysing matrix tubes and these were 
processed using a FastPrep® instrument (Q-Biogene) for 30 s with speed set at 5.5. The 
resulting solution was centrifuged at 13000 rpm for 30 s. The supernatant was transferred 
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to a clean tube and 250 μl of PPS reagent was added. The solution was mixed by 
manually shaking the tube ten times. Centrifugation at 13000 rpm for 5 min followed to 
pellet the precipitate. The resulting supernatant was transferred to a clean 2-ml microfuge 
tube. One milliliter of binding matrix suspension was added to the supernatant and the 
mixture was mixed for 2 min to allow binding of the DNA to the matrix. The tube was 
placed in a rack and allowed to stand for 3 min to allow settling of the silica matrix. Five 
hundred microliters of the supernatant was discarded while 600 μl was transferred to a 
spin filter provided by the kit. This was then centrifuged at 13000 rpm for 1 min. The catch 
tube was emptied and the remaining supernatant was added to the spin filter. 
Centrifugation at 13000 rpm for 1 min was repeated. To the spin filter, 500 μl of SEWS-M 
was added which was followed by the same centrifugation step. The flow-through was 
discarded and the spin filter was centrifuged at 13000 rpm for 2 min. The spin filter was 
removed, placed in a new catch tube and subsequently air-dried for 5 min at room 
temperature. Fifty microliters of DES (DNAse/pyrogen-free) water was then added and 
the filter matrix was gently stirred using a pipette tip to resuspend the silica and to 
efficiently elute the DNA.  Centrifugation at 13000 rpm for 1 min followed to transfer the 
eluted DNA to the catch tube. The resulting DNA extract was stored at -20°C. 
 
PCR amplification using the specific primers S-C-Act-0235-a-S-20 (5’-
CGCGGCCTATCAGCTTGTTG-3’) and S-C-Act-0878-A-19 (5’-
CCGTACTCCCCAGGCGG GG-3’) targeting the class Actinobacteria was performed to 
initially screen the isolates (Stach et al. 2003). This was used to minimize bias in 
selecting isolates based solely on morphological characteristics typical for actinomycetes.  
Amplification of the 16S rRNA gene was then performed using the universal primers 27f 
(5’-GAGTTTGATCCTGGCTCA-3’) and 1492r (5’-TACGGCTACCTTGTTACGACTT-3’) 
corresponding to E. coli numbering (Lane 1991). A standard PCR reaction mix (50 μl) 
was prepared which consisted of the following: 10x reaction buffer, 5 μl; Q solution, 10 μl; 
25 mM MgCl2, 2 μl; 10 mM dNTPs, 1 μl; 100 μM of each primer, 1 μl; 5 U/μl Taq 
polymerase, 0.25 μl; H2O, 28.75 μl; DNA template, 1 μl. PCR conditions were as follows:  
initial denaturation (2 min at 95°C) followed by 30 cycles of denaturation (1 min at 95°C), 
primer annealing (1 min at 56°C for 27f/1492r and 60°C for S-C-Act-0235-a-S-20/S-C-
Act-0878-A-19), primer extension (1.5 min at 72°C) and a final extension step (10 min at 
72°C). PCR products were purified using the QIAquick PCR purification kit (Qiagen). Five 
volumes of buffer PB was added to one volume of PCR product and mixed using a 
pipette. The mixture was applied to a QIAquick column and centrifuged at 13000 rpm for 
1 min. The flow-through was discarded and the column was placed back into the same 
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tube.  Buffer PE (750 μl) was added to the column followed by centrifugation at 13000 
rpm for 1 min. The flow-through was discarded and the column was centrifuged for an 
additional min at 13000 rpm. The column was then placed in a clean 1.5-ml microfuge 
tube, added with 30 μl of buffer EB and allowed to stand for 1 min. A final centrifugation 
step at 13000 rpm for 1 min was performed and the resulting purified PCR product was 
stored at -20 °C. 
 
Ligation of the purified PCR products and transformation in competent E. coli XL1-Blue 
cells were subsequently performed. The following were mixed on ice: 2x T4 DNA ligase 
buffer, 5 μl; 50 ng/μl pGEM-Teasy vector (Promega), 1 μl; 3 U/μl T4 DNA ligase, 1 μl; 
PCR product, 4 μl. The ligation solution was incubated overnight at 4°C for maximum 
number of transformants.  For transformation, 2-3 μl of the ligation solution was added to 
50 μl of the competent E. coli cells. The resulting mixture was transferred to a UV-
sterilized electroporation cuvette. Electroporation was applied using an Easyject Prima 
Electroporator (Equibio) at 2500V.  The solution was transferred to a clean 2-ml 
microfuge tube, added with 1 ml of SOC medium with mixing to resuspend the pellet and 
incubated with shaking at 37°C for at least 3 hours. After incubation, 20% and 80% of the 
cells were plated out on LB/amp/IPTG/X-gal agar. The plates were incubated at 37°C 
overnight and successful transformants were observed using the blue-white colony 
screening. The plasmid DNA was then isolated using a standard miniprep protocol. 
Single, white colonies were picked up, inoculated in 2 ml of LB/amp broth and incubated 
with shaking at 37°C overnight.  Following incubation, the culture was centrifuged at 
13000 rpm for 5 min and the supernatant was discarded. The pellet was resuspended in 
150 μl of buffer P1. Addition of 150 μl of buffer P2 with standing for 5 min at room 
temperature followed by the addition of 150 μl of buffer P3 on ice for 5 min were 
subsequently done. The solution was mixed by gentle flicking of the tube after each 
addition of the buffer. The resulting mixture was centrifuged at 13000 rpm for 10 min. The 
supernatant was transferred to clean 1.5-ml microfuge tube and the centrifugation step 
was repeated. The supernatant was again transferred to clean tube, added with 0.7 
volume of isopropanol and mixed by gently flicking the tube.  This was then centrifuged at 
13000 rpm for 15 min. The resulting pellet containing the plasmid DNA was washed with 
70% ethanol and allowed to air-dry. Sterile water (50 μl) was added to resuspend the 
pellet and the plasmid DNA was stored in -20°C until use. To verify the correct clones, the 
plasmid DNA was digested with a restriction endonuclease.  Restriction digestion with 
EcoRI (New England Biolabs) was done by mixing the following: 10x EcoRI buffer, 2 μl; 
water, 12 μl; 20,000 U/ml EcoRI, 1 μl; plasmid DNA, 5 μl.  The reaction mix was 
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incubated at 37°C for 2-3 hours and the restriction patterns were analyzed by agarose gel 
electrophoresis.   
 
For amplification of the pGEM-T easy insert, sequencing PCR was done using the 
primers SP6 (5’- ATTTAGGTGACACTATAG-3’) and T7 (5’- 
GTAATACGACTCACTATAGGG-3’) and the BigDye® terminator cycle sequencing kit 
(Applied Biosystems). The PCR reaction mix was composed of the following: 5x BigDye® 
terminator v1.1 sequencing buffer, 2 μl; BigDye® terminator v1.1 premix, 2 μl; plasmid 
DNA, 2 μl; 25 μM of primer, 1 μl; sterile water, 3 μl.  The PCR conditions were as follows: 
initial denaturation (2 min at 96°C), 25 cycles of denaturation (30 s at 96°C), primer 
annealing (15 s at 45°C), primer extension (4 min at 72°C) and a final extension step (10 
min at 60°C). DNA sequencing was performed using an ABI 377XL automated sequencer 
(Applied Biosystems). Sequences were assembled using the ContigExpress tool in 
Vector NTI suite 6.0 (InforMax, Inc) and subsequently aligned using Clustal X. 
Phylogenetic analysis was done using the ARB software (Strunk and Ludwig 1997).   
 
2.1.3 Morphological, physiological and biochemical characterization of selected 
strains 
 
The strains were cultivated in liquid medium and the bacterial biomass was subsequently 
fixed with 2.5% glutaraldehyde and washed with 50 mM cacodylate buffer. The samples 
were fixed in 2% osmium tetroxide, washed with water five times, followed by dehydration 
with a series of ethanol solutions (50%, 70%, 90% and 100%) and incubation in 
propylene oxide. This was followed by overnight incubation in propylene oxide/glycidether 
(Epon 812, Roth) and polymerization of the resin for three days at 60°C.  The samples 
were sectioned using an ultramicrotome (OM U3, C. Reichert) and contrasted with 1% 
uranyl acetate and lead citrate. The sections were examined with a Zeiss EM 10 electron 
microscope operating at 80V.  
 
For scanning electron microscopy, colonies grown on agar plates were stanced out using 
a sterile cork borer with surrounding material. These were then fixed in 6.25% 
glutaraldehyde, washed five times with Sörensen-phosphate buffer pH 7.4 and 
dehydrated with increasing concentrations of acetone (30%, 50%, 75%, 90% and 100%). 
After critical-point drying and platinum coating of the dried material, colonies were 
examined with a Zeiss DSM 962 scanning electron microscope.  
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Cultural characteristics of the strains such as mycelial morphology and production of 
diffusible pigments were observed on a number of standard International Streptomyces 
Project (ISP) agar media, namely: yeast-malt extract (ISP 2), oatmeal (ISP 3), inorganic 
salts-starch (ISP 4), glycerol-asparagine (ISP 5) and peptone-yeast extract-iron (ISP 6) 
and tyrosine (ISP 7) (Shirling and Gottlieb 1966). Growth requirement for seawater and 
salt tolerance were tested using various amounts of NaCl (0%, 2.5%, 5.0%, 7.5%, 10.0%, 
12.5% and 15.0%) as well as artificial seawater (25%, 50%, 75% and 100%) in 
appropriate media. Optimum temperature for growth was also determined by growing the 
strains in different temperature conditions (4, 10, 15, 20, 25, 30, 37, 45 and 55 °C). 
Sensitivity to different antibiotics (100 μg/ml) such as ampicillin, chloramphenicol, 
gentamicin, kanamycin, lincomycin, oxacillin, penicillin, rifampin, streptomycin, 
tetracycline and vancomycin was also determined by observing the growth as turbidity in 
liquid medium supplemented with the antibiotics after incubation at 30°C for 7-10 days. 
Oxygen requirement for growth was also determined by incubating the agar plates in an 
anaerobic jar. For phenotypic characterization, API kits (Biomerieux) and Biolog (Biolog 
Inc.) plates were used following manufacturer’s instructions.  API CH system and Biolog 
SF-P2 plates were used to evaluate the utilization of different carbon sources while 
enzymatic activities were detected using the API Zym kit.  The cells were harvested by 
aseptically scraping the spores and mycelial fragments on the agar media and suspended 
either in artificial seawater for use in the API kits or in 0.2% phytagel (Sigma) for Biolog 
SF-P2. Appropriate reagents supplied together with the kit were added to individual 
cupules following manufacturer’s instructions and positive reactions were noted. For the 
carbon utilization tests, a positive reaction was noted as turbidity on the cupules or wells 
after incubation at 30°C for 7-10 days. Furthermore, the ability to degrade 
macromolecules was determined as clearing zones around colonies growing on agar 
media containing adenine, casein, chitin, hypoxanthine and tyrosine (Korn-Wendisch et 
al. 1989).   
 
Diagnostic cell wall components, G+C content of the genomic DNA as well as DNA-DNA 
relatedness of the strains were determined and performed by the Deutsche Sammlung 
von Mikroorganismen und Zellkulturen (DSMZ). Established procedures were used to 
determine the diagnostic isomers of the diaminopimelic acid (A2pm) and the predominant 
sugars of the whole organism (Staneck and Roberts 1974). A quinone analysis was 
carried out as described by Kroppenstedt (1985).  The presence of mycolic acids was 
investigated following the procedure of Minnikin et al. (1975). The polar lipids were 
extracted and analyzed following the integrated procedure of Minnikin et al. (1984).  The 
composition of the fatty acid pattern was determined by gas chromatography using MIDI 
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software. The DNA base composition of genomic DNA was determined by HPLC 
(Tamaoka and Komagata 1984; Mesbah et al. 1989).   
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2.2 Results 
2.2.1 Strain description of new actinomycete species  
2.2.1.1 Saccharopolyspora cebuensis sp. strain SPE 10-1T (Pimentel-Elardo et al. 
2008b) 
 
Strain SPE 10-1T was isolated from the marine sponge Haliclona sp. (Fig. 2.1A) collected 
from Cebu, Philippines and was cultivated on M1 agar, a medium specifically designed 
for the selective isolation of marine actinomycetes (Mincer et al. 2002). 
 
 
 
 
Fig. 2.1 (A) marine sponge Haliclona sp. (underwater photography by J. Apurado,  
 University of San Carlos); (B) Strain SPE 10-1T colonies on M1 agar  
 
 
An almost complete 16S rDNA sequence (1483 nucleotides) was generated for the strain 
and compared to the validly described species of the genus Saccharopolyspora as its 
closest neighbors as well as representative genera from the family Pseudonocardiaceae 
(Fig. 2.2). Phylogenetic analysis revealed that the strain SPE 10-1T has highest sequence 
similarity (96%) with Saccharopolyspora gregorii and 93-95% similarity with all other 
species of the genus Saccharopolyspora.  
 
 
 
 
 
 
 
 
A B
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Saccharopolyspora taberi DSM 43856T
(EF030715) Saccharopolyspora cebuensis SPE 10-1T 
Saccharopolyspora gregorii NCIB 12823T 
Saccharopolyspora rectivirgula DSM 43747T 
Saccharomonospora viridis NCIB 9602T 
Pseudonocardia hydrocarbonoxydans IMSNU 22140T 
Saccharomonospora azurea SB-01T 
Pseudonocardia saturnea IMSNU 20052T 
Pseudonocardia autotrophica IMSNU 20050T 
Kibdelosporangium aridum DSM 43828T
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Amycolatopsis mediterranei NRRL B-3240T 
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Saccharopolyspora thermophila AS4.1511T 
Saccharopolyspora hirsuta subsp. hirsuta ATCC 27875T 
Saccharopolyspora flava AS4.1520T
(AF127526)
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Fig. 2.2 Neighbor-joining tree based on nearly complete 16S rDNA sequences of strain SPE 10-1T
and representative strains of the family Pseudonocardiaceae and related taxa. Escherichia coli
(DQ360844) was used as outgroup. Numbers at the nodes indicate the levels of bootstrap support 
based on 100 resampled data sets; only values greater than 50% are shown. The scale bar 
indicates 0.01 substitutions per nucleotide position. 
 
Saccharopolyspora spinosa DSM 44228T 
Saccharothrix longispora NRRL B-116116T 
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Strain SPE 10-1T exhibited morphological properties characteristic of Saccharopolyspora, 
forming extensively branched substrate mycelia which fragments into rod-shaped 
elements (Fig. 2.3A). Scanning electron microscopy showed hyphae bearing short chains 
of spores as well as single spore cells (Fig. 2.3B). The spores were round to oval and the 
surface was smooth. Light microscopy of colonies confirmed the presence of spores in 
aerial mycelia. 
 
 
 
Fig. 2.3 Hyphae and spores of strain SPE 10-1T grown in M1 broth (A) and on M1 agar (B) at 30°C 
for 7 days; (A), transmission electron microscopy, bar = 0.5 µm; (B), scanning electron 
microscopy, bar = 5 µm 
 
 
Furthermore, strain SPE 10-1T was able to grow in ISP medium 2 with ASW as well as in 
Zobell marine medium (Oppenheimer and Zobell 1952). Brown diffusible pigment was 
also observed. Growth was observed at temperatures from 15 to 37°C, with optimal 
growth at 25 to 30°C. Colonies displayed chalky-white mycelia with brownish soluble 
pigment on M1 agar. Cultures of the strain SPE 10-1T grown in M1 broth for 7-14 days 
appeared yellowish-brown to brown in color. Strain SPE 10-1T did not grow in ISP 
medium 2 without ASW. M1 media supplied with different amounts of ASW or NaCl were 
used to test for requirement for seawater and salt tolerance. Growth was possible in 
regular strength M1 (100% ASW) and in M1 containing 75, 50 and 25% but not 0% ASW. 
Growth was also possible when regular strength ASW was replaced with 12.5, 10, 7.5 or 
5% NaCl in distilled water. Growth was poor in M1 with 2.5% NaCl and growth was not 
observed without NaCl or with 15% NaCl. Furthermore, strain SPE 10-1T was able to 
grow in M1 liquid medium supplemented with antibiotics (100 μg/ml) gentamicin and 
kanamycin but not with rifampin, penicillin, streptomycin, lincomycin, vancomycin, 
oxacillin, chloramphenicol, ampicillin and tetracycline. No growth was observed on M1 
A B 
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agar plates incubated in an anaerobic jar. Using the API CH system, the strain was able 
to utilize a variety of organic compounds such as glycerol, erythritol, D-arabinose, L-
arabinose, D-ribose, D-xylose, D-adonitol, D-galactose, D-glucose, D-fructose, D-
mannose, L-rhamnose, N-acetylglucosamine, amygdalin, esculin, D-cellobiose, D-
maltose, D-lactose, D-saccharose, D-trehalose, inulin, D-raffinose, amidon, glycogen, 
gentibiose, D-fucose, D-arabitol, and potassium gluconate as sole carbon source. Using 
the API Zym system, the following enzymes were tested positive:  alkaline phosphatase, 
esterase (C4), esterase lipase (C8), lipase (C14), leucine arylamidase, valine 
arylamidase, acid phosphatase, naphthol-AS-B1-phosphohydrolase, α-glucosidase, N-
acetyl-β-glucosaminidase and α-mannosidase. The strain is able to degrade tyrosine but 
not adenine, casein, chitin and hypoxanthine. Furthermore, strain SPE 10-1T stained 
positive by Gram-staining and was positive for catalase following standard reaction to 
hydrogen peroxide. Strain SPE 10-1T tested negative for oxidase activity and for 
reduction of nitrate to nitrite. The organism can be distinguished from the other type 
strains of the validly described species of Saccharopolyspora by using a combination of 
phenotypic properties (Table 2.1). 
 
The strain contained meso-A2pm as the wall diamino acid, the diagnostic sugars 
arabinose and galactose were present but glucose and ribose were found in addition. A 
menaquinone with a tetra-hydrogenated-isoprenoid side chain of nine units MK-9 (H4) 
was the principal isoprenoid quinone. Small amounts of MK-8(H4) and MK-10(H4) were 
found in addition. Mycolic acids were not detected. The phospholipid pattern was 
composed of phosphatidyl-choline, phosphatidyl-ethanol amine, phosphatidyl-
methylethanolamine, diphosphatidyl-glycerol, phosphatidyl-glycerol and phosphatidyl-
inositol. Two unknown glycolipids were found in addition. The fatty acid pattern was 
mainly composed of terminally branched iso- and anteiso-fatty acids but small amounts of 
diagnostic 10-methyl-branched fatty acids were found in addition while 2-hydroxy fatty 
acids were missing. The DNA G+C content was 72.6 mol%. 
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Table 2.1 Selected physiological properties of S. cebuensis sp. nov. SPE 10-1T in 
comparison to validly described Saccharopolyspora type strains 
 
Strains: 1, S. cebuensis SPE 10-1T; 2, S. gregorii (DSM 44324T), 3, S. spinosporotrichia 
(DSM 44350T), 4, S. spinosa (DSM 44228T); 5, S. erythraea (DSM 40517T); 6, S. hirsuta 
(DSM 43463T); 7, S. hordei (DSM 44065T); 8, S. rectivirgula (DSM 43747T); 9, S. flava 
(AS4.1520T); 10, S. thermophila (AS4.1511T); 11, S. taberi (DSM 43856T).  Data for the 
reference strains other than S. cebuensis sp. nov. SPE 10-1T were taken from Lu et al. 
(2001) except for the data on hypoxanthine, G+C content and D-mannitol utilization which 
were taken from Goodfellow et al. (1989), Labeda (1987), Lacey & Goodfellow (Lacey 
and Goodfellow 1975), Mertz & Yao (1990) and Zhou et al. (1998).  Abbreviations: Bf, 
buff; Br, brown; C, colorless; G, grey; O, orange; P, pink; R, red; W, white; Y, yellow; +, 
positive; -, negative; n/a, no aerial mycelium; nd, not determined. All Saccharopolyspora 
strains were positive for utilization of D-fructose, glycerol and D-mannose as sole carbon 
source. 
 
a: The temperature data from Lu et al. (2001) on the type strains differ slightly from those of Korn-
Wendisch et al. (1989) who reported a temperature range of 20-50°C for S. hirsuta and 37-60°C 
for S. rectivirgula species. 
b: S. cebuensis SPE 10-1T is the only known isolate with a strict requirement for salt. 
c: Note that the ISP medium 2 was supplemented with ASW and that mycelia color may vary 
depending on media composition.  
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Characteristics Saccharopolyspora reference strains 
 1 2 3 4 5 6 7 8 9 10 11 
Carbon source utilization 
   L-Arabinose + + - + + - + - - - - 
   D-Galactose + + + - + + + + + + + 
   D-Lactose + - - - - + + + + + + 
   D-Maltose + + + - + + + + + + + 
   D-Mannitol - + + + + + + + + + + 
   D-Raffinose + + + - + + + + + + + 
   L-Rhamnose + + + - + + + + + + + 
   Sucrose + + + - + + + + + + + 
   D-Xylose + + + - + + + + + - + 
  
  
Temp. range (°C)     15-37 10-35 28-37 15-37 20-42 25-50a 20-60 37-63a 28-37 45-55 20-45 
Nitrate reduction - - - + + - - + + - + 
NaCl tolerance (%) 2.5-12.5b 13 <3 <11 <5 <7 <13 <10 7 7 7 
Degradation ability            
   Adenine - - - - + + + - + + + 
   Casein - + + - - + + - - - + 
   Chitin   - - - - + - + - - - + 
   Hypoxanthine - + + + + + + + + - + 
   Tyrosine + + - + + + + + - + + 
            
Color of            
   Aerial mycelia W c W-Y W-G W-P P-BrG-W W W-Y W-lightP W W n/a 
   Substrate mycelia W c C-Bf Br-R G-OY-Br OY-RBr C-Bf C-Bf Y-O Y C-Bf C-Y 
            
G+C content (mol %) 72.6 74.0 70.4 nd 71.1 71.5 72.0 70.4 67.0 73.1 70.8 
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 2.2.1.2 Streptomyces axinellae strain Pol001T (Pimentel-Elardo et al. 2008a) 
Strain Pol001T was isolated from the marine sponge Axinella polypoides (Fig. 2.4A) 
collected from Banyuls-sur-mer, France (Scheuermayer 2006). 
 
 
   
 
Fig. 2.4 (A) marine sponge Axinella polypoides (photography by M. Scheuermayer,                   
University of Würzburg); (B) Strain Pol001T colonies on ISP medium 2  
 
 
An almost complete 16S rDNA sequence (1422 nucleotides) was generated for the strain 
and compared to the validly described species of the genus Streptomyces as its closest 
neighbors. Phylogenetic analysis revealed that the strain Pol001T exhibits closest 
sequence similarities with the following: Streptomyces sclerotialus DSM 46032T (97.61%), 
Streptomyces rimosus subsp. rimosus DSM 40260T (97.47%), Streptomyces niger DSM 
43049T (97.20%) and Streptomyces olivaceiscleroticus DSM 40595T (97.20%). 
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Fig. 2.5 Neighbor-joining tree of strain Pol001T and representative species of the genus 
Streptomyces based on nearly complete 16S rDNA sequences.  Numbers at the nodes indicate 
the levels of bootstrap support based on 1000 resampled data sets. Only values greater than 50% 
are shown. Arrow points to outgroup, Salinispora tropica (AY040618). The scale bar indicates 0.01 
substitutions per nucleotide position. 
 
Streptomyces olivaceiscleroticus DSM 40595T (AJ621606) 
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Streptomyces kasugaensis NBRC 13851T (AB184530) 
Streptomyces axinellae Pol001T (EU683612) 
Streptomyces endus NBRC 12859T (AB249959) 
Streptomyces hygroscopicus NRRL 2387T  (AJ391820) 
Streptomyces violaceusniger NRRL B-1476T (AJ391822) 
Streptomyces antimycoticus NBRC 12839T  (AB184185) 
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Streptomyces lavendulae subsp. lavendulae NBRC 12789T (AB184146) 
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Strain Pol001T grew well on a variety of standard International Streptomyces Project (ISP) 
agar media after incubation at 30°C for 21 days: yeast-malt extract (ISP 2), oatmeal (ISP 
3) and peptone-yeast extract-iron (ISP 6). A diffusible pigment was observed only on 
tyrosine agar (ISP 7) (Table 2.2). Extensively branched grey aerial and white substrate 
mycelia were abundant on ISP 2 medium (Fig. 2.4B). At 21 days, the strain produced 
spiral chains of spores with a smooth surface, elliptical shape and 0.8-0.9 μm in length 
(Fig. 2.6A). Furthermore, transmission electron microscopy revealed non-fragmenting 
hyphae (Fig. 2.6B). Strain Pol001T was able to grow at 20-37°C, with optimum growth at 
30°C. Growth was possible in 0, 2.5, 5, 7.5 % NaCl but not in 10, 12.5, and 15 % NaCl, 
with optimal growth at 0-2.5 % NaCl. Growth was also possible in ISP 2 medium with 25, 
50, 75 and 100% ASW. Furthermore, strain Pol001T was able to grow in medium 
supplemented with the antibiotics (100 μg/ml) ampicillin, chloramphenicol, nalidixic acid, 
penicillin and rifampicin but not with erythromycin, gentamicin, kanamycin and 
vancomycin. 
 
Table 2.2 Cultural characteristics of strain Pol001T on various agar media 
Medium Growth Diffusible pigment 
Aerial 
mycelium 
Substrate 
mycelium 
Yeast-malt extract (ISP 2) Abundant None Grey White 
Oatmeal (ISP 3) Abundant None Dark Brown Light Green 
Inorganic salts-starch (ISP 4) Few None Yellow Orange White 
Glycerol-asparagine (ISP 5) Moderate None White Light Yellow 
Peptone-yeast extract-iron (ISP 6) Abundant None Light Pink White 
Tyrosine (ISP 7) Moderate Red  Light Pink Light Green 
Czapek Abundant None Grey to Black Light Green 
LB agar Abundant None White White 
A 
2 μm 
Fig. 2.6 (A) Scanning electron micrograph and (B) transmission electron micrograph of spores 
and hyphae of strain Pol001T grown in ISP 2 media
B
1 μm
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Physiological tests indicated that strain Pol001T is able to utilize a variety of organic 
compounds as carbon sources such as N-acetyl-β-D-mannosamine, N-acetyl-D-
glucosamine, N-acetyl-L-glutamic acid, L-alaninamide, L-alanine, L-alanyl-glycine, D-
arabitol, D-cellobiose, dextrin, D-fructose, D-galactose, gentiobiose, D-gluconic acid, α-D-
glucose, L-glutamic acid, glycerol, DL-α-glycerol phosphate, α-D-lactose, L-malic acid, D-
mannitol, D-mannose, propionic acid, L-rhamnose, D-ribose, L-serine, Tween 40, Tween 
80, D-xylose but not acetic acid, adenosine, adenosine-5’-monophosphate, D-alanine, 
amygdalin, L-arabinose, arbutin, L-asparagine, 2,3-butanediol, α-cyclodextrin, β-
cyclodextrin, 2’-deoxyadenosine, D-fructose-6-phosphate, L-fucose, D-galacturonic acid, 
α-D-glucose-1-phosphate, D-glucose-6-phosphate, glycogen, glycyl-L-glutamic acid, α-
hydroxybutyric acid, β-hydroxybutyric acid, γ-hydroxybutyric acid, p-hydroxy-phenylacetic 
acid, inosine, m-inositol, inulin, α-ketoglutaric acid, α-ketovaleric acid, lactamide, L-lactic 
acid, D-lactic acid methyl ester, lactulose, D-malic acid, maltose, maltotriose, mannan, D-
melezitose, D-melibiose, α-methyl-D-galactoside, β-methyl-D-galactoside, 3-methyl-D-
glucose, α-methyl-D-glucoside, β-methyl-D-glucoside, α-methyl-D-mannoside, palatinose, 
D-psicose, putrescine, L-pyroglutamic acid, pyruvic acid, pyruvic acid methyl ester, D-
raffinose, salicin, sedoheptulosan, L-serine, D-sorbitol, stachyose, succinamic acid, 
succinic acid, succinic acid mono-methyl ester, sucrose, D-tagatose, thymidine, 
thymidine-5’-monophosphate, D-trehalose, turanose, uridine, uridine-5’-monophosphate 
and xylitol. Furthermore, the strain is positive for gelatin liquefaction but negative for 
melanin production, starch hydrolysis, nitrate reduction and hydrogen sulfide production. 
It is capable of degrading casein, but not adenine, chitin or hypoxanthine. 
 
Levels of DNA-DNA relatedness between strain Pol001T and four closely related 
Streptomyces species were as follows (average of two values): 26.8% (S. sclerotialus 
DSM 46032T), 16.9% (S. olivaceiscleroticus DSM 40595T), 8.75% (S. niger DSM 43049T) 
and 8.65% (S. rimosus subsp. rimosus DSM 40260T). 
 
Strain Pol001T contained LL-diaminopimelic acid in the cell wall. Analysis of the whole-cell 
sugar composition revealed the presence of glucose and ribose as well as traces of 
mannose. A menaquinone with a hexahydrogenated-isoprenoid side chain of nine units 
MK-9 (H6) were found as the principal isoprenoid quinone. Two additional quinones with 
nine isoprene units [MK-9 (H4, H8)] were also found. Phospholipid pattern consisted of 
diphosphatidylglycerol, phosphatidylglycerol, phosphatidylethanolamine, 
phosphatidylinositol, some unidentified phospholipids, phosphoglycolipids, glycolipids and 
an aminolipid. Fatty acid pattern consisted of iso-C16:0 (30.78%), anteiso-C15:0 (17.77%), 
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iso-C15:0 (12.03%), anteiso-C17:0 (9.80%), iso-C16:1 (6.92%), iso-C14:0 (5.77%) and iso-C17:1 
(4.58%).  The DNA G+C content of strain Pol001T was 71.0 mol%.   
 
 
Table 2.3 Selected physiological properties that separate strain Pol001T from closely 
related Streptomyces species 
 
 
Strains: 1, Pol001T; 2, S. sclerotialus DSM 46032T; 3, S. rimosus subsp. rimosus DSM 
40260T; 4, S. niger DSM 43049T; 5, S. olivaceiscleroticus DSM 40595T. Color of 
mycelium, reverse side of colony, production of diffusible and melanoid pigments were 
compared using growth on ISP 2 medium. Smooth spore surface, absence of melanoid 
pigment and utilization of glucose and fructose as carbon sources were observed for all 
strains. Data for reference strains were taken from Shirling & Gottlieb (Shirling and 
Gottlieb 1968a; Shirling and Gottlieb 1968b; Shirling and Gottlieb 1972). 
 
 
Characteristic 1 2 3 4 5 
Spore-chain morphology SP  SP SP, RA SP SP 
Color of aerial mycelium GW LYR  R or W YG  BG 
Reverse-side of colony W YB GY DB GY 
Production of diffusible pigment - - - + + 
Utilization of       
     L-Arabinose - + + + + 
     Inositol - + + + + 
     Mannitol + + + + + 
     Raffinose - + + + + 
     Rhamnose + + - + + 
     Sucrose - + - + + 
     Xylose + + d + + 
 
Abbreviations: SP, Spirales; RA, Retinaculiaperti; G, grey; W, white; Y, yellow; R, red; B, brown;        
L, light; D, dark; +, positive; -, negative; d, doubtful. 
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2.2.2 Isolation of other actinomycete strains 
Nineteen additional strains cultivated from various marine sponges exhibiting typical 
actinomycete morphology (Fig. 2.7) were identified by 16S rDNA sequencing (Table 2.4). 
These strains were found to cluster together with known species of different actinomycete 
genera such as Streptomyces, Isoptericola, Micromonospora, Gordonia, Nocardiopsis 
and Saccharopolyspora (Fig. 2.8). Furthermore, the strains account to about 60% of the 
total number of isolates positively identified from the strain collection, the majority of 
which were originally cultivated from M1 and ISP 2 media after 2-3 weeks of incubation at 
30°C. 
 
 
Table 2.4 16S rDNA phylogenetic affiliation of actinomycete strains 
 
Isolate 
code 
16S rDNA closest relative                  
(% homology) 
Source sponge 
Aer003* Streptomyces bingchengensis 226541 (99.5) Aplysina aerophoba 
A188* Actinomycetales bacterium XJSS-18 (100.0) Aplysina aerophoba 
Cr03 Nocardiopsis sp. 20052 (99.7) Chondrosia reniformis 
Da02 Streptomyces sp. CNS-774_SD06 (99.9) Dysidea avara 
T02 Streptomyces sp. CNS-774_SD06 (99.9) Tethya sp. 
T03 Streptomyces sp. MP47-91 (99.7) Tethya sp. 
4-3 Micromonospora sp. HBUM84229 (99.7) unidentified sponge 
8-6 Saccharopolyspora gregorii (96.0) ♣ unidentified sponge 
9-1 Streptomyces sp. C12 (99.0) ♣ unidentified sponge 
9-3 Gordonia terrae AIST-1 (99.8) unidentified sponge 
10** Streptomyces albogriseolus NBRC 3709 (99.9) Aplysina aerophoba 
10-11  Nocardiopsis sp. M048 (97.0) ♣ unidentified sponge 
11** Streptomyces spinoverrucosus 174464 (99.8) Tedania sp. 
11-2 Streptomyces sp. 3194 (99.0) ♣ unidentified sponge 
11-11 Isoptericola sp. TUT1258 (98.3) unidentified sponge 
17** Streptomyces variabilis strain 173733 (99.9) Aplysina aerophoba 
22** Streptomyces sp. VTT E-042674 (100.0) Aplysina aerophoba 
27** Streptomycetaceae bacterium WBF21 (99.6) Aplysina aerophoba 
34** Streptomyces sp. VTT E-042674 (99.9) Axinella polypoides 
 
* Strains from previous study (Scheuermayer 2006). 
** Strains isolated by S. Kozitska (AG Hentschel, University of Würzburg). 
♣ Based on partial 16S rDNA sequences. 
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       Fig. 2.7 Various colony morphologies of actinomycete strains grown on M1    
and ISP 2 media at 30°C for 7-14 days 
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Streptomyces sp. A446Ydz-DS (EU257265)
Actinomycetales bacterium XJSS-18  (EU598254)
Aplysina aerophoba isolate A188
Streptomyces griseoincarnatus NBRC 12871 (AB184207) 
Streptomyces vinaceus NBRC 3406 (AB184763)
Aplysina aerophoba isolate 10
Streptomyces thermoluteus NBRC 14269 (AB184581)
Streptomyces albogriseolus NBRC 3709 (AB184780)
Streptomyces sp. MP47-91 (EU263063)
Streptomyces sp. S240 (EU443837) 
Streptomyces flavofungini  (EF571003)
Tethya sp. isolate T03
Streptomyces champavatii 173753 (EU570715)
Tedania sp. isolate 11
Streptomyces spinoverrucosus 174464 (EU593714) 
Aplysina aerophoba isolate 17
Streptomyces variabilis 173733 (EU570717) 
Streptomyces sp. H7 (EF675608)
Aplysina aerophoba isolate 27 
Streptomycetaceae bacterium WBF21 (EU099411)
Streptomyces sp. CNR926 PL04 (DQ448729)
Dysidea avara isolate Da02
Tethya sp. isolate T02
Streptomyces sp. CNS-774_SD06 (EU214979)
Streptomyces sp. Fiji-204 (DQ013368)
Streptomyces sp. CNQ-624_SD01 (EU214920) 
Axinella polypoides isolate 34
Streptomyces anulatus NBRC 15393 (AB184644)
Streptomyces flavolimosus CGMCC 2027 (EF688620)
Streptomyces sp. VTT E-042674 (EF093122)
Streptomyces cavourensis NRRL B-8030 (DQ026671) 
Aplysina aerophoba isolate 22
Aplysina aerophoba isolate Aer003
Streptomyces sp. 1A01505 (EF012091)
Streptomyces aldersoniae NRRL 18513 (EU170123)
Streptomyces bingchengensis 226541 (DQ449953)
Isoptericola sp. TUT1258  (AB188225)
Isoptericola halotolerans YIM 70177 (AY789835) 
Sponge isolate 11-11
Isoptericola variabilis strain c95 (AB167235)
Isoptericola hypogeus HKI 0342T (AJ854061) 
Isoptericola dokdonensis DS-3 (DQ387860)
Micromonospora sp. CNQ-420_SD01 (EU214913) 
Micromonospora globosa DSM 43170 (X92600) 
Micromonospora sp. HBUM84229 (EU119232) 
Micromonospora aurantiaca W2b (AJ245712) 
Micromonospora marina JSM3-1 (AB196714) 
Sponge isolate 4-3
Gordonia terrae AIST-1 (AB355992)
Sponge isolate 9-3
Gordonia sp. CNJ752 PL04 (DQ448702)
Gordonia namibiensis NAM-BN063B (AF380931) 
Gordonia rubripertinctus DSM43197T (X80632) 
Gordonia desulfuricans 213E (AF101416) 
Nocardiopsis sp. 20052 (AY336517) 
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Fig. 2.8 Neighbor-joining tree based on nearly complete 16S rDNA sequences (>1400 bp) of the 
different sponge isolates. Escherichia coli (DQ360844) was used as outgroup. Numbers at the 
nodes indicate the levels of bootstrap support based on 100 resampled data sets; only values 
greater than 50% are shown. The scale bar indicates 0.01 substitutions per nucleotide position. 
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2.3 Discussion 
The order Actinomycetales is composed of approximately 80 genera, mostly from 
terrestrial soils (Magarvey et al. 2004). The order encompasses bacteria that are diverse 
with respect to morphology and biochemistry as well as having G+C-rich DNA. Members 
of this taxon are of significant interest primarily because these bacteria have consistently 
produced a considerable amount of bioactive metabolites of pharmacological and 
biomedical importance such as the antibiotics, erythromycin and streptomycin. As the 
search for producers of novel compounds continues, the rate of finding the same 
compounds from existing terrestrial actinomycete genera has increased (Kelecom 2002; 
Fenical and Jensen 2006) while the chance of finding new bioactive molecules from 
screening of large actinomycete libraries has decreased (Busti et al. 2006). Hence, efforts 
are now directed at exploiting new potential sources such as the marine environment. A 
number of reports have been published describing the isolation of novel actinomycete 
genera from marine sediments and invertebrates and these actinomycetes have been 
found to exhibit diverse biological activities, suggesting that the marine environment is an 
interesting source for bioprospecting (Fiedler et al. 2005; Jensen et al. 2005a; Jensen et 
al. 2005b; Kim et al. 2005; Montalvo et al. 2005; Fenical and Jensen 2006; Lam 2006). 
 
The aim of this Ph.D. study was to isolate novel actinomycete taxa from marine sponges 
using selective isolation procedures and polyphasic characterization of selected strains.  
The ability to order prokaryotic taxa hierarchically has been improved by high quality 16S 
rDNA sequence analyses (Stackebrandt et al. 2002).  The use of 16S rRNA gene 
sequences to study bacterial phylogeny and taxonomy has been by far the most common 
housekeeping genetic marker. It has been demonstrated that 16S rRNA gene sequence 
data on an individual strain with a nearest neighbor exhibiting a similarity score of <97% 
represents a new species (Janda and Abbott 2007). Based on 16S rDNA phylogenetic 
analysis of all the isolated strains in this study, it was found that 2 out of the 19 identified 
strains are new actinomycete species belonging to the genera Saccharopolyspora and 
Streptomyces.  
 
Strain SPE 10-1T isolated from the sponge Haliclona sp. was the first strain identified by 
16S rDNA sequencing belonging to the genus Saccharopolyspora.  This genus was first 
described by Lacey & Goodfellow from sugar-cane bagasse (1975) and at present 
comprises ten validly described species: Saccharopolyspora hirsuta (Korn-Wendisch et 
al. 1989), Saccharopolyspora erythraea (Labeda 1987), Saccharopolyspora taberi (Korn-
Wendisch et al. 1989), Saccharopolyspora gregorii (Goodfellow et al. 1989), 
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Saccharopolyspora hordei (Goodfellow et al. 1989), Saccharopolyspora rectivirgula 
(Korn-Wendisch et al. 1989), Saccharopolyspora spinosa (Mertz and Yao 1990), 
Saccharopolyspora spinosporotichia (Zhou et al. 1998), Saccharopolyspora flava (Lu et 
al. 2001) and Saccharopolyspora thermophila (Lu et al. 2001). Members of this genus are 
aerobic, Gram-positive, non-acid fast organisms with substrate hyphae that either 
fragments into rod-shaped elements, do not fragment or are transformed partially into 
chains of spores (Korn-Wendisch et al. 1989). They lack mycolic acid but contain meso-
diaminopimelic acid, arabinose and galactose in the cell wall and predominant amounts of 
tetra-hydrogenated menaquinones with nine isoprene units.  DNA base composition falls 
within the range of 67-74 mol% G+C for the type strains (Embley et al. 1987; Goodfellow 
et al. 1989; Korn-Wendisch et al. 1989). Strain SPE10-1T exhibited morphological and 
biochemical characteristics consistent with members of the genus Saccharopolyspora but 
can be distinguished from the other type strains of this genus based on a combination of 
phenotypic properties. The low 16S rDNA sequence similarities of the strain with validly 
described species of Saccharopolyspora further suggest that the strain constitutes a 
novel species of this genus. Interestingly, the strain is only able to grow in medium with 
sodium chloride or ASW indicating a strict requirement for salt and hence, suggests that it 
is an obligate marine bacterium. Taken together, the phenotypic and genotypic data 
obtained in this study clearly show that strain SPE 10-1T represents a novel and obligate 
marine species within the genus Saccharopolyspora. Thus, this type strain was assigned 
the species name as S. cebuensis (se.bu.en’sis N.L. fem. adj. cebuensis) pertaining to 
the province of Cebu in the Philippines, where the type strain was collected. It has been 
recently considered as a validly described species by the International Journal of 
Systematic and Evolutionary Microbiology (Pimentel-Elardo et al. 2008b) and is deposited 
at two public culture collections (=DSM 45019T, =CIP 109355T). It is also interesting that a 
similar strain 8-6 cultivated in this Ph.D. study from another sponge sample but from the 
same collection site also exhibited high sequence similarity (based on partial 16S rDNA 
sequence) with S. gregorii (96.0%), the closest relative of S. cebuensis suggesting that 
SPE 10-1 and 8-6 could possibly be the same strains. However, complete 16S rDNA 
sequencing and phenotypic characterization of the strain 8-6 must be done in order to 
confirm whether the same strain has been in fact, re-isolated from different sponge 
species.  
 
The second strain Pol001T isolated from the sponge Axinella polypoides was found by 
16S rDNA sequencing to belong to the genus Streptomyces. The genus Streptomyces 
was first proposed by Waksman and Henrici (1943) for aerobic, spore-forming 
actinomycetes. These Gram-positive bacteria have distinct features such as extensive 
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branching substrate and aerial mycelium, high DNA G+C content (69-78 mol %), 
presence of LL -diaminopimelic acid and the absence of characteristic sugars in the cell 
wall (Anderson and Wellington 2001). The strain Pol001T exhibited morphological, 
biochemical and chemotaxonomic characteristics consistent with the genus 
Streptomyces. There are currently more than 500 validly described species and 
subspecies under Streptomyces, making this genus to contain the largest number of 
species in the Bacteria domain (Hain et al. 1997). It is not surprising therefore that the 
16S rDNA sequence similarity of the strain Pol001T against reference Streptomyces 
strains was slightly above the 97% cut-off for species delineation (highest similarity value 
of 97.6%) considering the complexity of Streptomyces taxonomy. The 16S rDNA 
sequence similarity values still suggest that the strain Pol001T can be considered a new 
Streptomyces taxon and this is also supported by the distinct phyletic line formed by the 
strain as seen in the neighbor-joining tree shown in Fig. 2.5. To further support this claim, 
DNA-DNA hybridization was carried out against the four reference Streptomyces strains 
with which strain Pol001T exhibited the highest sequence similarities. The hypothesis for 
the species concept in the genus Streptomyces is that strains of the same species have 
DNA relatedness >70% (with a ∆Tm of <5°C) (Wayne et al. 1987; Labeda 1992; Anderson 
and Wellington 2001). Remarkably, the strain Pol001T showed very low DNA-DNA 
relatedness values (highest value at 26.8%), hence further confirming that the strain is 
indeed a novel taxon of the genus Streptomyces. Thus, the type strain was assigned the 
species name Streptomyces axinellae (a.xi.nel’la.e. N.L. gen. n. axinellae) pertaining to 
the marine sponge Axinella polypoides, from which the strain was originally isolated. The 
strain has likewise been recently considered as a validly described species by the 
International Journal of Systematic and Evolutionary Microbiology (Pimentel-Elardo et al. 
2008a) and is currently deposited in two internationally recognized culture collections (= 
DSM 41948T, = CIP 109838T). 
 
The remainder of the strains isolated from various marine sponges were found by 16S 
rDNA sequencing belonging to different actinomycete genera and exhibiting sequence 
similarities between 98-100% with known species, with the majority belonging to the 
genus Streptomyces. This is not surprising since Streptomyces bacteria are easy to 
cultivate and in fact, generally dominate several strain collections (Fiedler et al. 2005; 
Maldonado et al. 2005; Busti et al. 2006; Bredholdt et al. 2007). Several studies have also 
shown that diverse actinomycetes are associated with marine sponges using cultivation-
dependent and cultivation-independent approaches (Webster and Hill 2001; Webster et 
al. 2001; Hentschel et al. 2002; Kim et al. 2005; Montalvo et al. 2005; Zhang et al. 2006; 
Jiang et al. 2007; Xin et al. 2008). Interestingly, some representatives of the class 
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Actinobacteria have been found belonging to monophyletic, sponge-specific sequence 
clusters using 16S rRNA gene-based techniques (Hentschel et al. 2002). However, none 
of the strains cultivated in this Ph.D. study overlapped with the sponge-specific 
actinobacterial clusters. These results suggest that the strains are transient bacteria that 
have been taken up by the host sponge through its aquiferous canal at the time that the 
sponge samples were collected. It is also highly likely that these isolates are present in 
the surrounding seawater or sediments since the majority of the strains isolated in this 
study showed very high sequence similarities with those previously derived from marine 
sediments. For example, isolates Da02 and T02 cultivated from two different 
Mediterranean sponges Dysidea avara and Tethya sp., respectively showed 100% 16S 
rDNA sequence similarity against each other suggesting that these are the same strains 
and nearly identical sequences (99.9%) with Streptomyces sp. strain CNS-774_SD_06, 
previously isolated from the marine sediment off the coast of California. Remarkably, 
several studies have also shown that marine actinomycetes are in fact, abundant in 
various ocean sediments (Zobell and Upham 1944; Grein and Meyers 1958; Mincer et al. 
2002; Fiedler et al. 2005; Jensen et al. 2005a; Maldonado et al. 2005; Fenical and 
Jensen 2006; Pathom-Aree et al. 2006; Bredholdt et al. 2007).  
 
Thus, the results provided here illustrate further that indeed diverse genera, including 
taxonomically novel actinomycetes are associated with marine sponges. However, the 
type of association of actinomycetes with marine sponges and their functions were not 
the main aims of this Ph.D. study but rather, their potential to produce bioactive 
secondary metabolites which shall be discussed in the succeeding chapters. 
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Chapter 3 
Secondary metabolites from sponge-associated actinomycetes 
 
3.1 Materials and methods 
3.1.1 Preliminary bioactivity testing by disk diffusion  
The cultivated actinomycete strains were initially screened for bioactivity using a disk 
diffusion assay against the following test organisms: Staphylococcus epidermidis RP62A, 
Staphylococcus aureus NCTC 8325, Pseudomonas aeruginosa, Enterococcus faecalis 
JH212, Escherichia coli 536 and Candida albicans. Strains were grown in M1 culture 
broths (50 ml) as well as on agar plates (10 plates each) at 30°C for 7-14 days depending 
on the growth period of the strains.  An equal volume of methanol was added to the liquid 
cultures to effectively lyse the cells and release intracellular metabolites. A volume of 
300μl was impregnated on sterile 13-mm disks and the disks were air-dried.  Previously 
prepared LB (for bacteria) and YPD (for C. albicans) plates were uniformly inoculated with 
a lawn of the test bacterial strains on the agar surface. The disks were then pressed 
lightly on the agar surface in equidistant positions and incubated at 37°C overnight. 
Zones of inhibition were noted by measuring the diameter (in mm) of the clearing zones 
around the disks. As for the strains grown on agar plates, the colonies growing on the 
agar surface together with the rest of the solid media were cut into small pieces and these 
were macerated separately in methanol and ethyl acetate overnight. The resulting 
extracts were filtered and then dried using a rotary evaporator (Heidolph, Germany), 
weighed and re-dissolved in their original extracting solvent to make a 20 mg/ml stock 
solution. A volume of 300μl was impregnated on sterile disks and the same process of 
disk diffusion assay described previously was followed. 
 
3.1.2 Bioassay-guided isolation and purification 
Strains that were found to produce bioactive metabolites from the preliminary 
antimicrobial assays were cultured on large scale (2-5 L) using the same media, growth 
conditions and cell lysis with methanol. Ethyl acetate was used as the extracting solvent 
and the resulting extracts were dried in vacuo using a rotary evaporator (Heidolph, 
Germany). The crude extracts were subjected to pre-fractionation with Diaion HP-20ss 
resin (Mitsubishi Chemical Corporation, Japan) using the following eluents: water (FW); 
25% isopropanol: 75% water (F1); 50% isopropanol: 50% water (F2); 75% isopropanol: 
25% water (F3); 100% methanol (F4), yielding five fractions with 15 ml each. These 
fractions were completely dried using a Savant speedvac concentrator (Thermo Scientific, 
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USA), re-dissolved and subjected to the disk diffusion assay at a dose of 200 μg/6-mm 
disk.  HPLC analysis was performed on an Agilent 1100 series chromatography system 
(Agilent Technologies, USA) with a photodiode array detector to purify the active 
fractions. To determine the proper solvent gradient for purifying the fractions, analytical 
HPLC (Phenomenex Luna Analytical RP18e 4.6 x 250 mm) was first performed using 
H2O (A) and CH3OH (B) as the solvents and the following gradient: flow 1.0 ml/min; 0-5 
min 10% B, 35-40 min 100% B.  The solvent gradient was adjusted accordingly for 
improved resolution as well as separation of the peaks and the fractions were purified 
using semi-preparative HPLC (Phenomenex Luna SemiPrep RP18e 10 x 250 mm). 
 
For Saccharopolyspora cebuensis strain SPE 10-1, 100 µl of the glycerol stock was 
inoculated in 3 x 100 ml of ISP 2 medium, incubated with shaking at 180 rpm at 30˚C for 
five days. An aliquot of 50 ml of the inoculum was transferred to 6 x 750 ml of fresh ISP 2 
medium and the cultures were incubated further under the same conditions for 7 days. 
After incubation, methanol was added to each culture (1:2) with shaking at 20°C 
overnight.  The resulting mixtures were filtered and twice extracted with half-volume of 
ethyl acetate. The ethyl acetate layers were separated and dried by rotary evaporation. 
The same procedure was repeated for Streptomyces sp. strain A188 except that the 
strain was grown in 1.8 L of M1 medium. 
 
The following Streptomyces sp. strains 11, 22, 34 and T03 were grown on 100 M1 agar 
plates and incubated at 30°C for seven days.  Mycelial mass together with the agar were 
cut into small pieces and macerated overnight with sufficient volume of ethyl acetate.  
The resulting solution was filtered and maceration with ethyl acetate was repeated. Both 
filtrates were combined and subsequently dried. The same procedure was done for 
Streptomyces axinellae strain Pol001, except that the strain was grown on MS (Hobbs et 
al. 1989) agar. 
 
3.1.3 Structure elucidation of compounds 
1H, 13C, HMBC, HSQC and COSY NMR spectra were recorded on a Varian Inova 500 or 
600 MHz and Avance 400 MHz spectrometers. Accurate mass measurements were 
conducted on a Micromass Q-Tof Micro and microTOF mass spectrometers. 
 
3.1.4 Anti-infective profiling of compounds 
Pure compounds were dissolved in DMSO at 20mM concentration and were subjected to 
an anti-infective panel against bacteria (Staphylococcus aureus NCTC 8325, 
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Staphylococcus epidermidis RP62A, Enterococcus faecalis JH212, Enterococcus faecium 
6413, Escherichia coli 536, Pseudomonas aeruginosa, Yersinia pseudotuberculosis 252 
01A and Yersinia pestis KUMA), fungi (Candida albicans) and parasites (Trypanosoma 
brucei brucei 221, Leishmania major). Cytotoxity testing against J774.1 macrophages and 
293T kidney epithelial cells was also done. Furthermore, inhibitions of selected proteases 
such as SARS-PLPRO SARS-Coronavirus papain-like protease, SARS-MPRO SARS-
Coronavirus main protease, cathepsin B and L mammalian, rhodesain Trypanosoma 
brucei rhodesiense and falcipain-2 Plasmodium falciparum were tested. The anti-
parasitic, cytotoxicity assays and protease inhibition tests as were performed by the SFB 
630 collaboration partners: TP Z1 (T. Ölschläger and H. Bruhn, U. Würzburg) and TP A4 
(T. Schirmeister, U. Würzburg), respectively. 
 
3.1.4.1 Antimicrobial assays 
Antibacterial assay 
Bacterial (Staphylococcus aureus NCTC 8325, Staphylococcus epidermidis RP62A, 
Enterococcus faecalis JH212, Enterococcus faecium 6413, Escherichia coli 536, 
Pseudomonas aeruginosa, Yersinia pseudotuberculosis 252 01A and Yersinia pestis 
KUMA) strains were cultivated overnight at 37°C (30°C for Yersinia sp.) in LB medium in 
a shaking incubator. On the next day, the culture was diluted 1:100 in Müller-Hinton broth 
(23 g per liter; Fluka) and again cultivated until the cells reached the exponential growth 
phase. Approximately, 1 x 105 cells/ml were incubated with various concentrations of the 
compounds to make a final volume of 200 µl in a 96-well plate at 37°C for 18 h (at 30°C 
for 48 h for Yersinia sp.). The final concentration of DMSO was 0.8% in each well. After 
incubation, the optical density of the cultures was determined at 550 nm wavelength 
using an ELISA microplate reader with respect to the control without bacteria or fungi. 
The lowest concentration of the compound where no bacterial or fungal growth is 
detectable was determined as the minimal inhibitory concentration (MIC). 
 
Antifungal assay 
A colony of Candida albicans 5314 (ATCC 90028) was resuspended in 2 ml of 0.9% 
NaCl. Four microliters of this suspension was added to 2 ml of HR medium. This medium 
was prepared by adding 14.67 g HR Medium in 450 ml H2O, followed by the addition of 
1.0 g NaHCO3 in 50 ml H2O and subsequent incorporation of the following solutions: 420 
ml of sodium phosphate (35.60 g Na2HPO4.2H2O per liter) and 80 ml of potassium 
dihydrogen phosphate (27.22 g  KH2PO4 per liter, pH 7.2). The test compounds were 
diluted in various concentrations in 100 μl of medium in a 96-well microplate with final 
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DMSO concentration of 0.4%. One hundred microliters of the Candida suspension was 
added to each well followed by incubation at 37°C for 48 h. Optical density was measured 
at 530 nm with respect to a control well without cells. The minimal concentration of the 
compound where no growth is detectable was considered as the MIC value. 
 
3.1.4.2 Anti-parasitic assays 
Anti-Leishmania assay 
Leishmania major promastigotes were seeded at a cell density of 1 x 107 cells/ml into 96-
well plates in complete medium (RPMI with NaHCO3, 10% FCS, 2mM glutamine, 10 mM 
Hepes pH 7.2, 100 U/ml penicillin, 50 μg/ml gentamicin, 50 μM 2-mercaptoethanol) 
without phenol red (200 μl), in the absence or presence of different concentrations of the 
compounds. These were then incubated for 24 h at 26°C, 5% CO2 and 95% humidity. 
Following the addition of 20 μl of Alamar Blue, the plates were incubated again and the 
optical densities (ODs) measured 24 and 48 h later with an enzyme-linked 
immunosorbent assay (ELISA) reader (Multiskan Ascent, Germany) using a test 
wavelength of 540 nm and a reference wavelength of 630 nm. Absorbance in the 
absence of compounds was set as 100% of growth. Amphotericin B was used as a 
reference compound and positive control. The effects of cell density, incubation time and 
the concentration of DMSO were examined in control experiments. The final 
concentration of DMSO in the medium never exceeded 1% vol/vol and had no effect on 
the proliferation of extracellular or intracellular parasites. For each experiment, each drug 
concentration was assayed in duplicate wells (Ponte-Sucre et al. 2006).  
 
Anti-Trypanosoma assay 
Trypomastigote forms of Trypanosoma brucei brucei laboratory strain TC 221 were 
cultured in complete Baltz medium [80 ml Baltz medium basic solution, 0.8 ml 2 
mercaptoethanol stock solution (20 mM), 0.8 ml penicillin/streptomycin (10,000 U/ml), 16 
ml FCS (inactivated for 30 min at 56°C). Baltz medium basic solution is composed of the 
following: 500 ml MEM with Earle’s salts and L-glutamine, 3 g Hepes, 0.5 g monohydrate 
glucose, 0.110 g sodium pyruvate, 0.007 g hypoxanthine, 0.002 g thymidine, 0.0107 g 
adenosine, 0.0141 g bathocuproine disulfonic acid disodium salt, 0.146 g glutamine, 5 ml 
sterile non-essential amino acid concentrate (100x, pH 7.5) (Baltz et al. 1985). A defined 
number of parasites (104 trypanosomes per ml) were exposed in test chambers of 96-well 
plates to various concentrations of the test substances (previously dissolved in DMSO) to 
make a final volume of 200 µl in duplicates. Positive (trypanosomes in culture medium) 
and negative controls (test substance without trypanosomes) were run simultaneously 
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with each plate. The plates were then incubated at 37°C in an atmosphere of 5% CO2 for 
a total time period of 72 h. After 24 h, 20 µl of Alamar Blue was added. The activity of the 
test substances was measured by light absorption using MR 700 Microplate Reader at a 
wavelength of 550 nm with a reference wavelength of 630 nm. The first reading was done 
at 48 h and subsequently at 72 h. The effect of the test substances was quantified in IC50 
values by linear interpolation of three independent measurements (Huber and Koella 
1993; Raz et al. 1997). 
 
3.1.4.3 Cytotoxicity assays 
J774.1 macrophages were cultured in complete medium (RPMI with NaHCO3, 10% FCS, 
2mM glutamine, 10 mM Hepes pH 7.2, 100 U/ml penicillin, 50 μg/ml gentamicin, 50 μM 2-
mercaptoethanol) without phenol red in the absence or presence of increasing 
concentrations of the compounds at a cell density of 1 x 105 cells/ ml (200 µl) for 24 h at 
37°C, 5% CO2 and 95% humidity. Following the addition of 20 μl of Alamar Blue, the 
plates were incubated and the ODs measured at 24, 48 and 72 h. The same Alamar blue 
assay previously described for Leishmania was followed. Kidney epithelial 293T cells 
were also tested in the same manner as the macrophages but using complete DMEM 
medium (4.5 g/l solution of DMEM high glucose solution with sodium pyruvate but without 
L-glutamine, FBS superior at final concentration of 20%, 200mM L-glutamine 100x) and 
cell density (2 x 104 cells/ ml).  
 
3.1.4.4 Protease inhibition assays  
SARS Mpro and Plpro protease inhibition assay 
The fluorometric enzyme assays were performed on a Cary Eclipse fluorescence 
spectrophotometer (Varian, Darmstadt, Germany) using a microplate reader (excitation 
325 nm, emission 425 nm). For the inhibition assays, 96-well microplates (Nunc GmbH, 
Wiesbaden, Germany) were used. Assays were performed at 25°C in a 20 mM Tris-HCl 
buffer pH 7.5, containing 0.1 mM EDTA, 1 mM DTT, 200 mM NaCl, and 12.5% DMSO 
(final concentration) in a total volume of 200 μl. The final substrate (H2N-Abz-Ser-Val-Thr-
Leu-Gln-Ser-Gly-(NO2)Tyr-Arg-(MTS)-TFA-salt for Mpro and Z-Arg-Leu-Arg-Gly-Gly-AMC-
acetate salt for Plpro) concentration for inhibition assays was 50 μM, and the final enzyme 
concentration was 4.25 μg/mL. Inhibitors were used at 100 μM final concentration for 
preliminary screening. For determination of Km values, the substrate was used in 
concentrations between 50 and 300 μM. Values were corrected for the inner filter effect. 
Fluorescence increase was measured over a period of 10 min for Km determination and 
20 min for inhibition assays. Substrate and inhibitor stock solutions were prepared in 
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DMSO and were diluted with assay buffer, and the enzyme was dissolved in buffer. The 
Km value was calculated by nonlinear regression analyses using the program GraFit. All 
values were mean values from at least three independent assays (Kaeppler et al. 2005). 
 
Cathepsin L and B protease inhibition assay 
Assays were performed at 25°C in a 20 mM Tris-HCl buffer pH 6.0, containing 5 mm 
EDTA, 2.5 mm DTT, 200 mm NaCl, 0.005% Brij 35 in a total volume of 285 mL. Substrate 
(Cbz-Phe-Arg-AMC for both enzymes) and inhibitor stock solutions were prepared in 
DMSO (10% final concentration) and were diluted with assay buffer. The final substrate 
concentration for the inhibition assays was between 10.0 and 81.0 mm. The final enzyme 
concentration was 53 ng/mL for cathepsin L (P. tetraurelia) and 58 pg/mL for cathepsin B 
(recombinant, human liver) (Vicik et al. 2006a). Inhibitors were tested at 100 µM (final 
concentration). The fluorometric enzyme assays were performed on a Cary Eclipse 
fluorescence spectrophotometer (Varian, Darmstadt, Germany) using a microplate reader 
(excitation 365 nm, emission 460 nm). 
 
Rhodesain protease inhibition assay 
For inhibition of rhodesain, 96-well microplates were used. Assays were performed at 
25°C in 50 mM acetate, pH 5.5, containing 5 mM EDTA, 5 mM DTT, 200 mM NaCl, and 
0.005% Brij 35 in a total volume of 285 µL. Substrate (Cbz-Phe-Arg-AMC) and inhibitor 
stock solutions were prepared in DMSO (10% final concentration) and diluted with the 
assay buffer. The final substrate concentrations used in the inhibition assays ranged from 
12.4 to 81.0 µM and the final enzyme concentration was 41 nM. Inhibitors were used at a 
concentration of 100 µM (Vicik et al. 2006b). The fluorometric enzyme assay was 
performed in a Cary Eclipse fluorescence spectrophotometer (Varian, Darmstadt, 
Germany) using a microplate reader (excitation 365 nm, emission 460 nm). 
 
Falcipain protease inhibition assay 
The enzyme assay with the cysteine protease Cbz-Phe-Arg-AMC (falcipain-2, 50 μm) as 
substrate was performed. The enzyme was incubated with 100 µM concentration of the 
compounds for 0, 15 or 30 min prior to substrate addition. Inhibitor solutions were 
prepared from stocks in DMSO. Each assay was performed in 96-well plates in a total 
volume of 120 or 300 μl (n = 2-6 independent assays) with standard deviations of <10%. 
The following buffer was used: 100 mM acetate, pH 5.5, 10 mM DTT. The Cary Eclipse 
fluorescence spectrophotometer (Varian, Darmstadt, Germany) with a microplate reader 
(excitation 365 nm, emission 460 nm) was used to measure fluorescence. 
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3.2 Results 
3.2.1 Isolation and characterization of metabolites from actinomycete strains 
3.2.1.1 Novel macrolactam polyketides from Saccharopolyspora cebuensis strain 
SPE 10-1T 
 
The crude extract obtained from solvent partitioning with ethyl acetate was purified by 
preparative HPLC (Merck Chromolith SemiPrep RP18e 10 x 100 mm) using H2O + 0.05% 
TFA (A) and CH3CN + 0.05% TFA (B) as the solvents and the following gradient: flow 10 
ml/min; 0 min 75% B, 10 min 75% B. Two novel, constitutionally identical macrolactams 
(Fig. 3.1) named as cebulactam A1 (5.1 mg; Rt = 2.5 min) and cebulactam A2 (4.1 mg; Rt 
= 4.3 min) were identified. Their constitutionally identical structures, each bearing a 6-
membered cyclic ether as part of the macrocycle and their relative configurations were 
elucidated by MS methods and by 1D and 2D NMR techniques (Tables 3.1 and 3.2). 
HPLC-ESI-MS analysis revealed the molecular masses of both compounds to be identical 
(m/z 346.3 for [M+H]+), suggesting the two compounds to be structurally highly similar to 
each other. These assumptions were further corroborated by HR-ESIMS (TOF) 
measurements which clearly showed an identical molecular formula of C19H23NNaO5 (m/z 
368.1478 for [M+Na]+, calculated 368.1468) for cebulactams A1 and A2 (Gulder 2008; 
Pimentel-Elardo et al. 2008). The relative configurations of the stereocenters of 
cabulactams A1 and A2 were elucidated by NOESY NMR spectroscopy. This work was 
done in collaboration with T.A.M. Gulder (AG Bringmann, Institute of Organic Chemistry, 
University of Würzburg). The absolute configurations of both compounds have yet to be 
elucidated. 
 
 
 
 
 
 
 
    
                        
Figure 3.1 Cebulactam A1 (A) and cebulactam A2 (B) polyketides isolated from strain SPE 10-1T 
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Table 3.1 NMR spectroscopic data of cebulactam A1 acetone-d6  
(1H: 400 MHz; 13C: 100 MHz)*  
Position δC δH, mult (J in Hz) COSY HMBC 
1 70.9 4.38, d (10.1) 2 2, 2-CH3, 3, 11, 12, 13 
2 42.4 1.82, m 2-CH3, 1, 3 1, 2-CH3, 3, 12 
2-CH3 16.7 1.19, d (6.6) 2 1, 2, 3 
3 87.4 4.27, d (8.5) 2 2, 2-CH3, 4, 4-CH3, 5, 11 
4 140.5    
4-CH3 19.3 1.86, s 5 3, 4, 5, 6-CH3, 7 
5 124.7 4.98, d (9.8) 4-CH3, 6 3, 4-CH3, 6, 7 
6 46.2 3.19, m 6-CH3, 5 4, 5, 6-CH3, 6, 7 
6-CH3 17.8 1.00, d (6.3) 6 5, 6, 7 
7 207.1    
8 48.2 3.43, q (6.8) 8-CH3 7, 8-CH3, 9 
8-CH3 16.6 1.21, d (6.8) 8 7, 8, 9 
9 173.9    
10 131.0    
11 142.7    
12 140.9    
13 111.1 7.02, d (2.8)  1, 11, 14, 15 
14 154.4    
15 114.0 6.65, d (2.8)  10, 11, 13, 14 
NH  7.88, br   
*(Gulder 2008; Pimentel-Elardo et al. 2008) 
 
 
 
Table 3.2 NMR spectroscopic data of cebulactam A2 in acetone-d6  
(1H: 400 MHz; 13C: 100 MHz)*  
Position δC δH, mult (J in Hz) COSY HMBC 
1 70.8 4.36, d (10.1) 2 2, 2-CH3, 3, 11, 12, 13 
2 46.2 1.51, m 2-CH3, 1, 3 1, 2-CH3, 3, 12 
2- CH3 15.0 1.15, d (6.6) 2 1, 2, 3 
3 86.2 4.24, d (10.0) 2 2, 2-CH3, 4, 4-CH3, 5, 11 
4 145.4    
4-CH3 19.8 2.02, s 5 3, 4, 5 
5 125.1 5.07, d (10.5) 4-CH3, 6 3, 4-CH3, 6, 7 
6 48.3 3.34, m 6-CH3, 5 4, 5, 6-CH3, 6, 7 
6-CH3 16.9 0.99, d (6.8) 6 5, 6, 7 
7 205.2    
8 55.6 3.97, q (6.7) 8-CH3 7, 8-CH3, 9 
8-CH3 15.1 1.27, d (6.7) 8 7, 8, 9 
9 173.3    
10 130.4    
11 139.5    
12 138.1    
13 107.3 6.76, d (2.8)  1, 11, 14, 15 
14 153.4    
15 110.9 6.83, d (2.8)  10, 11, 13, 14 
NH  8.61, br   
*(Gulder 2008; Pimentel-Elardo et al. 2008) 
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Isolation and structure elucidation of the following compounds (3.2.1.2 to 3.2.1.6) were 
performed at the Ireland Research Lab, Department of Medicinal Chemistry, University of 
Utah.  
 
3.2.1.2 Novel tetromycin compounds from Streptomyces axinellae strain Pol001T 
The crude extract obtained from maceration of the mycelial mass with ethyl acetate was 
purified by preparative HPLC (Phenomenex Luna SemiPrep RP18e 10 x 250 mm) using 
H2O + 0.1% TFA (A) and CH3CN (B) as the solvents and the following gradient: flow 4.5 
ml/min; 0-10 min 90% B, 11-15 min 100% B. The following compounds were isolated 
(Fig. 3.2): Pol001-1 (2.7 mg; Rt = 5.938 min); Pol001-3 (4.4 mg; Rt = 7.746 min); Pol001-4 
(2.2 mg; Rt = 9.666 min); Pol001-5 (4.4 mg; Rt = 12.240 min); and Pol001-7 (2.1 mg; Rt = 
17.468 min). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Molecular formulas for each of the compounds were established using high-resolution 
mass spectrometry as follows: Pol001-1 = C50H65NO13 (m/z 910.4388 for [M+Na]+ , 
calculated 910.4354); Pol001-3 = C50H64O14 (m/z 911.4232 for [M+H]+ , calculated 
911.4219); Pol001-4 = C48H60O14 (m/z 861.4062 for [M+H]+ , calculated 861.4062); 
Pol001-5 = C49H62O14 (m/z 897.4066 for [M+Na]+ , calculated 897.4037); and Pol001-7 = 
C34H46O5 (m/z 557.3229 for [M+Na]+ , calculated 557.3243).   
Figure 3.2 HPLC chromatogram of EtOAc extract from Streptomyces axinellae strain Pol001T 
Pol001-1
Pol001-3
Pol001-4
Pol001-5
Pol001-7 
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Furthermore, the combination of NMR (1D and 2D), and comparison of the spectral data 
with the database using the SciFinder Scholar tool revealed that the compounds (Pol001-
1, Pol001-5, Pol001-7) are identical to the published family of tetromycin compounds 
previously isolated from Streptomyces sp. strain MK67-CF9 (Takeuchi et al. 1989) (Fig. 
3.3). 
 
 
 
 
 
 
 
 
 
 
Fig. 3.3 Tetromycin from Streptomyces sp. strain MK67-CF9 (Takeuchi et al. 1989) 
 
 
Interestingly, mass and NMR data of Pol001-3 and Pol001-4 suggest that these 
compounds are new derivatives of tetromycin. Partial structures (Fig. 3.4, 3.5, 3.6) were 
elucidated revealing a difference at position 10: hydroxyl function for Pol001-4 (Fig. 3.4) 
and a methoxy group for Pol001-3 (Fig. 3.5). Furthermore, the additional novelty of these 
structures is postulated to be found in the decalin ring of the tetromycins (Fig. 3.3) with 
the difference in the number or position of the methyl groups. Complete elucidation of the 
structures was not yet possible due to some ambiguous chemical shift assignments in 
some positions. Nevertheless, preliminary structure analyses still suggest that 
Streptomyces axinellae strain Pol001T produced novel tetromycin derivatives. Further 
NMR analysis should therefore be carried out in order to confirm and complete the 
structure elucidation of these interesting compounds. Stereochemical analysis is also 
worthwhile to pursue since relative or absolute configurations of the stereocenters in 
tetromycins have not been reported for any of the compounds. 
 
 
OH3C
HOOC
CH3
CH3
O
OH
O
O
OH
O
CH3
O
CH3
CH3
H3C
CH3
OH
H3C OCH3
OHO
Chapter 3 
 80
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3.3 NMR spectroscopic data of Pol001-4 partial structure A in acetone-d6 
(1H: 500 MHz; 13C: 125 MHz) 
Position δC δH, mult (J in Hz) COSY HMBC 
1 102.0 4.80, d (7.9) 2 2 
2 71.1 3.54, dd (7.9, 2.9) 1 3 
3 68.8 4.38, t (2.9) 4 3 
4 76.0 4.75, dd (10.0, 2.9) 3 4 
5 66.4 4.16, dq (10.0, 6.3) 5-CH3 3, 5-CH3 
5-CH3 17.5 1.25, d (6.3) 5  
6 170.2   4 
7 105.3   11, 8-CH3 
8 143.7   8-CH3 
8-CH3 23.6 2.55, s   
9 110.8 6.37, d (2.1)  8-CH3 
10 165.2   11 
11 98.7 6.34, d ( 2.1)   
12 164.3    
12-OCH3 54.9 3.83, s  12 
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Figure 3.4 Pol001-4 partial structure A 
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Table 3.4 NMR spectroscopic data of Pol001-3 partial structure A in acetone-d6 
(1H: 500 MHz; 13C: 125 MHz) 
Position δC δH, mult  COSY HMBC 
1 102.4 4.79,d 2  
2 71.4 3.54, dd 1  
3 69.5 4.34, t  5-CH3 
4 75.0 4.69, dd 5 5-CH3 
5 66.6 4.03, dq 4, 5-CH3 5-CH3 
5-CH3 17.2 1.26, d 5  
6 170.0    
7 106.9   8-CH3, 11 
8 143.0   8-CH3 
8-CH3 23.8 2.56, s  8 
9 110.8 6.37, d  8-CH3, 11 
10 161.6   10-OCH3 
10-OCH3 54.9 3.84, s   
11 96.0 6.46, d  9 
12 158.0   12-OCH3 
12-OCH3 55.4 3.83, s   
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Figure 3.5 Pol001-3 partial structure A 
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Table 3.5 NMR spectroscopic data of partial structure B of Pol001-4 and Pol001-3 in acetone-d6 
(1H: 500 MHz; 13C: 125 MHz) 
 
Position δC δH, mult  δC δH, mult  
1 201.0  200.0  
2 135.0  138.0  
3 206.0  205.0  
4 166.6  168.0  
5 81.8  84.6  
6 34.9 2.29, br; 1.77, br 33.6 2.26, br; 1.67, br 
7 27.4 2.86, br 27.0 2.94, br 
7-CH3 20.2 1.31, d  20.9 1.32, d 
8 120.9  119.8  
8-COOH 166.7  167.0  
9 138.8 6.67, s 147.6 6.93, s 
10 68.8  68.0  
10-CH3 22.6 1.51, s 23.3 1.48, s 
11 122.0 6.15, s 122.1 6.18, s 
12 124.6  116.5  
12-CH3 22.4 1.49, s 24.8 1.47, s 
13 24.6 2.23, br; 1.93, br 24.6 2.23, br; 1.92, br 
14 24.8 2.26, br; 1.95, br 24.8 2.24, br; 1.94, br 
15 130.0 5.06, d 130.5 5.14, d 
16 135.0  134.9  
16-CH3 13.1 1.38, s 12.4 1.35, s 
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Figure 3.6 Pol001-4 and Pol001-3 partial structure B 
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3.2.1.3 Valinomycin from Streptomyces sp. strains 34 and 22  
The crude ethyl extract obtained from maceration of the mycelial mass of Streptomyces 
sp. strain 34 with ethyl acetate was found to exhibit activities (zones of inhibition in mm, 
600 μg/ 6-mm disk) against the following organisms: Staphylococcus aureus (20 mm), 
Staphylococcus epidermidis (23 mm), and Escherichia coli (8 mm). No activities were 
found against Pseudomonas aeruginosa and Candida albicans. The ethyl acetate extract 
was further pre-fractionated using Diaion HP-20ss resin. Out of the five fractions obtained 
(FW, F1, F2, F3, F4), secondary antibacterial assay against Staphylococcus aureus and 
Escherichia coli revealed that fractions F2 and F3 were found to exhibit activity (200 μg/ 
6-mm disk) against S. aureus with zones of inhibition values of 9 and 8 mm, respectively.  
All other Diaion fractions were not active against E. coli. HPLC chromatograms of both 
fractions also revealed the same profile. Thus, fraction 11-F3 (20 mg) was further purified 
by HPLC (Phenomenex Luna SemiPrep RP18e 10 x 250 mm) using H2O (A) and CH3OH 
(B) as the solvents and the following gradient: flow 4.5 ml/min; 0-5 min 90% B, 11-15 min 
100% B. The major peak, 34-F3-3 (8.4 mg; Rt = 13.085 min) (Fig. 3.7) yielded the cyclic 
peptide, valinomycin (Fig. 3.8; Table 3.6).  
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.7 HPLC chromatogram of fraction 34-F3 from Streptomyces sp. strain 34 
 
High-resolution mass spectrometry of the purified compound established a molecular 
formula of C54H90N6NaO18 (m/z 1133.6385 for [M+Na]+, calculated 1133.6394). A 
combination of NMR (1D and 2D), MS-MS fragmentation and comparison of the spectral 
data with the database, Dictionary of Natural Products (www.chemnetbase.com) 
suggested that 34-F3-3 contains one α-hydroxyisovaleryl unit (Hiv), a lactoyl group (Lac), 
and two valines (Val), thus confirming the identity of the compound as valinomycin. 
However, the stereochemical properties of this compound were not determined. 
 
34-F3-3 
34-F3-2
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Furthermore, the structure was also confirmed by comparison of the 1H NMR and 13C 
NMR data with published data (Brockmann and Schmidt-Kastner 1955; Heisey et al. 
1988). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.8 Chemical structure of 34-F3-3 (valinomycin) 
 
 
 
 
 
Table 3.6 NMR spectroscopic data of 34-F3-3 (valinomycin) in CDCl3  
(1H: 500 MHz; 13C: 125 MHz) 
Unit Position δC δH, mult COSY  HMBC 
 1-CO 171.0   2 
 2-CH 78.8 5.02, d 3 4, 5 
Hiv 3-CH 28.8 2.30, m 4, 5 4, 5 
 4-CH3 22.9 0.85, d   
 5- CH3 22.8 0.86, d   
 6-CO 170.4    
 7-CH 59.1 4.10, t 8 9, 10 
Val 8-CH 28.6 2.25, m 9, 10 9, 10 
 9-CH3 19.5 0.96, d   
 10-CH3 16.8 0.97, d   
 NH  7.85, d 7  
 11-CO 172.6   13 
Lac 12-CH 70.4 5.30, q 13 13 
 13-CH3 17.2 1.46, d  12 
 14-CO 171.9   15 
 15-CH 60.5 4.00, t 16 17, 18 
Val 16-CH 27.4 2.04, m 17, 18 17, 18 
 17-CH3 19.2 0.98, d   
 18-CH3 18.4 0.99, d   
 NH  7.73, d 15  
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This cyclodepsipeptide contains a three-repeat sequence of a tetradepsipeptide basic 
unit, D-α-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl to form a symmetric 36-membered 
ring molecule. Interestingly, the same compound was isolated from Streptomyces sp. 
strain 22. The fractions in fact, obtained from this strain exhibited exactly the same 
chromatographic and NMR profiles suggesting that Streptomyces sp. strains 22 and 34 
produced exactly the same metabolites when cultivated under the same conditions. This 
is not surprising since a close look at their 16S rDNA sequence revealed that they 
exhibited 99.93% sequence similarity (1409/1410) with only one nucleotide difference 
indicating that these are the same strains regardless of the fact that these were isolated 
from different sponge sources (Axinella polypoides for strain 34 and Aplysina aerophoba 
for strain 22). 
 
A derivative of valinomycin was also detected in the fraction 34-F3-2 (1.5 mg; Rt = 12.489 
min) (Fig.3.7) with a molecular formula of C53H88N6NaO18 (m/z 1119.6064 for [M+Na]+, 
calculated 1119.6053). This could possibly be a new analog of valinomycin exhibiting a 
difference of a CH2 unit but complete spectroscopic analysis should be done to confirm 
the structure of this potentially novel compound. 
 
3.2.1.4 Staurosporine from Streptomyces sp. strain 11 
Preliminary disk diffusion assay of the crude ethyl extract obtained from maceration of the 
mycelial mass of Streptomyces sp. strain 11 with ethyl acetate revealed the following 
activities (zones of inhibition in mm, 600 μg/ 6-mm disk) against the following organisms: 
Staphylococcus epidermidis (8 mm), and Candida albicans (9 mm). No activities were 
found against Staphylococcus aureus, Pseudomonas aeruginosa and Escherichia coli. 
The ethyl acetate extract was further pre-fractionated using Diaion HP-20ss resin. For a 
bioassay-guided isolation, the five fractions obtained (FW, F1, F2, F3, F4) were subjected 
to secondary antibacterial assay. Fractions F2 and F3 were found to exhibit activity (200 
μg/ 6-mm disk) against S. aureus (7 mm) and no activity against Escherichia coli. 1H 
NMR of both fractions revealed the same profile. Fraction 11-F3 (13.9 mg) was then 
further purified by HPLC (Phenomenex Luna SemiPrep RP18e 10 x 250 mm) using H2O 
+ 0.1% TFA (A) and CH3OH (B) as the solvents and the following gradient: flow 4.5 
ml/min; 0-5 min 70% B, 10 min 80% B, 20-25 min 100% B.   
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Fig. 3.9 HPLC chromatogram of fraction 11-F3 from Streptomyces sp. strain 11 
 
 
The major peak, 11-F3-0 (1.4 mg; Rt = 4.162 min) (Fig. 3.9) yielded the indolocarbazole, 
staurosporine (Fig. 3.10). This was confirmed by mass spectrometry revealing the 
compound to have a molecular formula of C28H26N4O3 (m/z 467.2078 for [M+H]+ , 
calculated 467.2083) coupled with NMR (1D and 2D) analysis (Table 3.7) and 
comparison of the spectral data with the database, Dictionary of Natural Products 
(www.chemnetbase.com). Furthermore, the structure was also confirmed by comparison 
of the 1H NMR and 13C NMR data with published data (Meksuriyen and Cordell 1988; 
Schupp et al. 1999). However, the stereochemical properties of this compound were not 
determined. 
 
 
 
 
 
 
 
 
 
N
N
NH
O
2
3
4
1
5
6
7
8
9
10
11
O
H3CO
H3CHN
H3C
5'4'
3'
2'
6'
13a
12b
12a11a
7c 7b
7a
4c
4b
4a
Fig. 3.10 Chemical structure of 11-F3-0 (staurosporine) 
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Table 3.7 NMR spectroscopic data of 11-F3-0 (staurosporine) in CD3OD  
(1H: 500 MHz; 13C: 125 MHz) 
Position δC δH, (H, mult) COSY  HMBC 
1 109.3 7.16 (1H, d) 2 4 
2 126.5 7.52 (1H, t) 3 4 
3 126.6 7.41 (1H, t) 2 1 
4 127.2 9.22 (1H, d) 3 1, 4a, 12b, 13a 
4a 127.6   4 
4b 115.8   4 
4c 120.2   7A, 7B 
5 175.1   7A, 7B 
7 46.8 7A: 4.73 (1H)  4b, 4c, 5, 7a 
  7B: 4.44 1H)   
7a 133.8   7A, 7B 
7b 115.8    
7c 124.5   11 
8 122.7 7.81 (1H, d) 9 9 
9 120.7 7.26 (1H, t) 10  
10 122.0 7.38 (1H, t) 9 11 
11 113.4 7.96 (1H, d) 10 2’-CH3 
11a 139.4   11 
12a 131.4   7A, 7B 
12b 125.9   6’ 
13a 137.7   4 
2’ 94.2   2’-CH3 
3’ 81.4 4.21 (1H, s) 4’ 2’, 2’-CH3, 3’, 4’ 
4’ 55.9 3.90 (1H, dd) 3’, 5’A, 5’B 3’, 4’-NCH3 
5’ 28.8 5’A: 2.13 (1H) 4’, 6’ 6’ 
  5’B: 3.20 (1H)   
6’ 82.0 6.44 (1H, dd) 5’A, 5’B  
2’-CH3 28.7 2.53 (3H, s)  2’, 6’, 11 
3’-OCH3 60.6 2.14 (3H, s)  3’ 
4’-NCH3 31.3 2.78 (3H, s)  4’ 
    
    
 
3.2.1.5 Cycloisoleucylprolyl from Streptomyces sp. strain A188 
Initial bioassay testing of the metabolites produced by Streptomyces sp. strain A188 after 
growing in M1 broth indicated activity against Staphylococcus aureus (300 μl/ 13-mm 
disk) with a zone of inhibition of 26 mm. No activity was found against Staphylococcus 
epidermidis, Escherichia coli, Pseudomonas aeruginosa and Candida albicans. The 
crude extract obtained from solvent partitioning with ethyl acetate was pre-fractioned with 
Diaion HP-20ss. The fraction F1 was found to exhibit antibacterial activities against S. 
aureus and E. coli with zones of inhibition (200 μg/ 6-mm disk) of 1.0 and 2.2 mm, 
respectively. Thus, fraction A188-F1 (22 mg) was further purified by HPLC (Phenomenex 
Luna SemiPrep RP18e 10 x 250 mm) using H2O (A) and CH3OH (B) as the solvents and 
the following gradient: flow 4.5 ml/min; 0-5 min 15% B, 25 min 60% B, 30-35 min 100% B.   
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Fig. 3.11 Chemical structure of A188-F1-3 (cycloisoleucylprolyl) 
 
 
The fraction A188-F1-3 obtained from HPLC yielded the diketopiperazine, 
cycloisoleucylprolyl (Fig 3.11) (2.2 mg; Rt = 20.295 min). Mass analysis revealed a 
molecular formula of C11H18N2NaO2 (m/z 233.1262 for [M+Na]+, calculated 233.1266). 
The structure was confirmed by comparison of NMR (1D and 2D) analysis (Table 3.8) 
with published spectral data of the compound (Adamczeski et al. 1995; Fdhila et al. 2003) 
but the stereochemical properties of this compound were not further investigated. 
 
 
 
 
Table 3.8 NMR spectroscopic data of A188-F1-3 (cycloisoleucylprolyl) in CD3OD  
(1H: 500 MHz; 13C: 125 MHz) 
Position δC δH, (H, mult) COSY HMBC 
1 167.3   11 
3 46.4 3A: 3.50 (1H, m) 4  
  3B: 3.51 (1H, m)   
4 25.8 4A: 1.94 (1H, m) 3  
  4B: 2.00 (1H, m)  3 
5 29.1 5A: 2.02 (1H, m) 5B, 6 3 
  5B: 2.30 (1H, m) 5A, 6  
6 60.3 4.26 (1H, t)  5A, 5B  
7 167.8    
9 54.6 4.13 (1H, m) 10 11 
10 23.6 1.89 (1H, m)  11B, 10-CH3 
11 39.4 11A: 1.91 (1H, m)  10-CH3 
  11B: 1.53 (1H, m) 11A 9, 12 
12 22.2 0.96 (3H, d)  11A 11B 
10-CH3 23.3 0.97 (3H, d) 10 12 
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3.2.1.6 Butenolide from Streptomyces sp. strain T03 
The crude ethyl extract obtained from maceration of the mycelial biomass of 
Streptomyces sp. strain T03 was further fractioned with Diaion HP-20ss resin. Fraction 
T03-F1 which was found to be active against Staphylococcus aureus with a zone of 
inhibition (200 μg/ 6-mm disk) was further purified by HPLC (Phenomenex Luna 
SemiPrep RP18e 10 x 250 mm) using H2O (A) and CH3OH (B) as the solvents and the 
following gradient: flow 4.5 ml/min; 0-5 min 40% B, 25 min 60% B, 15 min 70% B, 20 min 
85% B, 21-26 min 100% B. The fraction T03-F1-2A yielded a compound (1.0 mg; Rt = 
17.168 min) with a molecular formula of C13H22O3Na (m/z 249.1447 for [M+Na]+, 
calculated 249.1467). NMR analysis (Table 3.9) confirmed the compound to be a 
butenolide (Fig. 3.12), exhibiting identical spectral data with published literature (Mukku et 
al. 2000; Cho et al. 2001). However, the stereochemical properties of this compound 
were not determined. 
 
 
 
 
 
 
 
Fig. 3.12 Chemical structure of T03-F1-2A (butenolide) 
 
 
Table 3.9 NMR spectroscopic data of T03-F1-2A (butenolide) in CD3OD  
(1H: 500 MHz; 13C: 125 MHz) 
Position δC δH, (H, mult) COSY HMBC 
1 175.8   2 
2 121.6 6.11 (1H, ddd)  3 
3 159.6 7.71 (1H, ddd) 2, 4 2, 5A 
4 85.6 5.13 (1H, m) 2, 5A 2, 3, 5A 
5 34.9 5A: 1.81 (1H, m) 4, 6  
  5B: 1.64 (1H, m)   
6 25.8 1.45 (2H, m) 5A  
7 30.7 1.35 (2H, m)  5A, 6 
8 24.3 1.34 (2H, m)  9 
9 42.0 1.42 (2H, m)  11 
10 72.2   11, 12, 13 
11 41.1 1.46 (2H, q) 12 12, 13 
12 8.5 0.89 (3H, t)  11 
13 25.9 1.11 (3H, s)  11 
 
O CH3
CH2CH3
OH
5 7 9
1
O
3 12
13
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3.2.2 Bioactivity profile of compounds 
3.2.2.1 Antimicrobial activity  
 
The compounds were subjected to a panel of antimicrobial tests to determine the 
minimum inhibitory concentration against various Gram-positive and Gram-negative 
bacteria as well as fungi (Table 3.10).  Among the compounds tested, only four exhibited 
antibacterial activities as follows: the novel tetromycin derivative Pol001-3 exhibited MIC 
values of 100 μM and 50 μM against S. aureus and S. epidermidis, respectively; Pol001-4 
exhibited slight activity with MIC value of 200 μM against these two bacteria; Pol001-7 
exhibited MIC of 200 and 100 μM against S. aureus, S. epidermidis respectively; and 
staurosporine against S. aureus with MIC of 100 μM. The novel derivative Pol001-4 was 
the only compound that exhibited slight activity against E. faecalis (MIC of 200 μM). 
Valinomycin and staurosporine were the only compounds that exhibited significant anti-
Candida activity with MIC values of 0.63 and 0.31 μM, respectively. 
 
Surprisingly, neither the compounds cebulactam A1 and cebulactam A2 nor the 
combination of these 2 compounds exhibited any antimicrobial activities, despite the fact 
that the crude ethyl acetate extract showed antibacterial activity from the preliminary 
screen. The other tetromycin compounds Pol001-1 and Pol001-5 as well as butenolide 
also did not show any activity. The compound cycloisoleucylprolyl was not tested due to 
the lack of material. 
 
Table 3.10 Antimicrobial activity testing of compounds (Minimum inhibitory concentration, μM)  
Compound Sa Se Efa Efe Ec Pa Yps Ype Ca 
Cebulactam A1 >160 >160 >160 >160 >160 >160 >160 >160 >80 
Cebulactam A2 >160 >160 >160 >160 >160 >160 >160 >160 >80 
Cebulactam A1+A2 >160 >160 >160 >160 >160 >160 >160 >160 >80 
Pol001-1 >200 >200 >200 nd >200 >200 nd nd >80 
Pol001-3 100 50 >200 nd >200 >200 nd nd >80 
Pol001-4 200 200 200 nd >200 >200 nd nd >80 
Pol001-5 >200 >200 >200 nd >200 >200 nd nd >80 
Pol001-7 200 100 >200 nd >200 >200 nd nd >80 
Valinomycin >200 >200 >200 nd >200 >200 nd nd 0.63 
Staurosporine 100 >200 >200 nd >200 >200 nd nd 0.31 
Butenolide >200 >200 >200 nd >200 >200 nd nd >80 
 
Legend:  
  Sa  = Staphylococcus aureus NCTC 8325 Pa  = Pseudomonas aeruginosa 
  Se  = Staphylococcus epidermidis RP62A Yps =Yersinia pseudotuberculosis 
Efa = Enterococcus faecalis JH212  Yps = Yersinia pestis 
  Efe = Enterococcus faecium 6413  Ca  = Candida albicans 
  Ec  = Escherichia coli 536   nd  = not determined 
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3.2.2.2 Anti-parasitic and cytotoxic activities 
The compounds were further tested against the parasites Leishmania major and 
Trypanosoma brucei subsp. brucei as well as their cytotoxicities against the two cell lines, 
293T kidney epithelial cells and J774.1 macrophages. All of the compounds, except for 
the cebulactams A1 and A2 exhibited significant anti-Trypanosoma activities exhibiting 
IC50 values below 100 μM with valinomycin and staurosporine showing the lowest IC50 
values of 0.0032 and 0.022 μM, respectively.  Only three compounds showed activity 
against the parasite Leishmania major: Pol001-4 (IC50, 36.80 μM), valinomycin (IC50, 
<0.11 μM) and staurosporine (IC50, 5,30 μM). The majority of the compounds that showed 
significant anti-parasitic activities also showed cytotoxicities (<100 μM) with the exception 
of the compounds, Pol001-1 and butenolide (Table 3.11). 
 
It is interesting to note that among the tetromycin compounds isolated in this Ph.D. study, 
the novel derivative Pol001-4 exhibited significant anti-Leishmania activity. The 
cebulactams A1 and A2 including the mixture of both substances did not exhibit any 
activities at all. 
 
Table 3.11 Antiparasitic and cytototoxic activities (IC50, μM) of compounds  
Compound LM TB, 48 h TB, 72 h KE JM 
Cebulactam A1 >100 >100 >100 nd >100 
Cebulactam A2 >100 >100 >100 nd >100 
Cebulactam A1+A2 >100 >100 >100 nd >100 
Pol001-1 >100 29.30 31.69 123.38 >100 
Pol001-3 >100 45.39 80.27 160.00 50.21 
Pol001-4 36.80 26.90 30.35 33.38 25.72 
Pol001-5 >100 35.85 41.61 58.58 27.54 
Pol001-7 >100 30.87 34.22 71.77 20.20 
Valinomycin <0.11 0.0032 0.0036 11.24 <0.1 
Staurosporine 5.30 0.022 0.035 1.30 <0.13 
Butenolide >100 31.77 33.08 >100 >100 
         *Activity not determined for cycloisoleucylprolyl due to lack of material. 
 
Legend: 
   KE = 293T kidney epithelial cells 
   JM = J774.1 macrophages 
   LM = Leishmania major 
   TB = Trypanosoma brucei brucei 221 
   nd = not determined 
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3.2.2.3 Protease inhibition 
Different cysteine proteases were tested to evaluate the ability of the compounds to 
inhibit these enzymes found in the parasites Plasmodium falciparum (falcipain-2) and 
Trypanosoma brucei rhodesiense (rhodesain), mammalian cells (cathepsin B and L), and 
SARS coronavirus (SARS-PLpro and SARS-Mpro) (Table 3.12).  A percent inhibition value 
above 70% at 100 μM concentration was considered as significant protease inhibition 
activity (T. Schirmeister, personal communication).  Among the compounds tested, the 
tetromycin family of compounds (Pol001 series) showed interesting activities. For 
example, inhibition of the malarial protease, falcipain-2 was exhibited by three of the 
tetromycin compounds namely, Pol001-4, Pol001-5 and Pol001-7 at 91.2, 92.9 and 81.4 
% inhibition, respectively. Furthermore, only two compounds showed rhodesain inhibition: 
Pol001-4 (79.9%) and Pol001-5 (77.5%). Inhibition against the mammalian protease, 
cathepsin B, was found to be exhibited by the compounds Pol001-3 (70.6%), Pol001-5 
(77.9%) and Pol001-7 (79.2%), while Pol001-5 was the only compound that inhibited 
cathepsin L at 72.7% and SARS-Plpro at 73.4%. Interestingly, the novel tetromycin 
derivative Pol001-4 displayed specific inhibition against only the parasite proteases, 
falcipain-2 and rhodesain. On the other hand, the compounds Pol001-1, cebulactam A1 
and A2, valinomycin and staurosporine did not show any inhibition against a single 
protease in these assays. The compound cycloisoleucylprolyl was not tested due to the 
lack of material. 
 
 
Table 3.12 Percent inhibition values* (100 μM) against different proteases 
Compound Falcipain-2 Rhodesain 
SARS 
Plpro 
SARS     
Mpro 
Cathepsin 
B 
Cathepsin 
L 
Cebulactam A1 51.7 8.3 3.8 5.5 5.8 7.5 
Cebulactam A2 51.7 15.0 20.5 10.9 8.3 ni 
Cebulactam A1+A2 53.7 17.2 9.4 3.3 7.8 ni 
Pol001-1 nd 7.1 16.4 4.8 68.9 nd 
Pol001-3 50.7 43.8 34.5 ni 70.6 50.3 
Pol001-4 91.2 79.9 59.6 8.2 67.5 62.9 
Pol001-5 92.9 77.5 73.4 9.5 77.9 72.7 
Pol001-7 81.4 53.6 32.1 9.5 79.2 37.8 
Valinomycin nd 13.6 ni ni 4.9 ni 
Butenolide nd ni 2.6 ni 2.5 2.0 
*Mean values of two independent assays; nd = not determined; ni = no inhibition 
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3.3 Discussion 
The actinomycetes isolated in this study were found to produce diverse compounds with 
interesting chemistry and biological activities. The strains belonging to the new 
actinomycete taxa namely, Saccharopolyspora cebuensis strain SPE 10-1T and 
Streptomyces axinellae strain Pol001T produced the novel secondary metabolites, 
cebulactams and the tetromycin family of compounds including novel derivatives, 
respectively. These results clearly indicate that the cultivation of novel actinomycetes 
proves to be a good strategy for isolating new chemical entities and minimizes the 
exhaustive effort of re-isolating known compounds. The cebulactams A1 and A2 
represent constitutionally identical macrolactams with the unique cyclic ether connecting 
the aromatic ring system to the highly functionalized, polyketide-derived carbon chain 
(Pimentel-Elardo et al. 2008). There are structurally related secondary metabolites that 
resemble these macrolactams, but are lacking the characteristic cyclic ether.  Examples 
are the anti-oxidative compounds from Pseudonocardia Q-1047 isolated from a soil 
sample from the Zamami Islands, Okinawa Prefecture, Japan (Imai et al. 1989a; Imai et 
al. 1989b; Yazawa et al. 1990) and the ansamycin antibiotics geldanamycin (Rascher et 
al. 2003) and herbimycin (Rascher et al. 2005) isolated from Streptomyces 
hygroscopicus. Despite the fact that the cebulactam polyketides produced by 
Saccharopolyspora cebuensis sp. strain SPE10-1T are structurally related to the 
ansamycin antibiotics and that the crude extract from which these polyketides were 
isolated showed preliminary activity, these compounds, still did not exhibit any 
bioactivities using the different anti-infective screening panel used in this study. The 
question of synergistic action of the two compounds has also been addressed since a 
cocktail of these substances also did not show any activity. In contrast to the other 
structurally related bioactive metabolites, the aromatic ring via the cyclic ether in the 
cebulactams might possibly be protected from oxidation, preventing the formation of the 
benzoquinone moeity which appears to be the putative bioactive part of the molecule. In 
this regard, conversion of the compounds to its oxidized form (i.e. benzophenonic) has 
been attempted (T.A.M Gulder, University of Würzburg) but the testing of the resulting 
oxidation products also did not yield bioactivities. Therefore, this semi-synthetic work 
warrants further investigation to improve the bioactivity potential of the compounds.   
 
The compounds isolated from Streptomyces axinellae strain Pol001T exhibited structural 
resemblance to tetromycins isolated from Streptomyces sp. strain MK67-CF9 (Takeuchi 
et al. 1989) with the exception of the novel derivatives Pol001-3 and Pol001-4. The 
compounds reported in this Japanese patent were shown to exhibit activity against 
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methicillin-resistant Staphylococcus aureus. However, the compounds are reported in this 
study to have a wider spectrum of activity that includes anti-parasitic and protease 
inhibition activities. Moreover, it is worthwhile to examine whether Streptomyces axinellae 
strain Pol001T as well as Saccharopolyspora cebuensis sp. strain SPE10-1T produce 
other compounds when cultivated under different conditions given the fact that these 
strains belong to novel actinomycete taxa and as shown in this PhD study, have a great 
potential of producing new secondary metabolites. 
 
Additional interesting yet previously known compounds were also isolated in this Ph.D. 
study from the different actinomycete strains namely, valinomycin, staurosporine, 
cycloisoleucylprolyl and butenolide. Valinomycin was isolated from Streptomyces sp. 
strains 34 and 22 cultivated from the Mediterranean sponges Axinella polypoides and 
Aplysina aerophoba. This cyclodepsipetide was originally recovered from various soil-
derived actinomycetes: Streptomyces fulvissimus (Brockmann and Schmidt-Kastner 
1955; Brown et al. 1962),  Streptomyces roseochromogenes (Patterson and Wright 1970) 
and Streptomyces griseus var. flexipartum (Heisey et al. 1988). To date, this is the first 
report of valinomycin isolated from a marine organism. This cyclic depsipeptide is an 
oligomer similar to peptides but in which some of the amino acids are replaced by 
hydroxyl acids, so that amide and ester bonds are present along the chain. Furthermore, 
valinomycin is structurally similar to onchidin B isolated from a mollusc Onchidinium sp. 
(Fernández et al. 1996) and montanastatin, an antineoplastic compound from a soil-
derived Streptomyces annulatus (Pettit et al. 1999) possessing a cyclic structure with 
polar groups oriented toward the central cavity, whereas the rest of the molecule is 
relatively nonpolar. The structure behaves as an ionophore that modulates transport of 
ions such as potassium across biological membranes (Haynes et al. 1969).  It is for this 
reason that several studies have reported on the chemical synthesis of valinomycin and 
its analogs (Fonina et al. 1971; Smith et al. 1975; Vinogradova et al. 1975; Kuisle et al. 
1999). Valinomycin has also been reported to exhibit other biological activities such as 
insecticidal (Patterson and Wright 1970; Heisey et al. 1988), nematocidal (Patterson and 
Wright 1970) and antifungal (Park et al. 2008). In this Ph.D. study, valinomycin is found to 
exhibit not only antifungal activity but also anti-parasitic activities thus extending the 
pharmacological value of this known compound.   
 
Another interesting compound isolated in this study is staurosporine from Streptomyces 
sp. strain 11 cultivated from the sponge Tedania sp. which apparently has been identified 
from various sources. This indolocarbazole alkaloid was first isolated from Streptomyces 
staurosporeus Awaya AM-2282 (Omura et al. 1977) and subsequently from various 
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terrestrial actinomycetes: Streptomyces actuosus (Morioka et al. 1985), Streptomyces  
sp. strain M-193 (Oka et al. 1986), Streptomyces platensis subsp. malvinus RK-1409 
(Osada et al. 1992), Streptomyces sp. AB 1869R-359 (McAlpine et al. 1994) and 
Streptomyces longisporoflavus (Cai et al. 1995; Cai et al. 1996). Interestingly, 
staurosporine and its derivatives have been reported to be produced by the marine 
ascidian Eudistoma toealensis and its predatory flatworm Pseudoceros sp. (Schupp et al. 
1999; Schupp et al. 2002).  Furthermore, staurosporine and its derivatives have aroused 
considerable interest as these compounds exhibit strong inhibitory activities against 
protein kinase C (Tamaoki et al. 1986) as well as inhibition of platelet aggregation (Oka et 
al. 1986), blocking of growth phases in cancer cells (Beltran et al. 1997) and reversal of 
multidrug resistance (Utz et al. 1998). Additionally, staurosporine was found in this Ph.D. 
study to exhibit significant inhibitory activity against the parasites Leishmania major and 
Trypanosoma brucei which has not been previously reported for this compound.  
 
Another compound isolated in this Ph.D. study is cycloisoleucylprolyl from Streptomyces 
sp. strain A188 cultivated from the Mediterranean sponge Aplysina aerophoba. This 
diketopiperazine has also been previously isolated from the Caribbean sponge Calyx cf. 
podatypa (Adamczeski et al. 1995) and a structurally similar diketopiperazine from 
Pseudomonas aeruginosa isolated from an Antarctic sponge Isodictya setifera (Jayatilake 
et al. 1996). Diketopiperazines are the smallest peptides known, commonly 
biosynthesized from amino acids by different organisms and are considered to be 
secondary functional metabolites or side products of terminal peptide cleavage (Martins 
and Carvalho 2007). It is common to find diketopiperazines in fermentation mixtures as 
microorganisms are capable of protein hydrolysis and that a certain proportion of 
diketopiperazines present may arise during the fermentation to replace or supplement the 
quantity supplied in the medium (Mitscher et al. 1963). These compounds were in fact 
found to be produced by the majority of the strains cultivated in this study.   
 
Furthermore, butenolide was isolated from Streptomyces sp. strain T03 from Tethya sp. 
sponge and exhibited significant activity against Trypanosoma brucei. This lactone-
containing metabolite has also been previously isolated from a marine sediment-derived 
Streptomyces sp. strain M027750 (Cho et al. 2001). Butenolides are a family of α,β-
unsaturated lactones often encountered among fungi, bacteria and gorgonians 
(Rodriguez and Ramirez 1994; Braun et al. 1995; Smith et al. 2000). Their saturated 
analogues act as signaling substances in bacteria and enhance spore formation of 
Streptomyces sp. or induce metabolite formation (Mukku et al. 2000). 
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Bioassay data of the secondary metabolites isolated in this study revealed that the 
majority of the compounds exhibited significant anti-parasitic and protease inhibitory 
activities. The specificity of the various screening panels employed here provides further 
insights into the mechanisms of action against particular pathogens and underscores the 
anti-infective potential of the compounds. The parasites Leishmania major and 
Trypanosoma brucei are clinically important pathogens as these are known to cause 
leishmaniasis and the African trypanosomiasis, respectively (Fenwick 2006; Caffrey et al. 
2007). Furthermore, cysteine proteases play pivotal roles in the growth, differentiation 
and pathogenicity of various pathogens (Otto and Schirmeister 1997; Mahmoudzadeh-
Niknam and McKerrow 2004). Therefore, inhibition of cysteine proteases presents a 
promising strategy for combating infection.  For example, the enzyme rhodesain in 
Trypanosoma brucei rhodesiense has been the target in developing new anti-
trypanosomal drugs. Furthermore, proteases of Plasmodium falciparum parasites play 
important roles in the processes of host erythrocyte rupture, erythrocyte invasion and 
hemoglobin degradation (Rosenthal 2004). Treatment with cysteine protease falcipain 
inhibitors blocks hemoglobin hydrolysis and development of the parasite (Schulz et al. 
2007).  Additionally, the coronavirus SARS Co-V is another important pathogen causing 
the severe acute respiratory syndrome (SARS) which was responsible for the severe 
epidemic in 2002-2003 with more than 800 reported deaths worldwide (Peiris et al. 2003). 
Coronaviruses are plus-strand RNA viruses where the genome RNA is translated to 
produce two large replicase polyproteins that are autocatalytically cleaved by viral 
proteases (Kaeppler et al. 2005). The coronavirus main protease Mpro is the key enzyme 
in the proteolytic process and is therefore also considered as an attractive target for new 
antiviral drugs against SARS and other coronavirus infections (Anand et al. 2003).  
 
Therefore, the novelty of the chemical structures as well as the bioactivities exhibited by 
the different compounds isolated in this study clearly shows the potential of marine 
sponge-associated actinomycetes to produce pharmacologically important secondary 
metabolites. Expanding the anti-infective screening panel to include more clinically 
relevant pathogens and improving the bioactivity of the compounds by structure-activity 
studies are thus worthwhile pursuing. 
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Chapter 4 
Identification of biosynthetic gene clusters in actinomycete strains 
 
4.1 Materials and methods 
4.1.1 Screening of actinomycete strains for NRPS and PKS genes 
Cultivated actinomycete strains were screened for the presence of biosynthetic gene 
clusters specifically nonribosomal peptide synthetases (NRPS) and polyketide synthases 
(PKS) using the following degenerated primers: NRPS A7R (5’-
SASGTCVCCSGTSCGGTAS-3’) and A3 (5’-GCSTACSYSATSTACACSTCSGG-3’) 
(Ayuso-Sacido and Genilloud 2005); type 1 PKS (PKS-1): K1 (5’-
TSAAGTCSAACATCGGBCA-3’) and M6R (5’-CGCAGGTTSCSGTACCAGTA-3’) (Ayuso-
Sacido and Genilloud 2005); type 2 PKS (PKS-II): KSα (5’-
TSGRCTACRTCAACGGSCACGG-3’) and KSβ (5’-TACSAGTCSWTCGCCTGGTTC-3’) 
(Ayuso et al. 2005), KS1 (5’-TSGCSTGCTTCGAYGCSATC-3’) and KS2 (5’-
TGGAANCCGCCGAABCCGTC-3’) (Metsa-Ketela et al. 1999), 540F (5’-
GGITGCACSTCIGGIMTSGAC-3’) and 1100R (5’-CCGATSGCICCSAGIGAGTG-3’) 
(Wawrik et al. 2005); type 3 PKS (PKS-III): Fwd (5’- 
TCGCTSCTSTCGAACGGCCTSTTCGGCGACGCSCTSTCGGC-3’) and Rev (5’-
CTCSGCGGTGATSCCGGGSCCGAAGCCSGCGATSAGGC-3’) (Cortes et al. 2002). A 
standard PCR reaction mix (50 μl) was prepared which consisted of the following: 10x 
reaction buffer, 5 μl; Q solution, 10 μl; 25 mM MgCl2, 2 μl; 10 mM dNTPs, 1 μl; 100 μM of 
each primer, 1 μl; 5 U/μl Taq polymerase, 0.25 μl; H2O, 28.75 μl; DNA template, 1 μl. 
PCR conditions were as follows: initial denaturation (5 min at 95°C) followed by 35 cycles 
of denaturation (30 s at 95°C), primer annealing (2 min at 59°C for A7R/A3, 55°C for 
K1/M6R, 58°C for KSα/KSβ, KS1/KS2 and PKS-IIIFwd/Rev and 64°C for 540F/1100R), 
primer extension (4 min at 72°C) and final extension step (10 min at 72°C).  
 
4.1.2 Cloning, sequencing and phylogenetic analysis of NRPS adenylation domains 
The PCR amplification products obtained with the NRPS adenylation primers A7R and A3 
were purified using the QIAquick PCR purification kit (Qiagen). Five volumes of buffer PB 
was added to one volume of PCR product and mixed using a pipette. The mixture was 
applied to a QIAquick column and centrifuged at 13000 rpm for 1 min. The flow-through 
was discarded and the column was placed back into the same tube.  Buffer PE (750 μl) 
was added to the column followed by centrifugation at 13000 rpm for 1 min. The flow-
through was discarded and the column was centrifuged for an additional min at 13000 
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rpm. The column was then placed in a clean 1.5-ml microfuge tube, added with 30 μl of 
buffer EB and allowed to stand for 1 min. A final centrifugation step at 13000 rpm for 1 
min was performed and the resulting purified PCR product was stored at -20°C. 
 
Ligation of the purified PCR products and transformation in competent E. coli XL1-Blue 
cells were subsequently performed. The following were mixed on ice: 2x T4 DNA ligase 
buffer, 5 μl; 50 ng/μl pGEM-Teasy vector (Promega), 1 μl; 3 U/μl T4 DNA ligase, 1 μl; 
PCR product, 4 μl. The ligation solution was incubated overnight at 4°C for maximum 
number of transformants.  For transformation, 2-3 μl of the ligation solution was added to 
50 μl of the competent E. coli cells. The resulting mixture was transferred to a UV-
sterilized electroporation cuvette. Electroporation was applied using an Easyject Prima 
Electroporator (Equibio) at 2500V. The solution was transferred to a clean 2-ml microfuge 
tube, added with 1 ml of SOC medium with mixing to resuspend the pellet and incubated 
with shaking at 37°C for at least 3 hours. After incubation, 20% and 80% of the cells were 
plated out on LB/amp/IPTG/X-gal agar. The plates were incubated at 37°C overnight and 
successful transformants were observed using the blue-white colony screening. The 
plasmid DNA was isolated using a standard miniprep protocol. Single, white colonies 
were picked up, inoculated in 2 ml of LB/amp broth and incubated with shaking at 37°C 
overnight. Following incubation, the culture was centrifuged at 13000 rpm for 5 min and 
the supernatant was discarded. The pellet was resuspended in 150 μl of buffer P1. 
Addition of 150 μl of buffer P2 with standing for 5 min at room temperature followed by 
the addition of 150 μl of buffer P3 on ice for 5 min were subsequently done. The solution 
was mixed by gentle flicking of the tube after each addition of the buffer. The resulting 
mixture was centrifuged at 13000 rpm for 10 min. The supernatant was transferred to 
clean 1.5-ml microfuge tube and the centrifugation step was repeated. The supernatant 
was again transferred to clean tube, added with 0.7 volume of isopropanol and mixed by 
gently flicking the tube.  This was then centrifuged at 13000 rpm for 15 min. The resulting 
pellet containing the plasmid DNA was washed with 70% ethanol and allowed to air-dry. 
Sterile water (50 μl) was added to resuspend the pellet and the plasmid DNA was stored 
in -20°C until use. To verify the correct clones, the plasmid DNA was digested with a 
restriction endonuclease.  Restriction digestion with EcoRI (New England Biolabs) was 
done by mixing the following: 10x EcoRI buffer, 2 μl; water, 12 μl; 20,000 U/ml EcoRI, 1 
μl; plasmid DNA, 5 μl. The reaction mix was incubated at 37°C for 2-3 hours and the 
restriction patterns were analyzed by agarose gel electrophoresis.   
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For amplification of the pGEM-T easy insert, sequencing PCR was done using the 
primers SP6 (5’- ATTTAGGTGACACTATAG-3’) and T7 (5’- 
GTAATACGACTCACTATAGGG-3’) and the BigDye® terminator cycle sequencing kit 
(Applied Biosystems). The PCR reaction mix was composed of the following: 5x BigDye® 
terminator v1.1 sequencing buffer, 2 μl; BigDye® terminator v1.1 premix, 2 μl; plasmid 
DNA, 2 μl; 25 μM of primer, 1 μl; sterile water, 3 μl.  The PCR conditions were as follows: 
initial denaturation (2 min at 96°C), 25 cycles of denaturation (30 s at 96°C), primer 
annealing (15 s at 45°C), primer extension (4 min at 72°C) and a final extension step (10 
min at 60°C). DNA sequencing was performed using an ABI 377XL automated sequencer 
(Applied Biosystems). Sequences were assembled using the ContigExpress tool in 
Vector NTI AdvanceTM 10.0 (InforMax, Inc) and subsequently aligned using Clustal X. 
Phylogenetic analysis was done using the ARB software (Strunk and Ludwig 1997).   
 
4.1.3 Genomic library construction  
Genomic libraries were constructed for the following strains: Streptomyces sp. strain 
Aer003 and Saccharopolyspora cebuensis strain SPE10-1 using the pWEBTM cosmid 
cloning kit (Epicentre, Madison) and the libraries were designated as Aer003pWEB and 
SPE10-1pWEB, respectively. 
 
4.1.3.1 Genomic DNA isolation 
Saccharopolyspora cebuensis strain SPE 10-1T and Streptomyces axinellae strain 
Pol001T were grown in M1 and ISP 2 broth, respectively at 30°C for 7-10 days until 
sufficient biomass was obtained. Cells were centrifuged at 8000 rpm for 5 min. The 
salting-out procedure for the isolation of genomic DNA was followed (Pospiech and 
Neumann 1995; Kieser et al. 2000). The cell pellet was washed with SET buffer to 
remove adhering media components and resuspended in 500 μl SET buffer. Addition of 
10 μl of lysozyme solution (50 mg/ml) and incubation at 37°C for 30 min followed. After 
incubation, 14 μl of proteinase K solution (20 mg/ml) and 60 μl of 10% SDS were added 
with mixing by inversion. The solution was incubated at 55°C for 2 hours with occasional 
inversion. An additional amount of proteinase K was added, if necessary, until the 
solution was clear.  Following incubation, 200 μl of 5M NaCl was added and allowed to 
cool to 37°C. Five hundred microliters of chloroform was then added and the solution was 
thoroughly mixed by shaking for 30 min at room temperature. The resulting solution was 
centrifuged at 6000 rpm for 15 min. The supernatant was transferred to a fresh Eppendorf 
tube and 0.6 volume of isopropanol was added followed by mixing with inversion. The 
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DNA was spooled from the solution using a flame-bent Pasteur pipet. The DNA was 
rinsed with 70% ethanol, air-dried and dissolved in 100 μl water. DNA concentration was 
then measured using a NanoDrop ND1000 spectrophotometer (PeqLab, Erlangen). 
 
4.1.3.2 Insert DNA end-repair reaction 
Following extraction of genomic DNA, end-repair reaction was done using the end-repair 
mix (Epicentre, Madison) to generate blunt ends for cloning into the vector. The following 
reagents were combined on ice:  8 μl 10X End-Repair buffer, 8 μl 2.5 mM dNTP Mix, 8 μl 
10 mM ATP, 20 μg insert DNA, 4 μl end-repair enzyme and sufficient volume of sterile 
water to make a total reaction volume of 80 μl. The resulting mixture was incubated at 
room temperature for 45 min. This was then followed by incubation at 70˚C for 10 min to 
inactivate the end-repair enzyme Mix. DNA was extracted using standard phenol-
chloroform procedure. Phenol (10 μl) was added and the solution was mixed by gentle 
inversion. Centrifugation at 9000 rpm for 10 min followed and the supernatant was then 
transferred to a clean Eppendorf tube. Chloroform (10 μl) was added, followed again by 
centrifugation at 9000 rpm for 10 min. The resulting supernatant was transferred to a 
clean Eppendorf tube and 0.1 volume of 3M sodium acetate and 2.5 volumes of ice-cold 
100% ethanol were subsequently added. The whole solution was centrifuged at 9000 rpm 
for 10 min followed by washing of the DNA with 70% ethanol and air-drying. The resulting 
DNA was re-dissolved in 20 μl water and stored at 4°C. 
 
4.1.3.3 Ligation of insert DNA into the pWEB vector 
The following reagents were combined in the order as listed and mixed thoroughly after 
each addition: 5 μl sterile water, 2 μl 10X fast-link ligation buffer (Epicentre, Madison), 1 
μl 10 mM ATP (Epicentre, Madison), 1 μl pWEB vector (0.5 μg, ~8 kb) (Epicentre, 
Madison), 10 μl concentrated insert DNA (from previous step) and 1 μl fast-link DNA 
ligase (Epicentre, Madison) for a total reaction volume of 20 μl. The resulting solution was 
incubated at room temperature for 2 hours and further incubated at 70°C for 10 min to 
inactivate the fast-link ligase.  
 
4.1.3.4 In Vitro packaging 
An overnight culture of EPI100-T1R (Epicentre, Madison) was prepared by inoculating 10 
μl of EPI100-T1R Phage T1-Resistant E. coli Plating Strain in 5 ml of LB broth 
supplemented with 10 mM MgSO4 and shaking at 37°C. Fifty milliliters of LB 
supplemented with 10 mM MgSO4 was inoculated with 100 μl of the overnight culture and 
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was shaken at 37°C until the cell density reached an OD600 of 0.8-1.0. MaxPlax Lambda 
Packaging Extracts (Epicentre, Madison) were thawed on ice. Half of each packaging 
extract (25 μl) was transferred to a 1.5-ml eppendorf tube. Ten microliters of the ligated 
cosmid DNA was added. The mixture was mixed by pipetting several times with care not 
to introduce air bubbles in the process. The tube was then centrifuged briefly to pool 
again all the contents of the tube. The reaction was then incubated at 30°C for 90 min. At 
the end of this incubation, the remaining 25 μl of the packaging extract was added to the 
reaction and incubated further for an additional 90 min at 30°C. Five hundred microliters 
of the phage dilution buffer (10 mM Tris-HCl pH 8.3, 100 mM NaCl, 10 mM MgCl2) was 
added and mixed by gentle vortexing, followed by the addition of 25 μl of chloroform and 
gentle vortexing again. The resulting solution was stored at 4°C until use.  For every 100 
μl of the previously prepared EPI100-T1R host cells, 10 μl of the packaged cosmids was 
added.  Adsorption by incubation at 37°C for 20 min was subsequently done. After 
incubation, the transfected bacteria (100 μl per plate) were spread on LB-ampicillin (100 
μg/ml) agar plates and incubated overnight at 37°C. Single colonies were then picked up, 
streaked on LB-ampicillin agar plates in an organized fashion corresponding to a 384-well 
format arrangement and incubated further at 37°C. The grown colonies were then 
stamped from the plates using a flame-sterilized pin replicator into a 384-well microplate 
containing LB-ampicillin medium with 15% glycerol. The plates were incubated again at 
37°C overnight and subsequently stored at -80°C. 
 
4.1.3.5 Genomic library screening 
Clones generated from the genomic library were screened for the biosynthetic gene of 
interest by PCR.  Pools of clones were generated by scraping colonies according to their 
arrangement by columns and rows on the plates. The colonies were resuspended in 100 
μl sterile water and heated at 90°C for 10 min. The corresponding suspension was then 
used as template for subsequent PCR reactions. The following primer pairs were used: 
sebNRPS-1 (5’-GGCAGGCTGGTTGACGTAG-3’) and sebNRPS-2 (5’-GTGTGGTGGA 
GCTGGCTTT-3’) (Proksch 2008); degAH-F2 (5’-ATCATGCCSGTSCAYATGGCSGG-3’) 
and degAH-R2 (5’-CKRTGRTGSARCCASTKRCARTC-3’) (Rascher et al. 2003) to screen 
Aer003pWEB and SPE10-1pWEB libraries, respectively. A standard PCR reaction mix 
(25 μl) was prepared which consisted of the following: RedTaq™ ReadyMix™ PCR 
reaction mix (Sigma), 12.5 μl; 100 μM of each primer, 0.5 μl; H2O, 11.5 μl; DNA template, 
1 μl. PCR conditions were as follows:  initial denaturation (3 min at 94°C) followed by 35 
cycles of denaturation (30 s at 94°C), primer annealing (1 min at 59°C for sebNRPS-1/-2 
and 2 min at 52°C for degAH-F2/-R2 primers), primer extension (1.5 min at 72°C) and 
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final extension step (10 min at 72°C).  Individual clones from the positive pools were 
again screened by PCR using the same set of primers. The cosmid DNA from the positive 
clones were extracted using a standard miniprep protocol described previously. The 
same PCR reactions were repeated using the extracted cosmid DNA as template and the 
PCR products were purified using the QIAgen PCR purification kit. Sequencing PCR was 
then done to verify the PCR products. Restriction digestion of the cosmid DNA was 
performed using the restriction enzymes EcoRI and NotI (New England Biolabs) to check 
insert sizes. To ensure that the cosmid DNA from each clone was not a mixture of 
different cosmid DNA, these were transformed in heat-competent E. coli XL1-Blue cells. 
Five microliters of cosmid DNA was added to 50 μl of E. coli cells and incubated for 30 
min on ice. The mixture was incubated further at 42°C for 1 min 15 s and subsequently 
transferred on ice for an additional 5 min. One milliliter of SOC broth was added followed 
by incubation with shaking at 37°C for at least 3 hours. After incubation, 20% and 80% of 
the cells were plated out on LB/amp/IPTG/X-gal agar. The plates were incubated at 37°C 
overnight and successful transformants were observed using the blue-white colony 
screening. Transformants were screened by colony PCR and the cosmids verified again 
by restriction digestion and PCR. 
 
4.1.3.6 Cosmid sequencing and annotation 
Clones harboring the positive cosmid DNA from each library were sent to Macrogen, 
South Korea for end sequencing and shotgun sequencing of the entire cosmid.  
Assembled contigs sent by Macrogen were then analyzed and annotated using Vector 
NTI 10 (Invitrogen). 
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4.2 Results 
4.2.1 NRPS and PKS clusters identified by PCR and phylogenetic analysis 
 
Biosynthetic gene clusters encoding for nonribosomal peptide synthetases were detected 
in the majority of the actinomycete strains as well as polyketide synthases in some of the 
strains cultivated in this study (Table 4.1). Degenerated primers designed specifically to 
amplify the conserved regions of the adenylation (NRPS) and ketosynthase domains 
(PKS) in actinomycetes (Ayuso-Sacido and Genilloud 2005; Ayuso et al. 2005) were 
used. The majority of the strains (14 out of 20) were positive for NRPS and five strains 
possessed both NRPS and PKS systems. Type I PKS was detected in five strains while 
four strains exhibited type II PKS. However, all of the strains were negative for type III 
PKS.   
 
Table 4.1 PCR screening results of actinomycete isolates for the presence of NRPS and PKS 
clusters 
 
Isolate 
code 
16S rDNA closest homology/identity NRPS Type I 
PKS 
Type II 
PKS 
SPE 10-1 Saccharopolyspora cebuensis - + - 
A188* Actinomycetales bacterium XJSS-18 + - - 
10 Streptomyces albogriseolus NBRC 3709 - - - 
T03 Streptomyces sp. MP47-91 + - + 
11 Streptomyces spinoverrucosus strain 174464  - - - 
17 Streptomyces variabilis strain 173733 + - - 
27 Streptomycetaceae bacterium WBF21 - - - 
Da02 Streptomyces sp. CNS-774_SD06 + - - 
T02 Streptomyces sp. CNS-774_SD06 + - - 
34 Streptomyces sp. VTT E-042674  + - - 
22 Streptomyces sp. VTT E-042674  + - - 
Aer003* Streptomyces bingchengensis strain 226541 + - - 
11-11 Isoptericola sp. TUT1258 - + - 
4-3 Micromonospora sp. HBUM84229 + + - 
9-3 Gordonia terrae strain AIST-1 + + - 
Cr03 Nocardiopsis sp. 20052 + - - 
Pol013* Streptomyces albiaxialis NBRC 101002 + + + 
Pol014* Streptomyces sp. VTT E-99-1334 - - + 
A233* Actinomycetales bacterium HPA66 + - - 
SB182* Streptomyces sp. VTT E-99-1334 + - + 
*Strains isolated from previous study by Scheuermayer (2006).   
  All strains were negative for type III PKS. 
 
 
The adenylation (A) domains of five NRPS-positive strains were cloned in pGEM-T easy 
vector and sequence analysis of the 700bp-PCR products was performed. In a Master’s 
thesis (Proksch 2008), the diversity and distribution of NRPS systems in the microbial 
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consortia of different sponge species, including seawater and an ascidian (Ecteinascidia 
turbinata) collected from Patch Reef, Bahamas and Banyuls-sur-Mer, France were 
investigated. Proksch (2008) screened for the presence of NRPS genes by PCR and 
sequencing using the same set of degenerated primers (A7R/A3) used in this study. 
Analysis of the adenylation domains revealed a single NRPS cluster present in majority of 
the sponge samples as well as from the sequences obtained from the seawater and 
ascidian samples. In another study, Grozdanov (unpublished data, AG Hentschel, 
University of Würzburg) constructed a metagenomic library from the microbial consortia of 
the Mediterranean sponge Aplysina aerophoba. Screening of the library revealed the 
presence of NRPS gene clusters (termed lubA1 and A2) speculated to encode for the 
Verongida brominated alkaloids.  Phylogenetic analysis of the adenylation domains of the 
five strains from this study together with those obtained from the previously mentioned 
studies was thus carried out to investigate further the diversity of the NRPS clusters 
detected in the actinomycete strains. Interestingly, phylogenetic analysis (Fig. 4.1) 
revealed that the Streptomyces sp. strain Aer003 forms one large distinct cluster (further 
on termed sebNRPS cluster) together with the majority of the sequences obtained from 
different sponge samples, seawater as well as from the ascidian. Their high amino acid 
sequence similarities (97-99%) also provide further evidence of the sebNRPS cluster. 
Moreover, the sequences in this clade share high amino acid sequence similarity with the 
enduracidin EndB peptide cluster of Streptomyces fungicidus ABD65957 (Identities: 65%, 
Positives: 73%) (Yin and Zabriskie 2006). The detection of such a cluster suggests a 
widely distributed NRPS system and that the corresponding A domain could be part of 
one and the same, or at least very similar, NRPS gene cluster present in microorganisms 
from seawater, sponges and ascidian animals. The sequence similarities of the A 
domains at the amino acid level are 97-99% indicating further that these are probably 
identical genes. On the other hand, Streptomyces sp. strains A188, Da02, T02 and T03 
formed separate clusters from strain Aer003 and the adenylation domains of the 
metagenomic clones from Aplysina aerophoba lubA1 and lubA2. It is important to note 
that the phylogenetic tree (Fig. 4.1) presented here was constructed using the ARB 
software (Strunk and Ludwig 1997). The high bootstrap values from neighbor-joining and 
maximum parsimony algorithms as well as the logical clustering of the different A 
domains based on their sequence similarities provided sufficient basis for considering 
such phylogenetic tree. Nevertheless, other suitable programs for phylogenetic analysis 
of functional genes such as MrBayes (Bayesian inference of phylogeny) can also be used 
for improved resolution of the tree.  
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Plakortis sp. 21
Xestospongia muta 7
Verongia gigantea 10
Smenospongia aurea 3
Seawater (Bahamas)
Plakortis sp. 9
Niphates digitalis 20
Tedania ignis 8
Streptomyces sp. strain Aer003 (Aplysina aerophoba) 
Niphates digitalis 24
Agelas citrina 14
Aplysina insularis 21
Tedania ignis 6
Aplysina archeri 8
Verongia gigantea 12
Callyspongia vaginalis 9
Callyspongia vaginalis 12
Smenospongia aurea 1
Aplysina cauliformis 24
Aplysina archeri 14
Ecteinascidia turbinata ascidian
actinomycin synthetase II Streptomyces chrysomallus (AAC38442) 
StaC Streptomyces toyocaensis (AAM80537)
AA adenylation Salinispora tropica CNB-440  (ZP_01430039) 
CDA peptide synthetase I Streptomyces coelicolor A3(2) (CAB38518) 
NRPS/PKS Myxococcus xanthus DK1622 (YP_631961) 
EndB Streptomyces fungicidus (ABD65957)
Tcp11 Actinoplanes teichomyceticus (CAE53352)
BpsB Amycolatopsis balhimycina (CAC48361)
ComD Streptomyces lavendulae (AAK81827)
PCZA363 Amycolatopsis orientalis (CAA11796)
adenylation domain Amycolatopsis lactamdurans  (AAQ17083) 
uncultured bacterium fosF-J17-NRPS-A52 (AAW84156) 
NRPS Myxococcus xanthus DK1622 (YP 631823)
NRPS Streptomyces lasaliensis (BAE98156)
Pristinamycin I synthase 2 Streptomyces pristinaespiralis (CAA72311) 
NRPS Micromonospora sp. ML1  (CAJ34375)
Streptomyces sp. strain T03 (Tethya sp.) 
uncult. bacterium fosF-J115-NRPS-30  (AAW84159) 
LgrB Brevibacillus brevis (CAD92850)
uncult. bacterium spT-NRPS-35 (AAW84164)
 PpsD Pseudomonas putida (CAC32046)
pyoverdine Pseudomonas entomophila L48  (YP_608783) 
uncultured bacterium spT-NRPS-21 (AAW84163)
 uncultured bacterium spT-NRPS-44 (AAW84165)
Streptomyces sp. strain A188 (Aplysina aerophoba) 
Streptomyces sp. strain Da02 (Dysidea avara)
Streptomyces sp. strain T02 (Tethya sp.) 
NRPS Pseudomonas syringae str. DC3000 (NP 794272)
saframycin Mx1 synthetase A Myxococcus xanthus (AAC44129) 
NRPS Myxococcus xanthus DK 1622 (YP 632760)
OnnI symbiont bacterium of Theonella swinhoei (AAV97877)
actinomycin synthetase III Streptomyces chrysomallus (AAF42473) 
 actinomycin synthetase II Streptomyces chrysomallus (AF204401 1) 
mixed type I PKS/NRPS symbiont bacterium of Paederus fuscipes (AAS47564)
uncultured bacterium fosF-J139-NRPS-22 (AAW84160)
Aplysina insularis 7
AMP-dependent synthetase Burkholderia xenovorans (YP 555617) 
Aplysina aerophoba 18
acyl-CoA dehydrogenase Mycobacterium avium 104 (YP_880813) 
lubA1 (Aplysina aerophoba) 
lubA2 (Aplysina aerophoba) 
adenylation Frankia sp. CcI3 (YP_481555)
Fig 4.1 Phylogenetic tree of adenylation domains from cultivated Streptomyces strains obtained in 
this study (blue font); from different sponges, seawater, E. turbinata ascidian (green font); and from 
metagenomic clones (red). Arrow points to outgroup, LysI E. coli (P40976). Numbers at the nodes 
indicate the levels of bootstrap support (neighbor-joining/maximum parsimony) based on 100 
resampled data sets; only values greater than 50% are shown. The scale bar indicates 0.1
substitutions per nucleotide position. 
Aplysina aerophoba 5 
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Furthermore, prediction of adenylation domain specificity was carried out using the NRPS 
predictor tool (Rausch et al. 2005). The analysis is based on computational data 
processing that leads to identification of the amino acid substrates of the nonribosomal 
peptide synthetases, according to the specificity-conferring code of their adenylation 
domains. The specificity of the A domains dictates the composition of the corresponding 
peptide product (Stachelhaus et al. 1999). Using this tool, the predicted substrate 
specificity of the adenylation domains of strain Aer003 as well as the other sequences 
from the distinct sebNRPS cluster was determined to be 4-hydroxy-phenylglycine (Hpg).  
Moreover, the predicted substrates for the other strains were alanine (Streptomyces sp. 
strain A188), valine (Streptomyces sp. strain T03) and glycine (Streptomyces sp. strains 
Da02 and T02). The substrate specificities of the adenylation domains were in agreement 
with the functional clustering of the sequences in the phylogenetic tree.  
 
4.2.2 NRPS gene cluster obtained from a genomic library (Aer003pWEB) of 
Streptomyces sp. strain Aer003 
 
The intriguing similarity of the adenylation domain of strain Aer003 with the majority of the 
sequences obtained from the different sponge samples as well as from seawater and an 
ascidian prompted the construction of a genomic library to further examine the gene 
organization of the NRPS cluster found in this strain. A cosmid genomic library 
(Aer003pWEB) of 706 clones was generated and screened with primers (sebNRPS-1 and 
sebNRPS-2) targeting the widely distributed sebNRPS cluster. Two PCR-positive clones 
were identified and hereafter named 1/C13 and 2/E12. The presence of the sebNRPS-
specific A domain sequence was verified by PCR and direct sequencing of the PCR 
products using the primers mentioned above.  Restriction fragment length analysis using 
the enzymes NotI and EcoRI suggested that these two cosmids do not overlap since no 
common bands were observed. Nevertheless, these cosmids were subjected to shotgun 
library construction and complete sequence analysis by the company Macrogen. 
 
Sequence analysis of the cosmid inserts of 1/C13 (34090 bp) and 2/E12 (42315 bp) 
revealed the presence of several putative open reading frames (ORF) (Fig. 2.2). The 
predicted function and the presence of conserved domains for each ORF was assigned 
by comparing the translated product with known proteins in the NCBI Genbank database 
using the BlastX tool (Tables 2.1 and 2.2). Organization of NRPS domains (Fig.2.2) and 
substrate recognition sequences (Table 2.3) were predicted using the NRPS analysis 
online tool (http://www.tigr.org/jravel/nrps/). 
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(A) 
 
 
                                                            
(B) 
 
 
 
 
Fig. 4.2 Genetic organization (not drawn to scale) of the DNA regions isolated from the strain 
Aer003 (A) cosmid 1/C13 (34090 bp) and (B) 2/E12 (42315 bp). Genes putatively belonging to the 
NRPS cluster are shaded in dark blue and NRPS-related genes in light blue. Modules and domain 
organization are indicated above each ORF: C, condensation; A, adenylation; T, thiolation; Te, 
thioesterase; E, epimerization; ?, unknown. 
 
 
There are four ORFs identified in cosmid 1/C13 (Fig. 4.2A) harboring putative NRPS 
genes. ORF 5 bears a single thiolation domain while ORF 6 harbors one module 
containing the following: adenylation domain with a novel A domain signature; thiolation; 
thioesterase; and an extra domain at the N-terminus spanning 394 amino acids. These 
two ORFS overlap by 453 nucleotides. Both ORFs 18 and 19 harbor a complete module 
each with condensation, adenylation and thiolation domains but with different substrate 
specificities (Table 4.2): aspartic acid (Asp) and 4-hydroxy-phenylglycine (Hpg), 
respectively. These modules seem to function as the elongation modules of the NRPS 
cluster. Apparently, the closest homolog (71%) of the Hpg-specific domain of ORF 19 is 
the A domain of CDA peptide synthetase I (module 6; CAB38518) of Streptomyces 
coelicolor A3(2). This particular domain exhibits also 65% similarity to that of the 
enduracidin gene cluster of Streptomyces fungicidus (ABD65957), which is expected 
since the cosmid was positively identified from the library using primers that amplify Hpg-
specific A domains of the sebNRPS cluster. ORF 19 is located at the end of this cosmid 
suggesting that the cluster is disrupted at this end. Furthermore, a loading module that 
normally consists of adenylation and thiolation domains could not be identified in the 
cosmid sequence, confirming that the cluster is not complete. ORF 6 bears a thioesterase 
domain which is usually found at the extreme C-terminal module with the function of 
catalyzing the release of the biosynthesized peptide. This indicates therefore that this is 
the final module of the entire cluster.  
         1     2   3      4   5        6    7                  8                       9  10  11 12 13 14  15 16     17    18  19 20  21 22
T ?-A?-T-Te C-AAsp-T C-AHpg-T 
C AIle AGly C-A?-T-E- C-AHpg-T-E Te T-C AAsp-T AGly
1   2 3     4             5             6          7   8       9         10    11 12 13  14  15  16   17        18                    19
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Several NRPS ORFs have been identified in the second cosmid 2/E12 mostly consisting 
of single domains as well as a large ORF with complete NRPS domain organization (Fig. 
4.2B). ORF 8 bears two complete modules, each bearing condensation, adenylation, 
thiolation and epimerization, an additional auxiliary domain.  Prediction of the substrate 
specificities of the A domains based on the residues found in the binding pockets 
revealed that the first A domain exhibits a novel sequence whereas Hpg is the predicted 
amino acid for the second A domain (Table 4.3). This ORF is followed by a thioesterase 
domain signaling the end of this cluster.  The residues in the binding pockets of this ORF 
(DAYHLGVG) are the same as that found in ORF 19 of cosmid 1/C13 suggesting Hpg as 
its predicted substrate. Comparison of their A domains revealed a high sequence 
similarity at the amino acid level (Identities=91%; Positives=93%). Their similarities were 
not high enough to speculate that the ORFs could possibly overlap to cover an entire 
biosynthetic cluster from both cosmids.  Nevertheless, these Hpg-specific domains from 
both cosmids exhibited 98-99% amino acid sequence similarities with the A domains of 
the sebNRPS cluster. Although domains were not predicted in some of the ORFs in 
cosmid 2/E12 (ORF 1, 2, 5, 7, 19, 21) despite displaying high sequence similarities with 
known NRPS clusters, these ORFs still play a role in the peptide synthesis. The 
sequences of the small ORFs are short enough such that domain prediction is not 
possible. 
 
Other genes necessary for regulation and export could be identified as well. Export of the 
peptide from the cell is likely to involve ORF 9 (1/C13) and ORF 10 (2/E12) predicted to 
function as components of ABC transporters similar to those found in other antibiotic 
biosynthetic gene clusters. Regulatory genes such that encoded by ORFs 7 and 14 
(1/C13) and ORF 11 (2/E12) are also identified. Interestingly, genes involved in 
polyketide synthesis are present in cosmid 2/E12, particularly ORF 12 to 14 encoding for 
the acyl carrier protein (ACP), an essential domain in PKS systems. This could be part of 
another biosynthetic cluster involving polyketide synthesis or the strain probably encodes 
a mixed NRPS/PKS product.   
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Table 4.2 Summary of ORFs identified in cosmid 1/C13 
 
ORF Putative function Most similar homolog (protein, accession no., origin) Identities/ Positives (%) 
No. of 
aa* 
DNA 
coordinates 
1 Dihydroxyacetone kinase subunit I  SAV_1285 (NP_822460), Streptomyces avermitilis MA-4680) 90/93 330 86..1075 
2 Dihydroxyacetone kinase subunit 2 
SAML0927 CAJ89913), Streptomyces ambofaciens ATCC 
23877 73/79 264 1003..1794 
3 Dihydroxyacetone kinase phosphotransfer protein 
SGR_6660(YP_001828172), Streptomyces griseus subsp. 
griseus NBRC 13350 81/89 137 1794..2204 
4 Polysaccharide lyase family protein 8 CPF_0394 (YP_694851), Clostridium perfringens ATCC 13124 29/49 919 2336..5092 
5 NRPS SAV_7165 (NP_828341), Streptomyces avermitilis MA-4680 72/81 852 5130..7685 
6 NRPS SACE_3015 (YP_001105218), Saccharopolyspora erythraea NRRL 2338 65/75 1262 7232..11017 
7 Syrp-like protein SAV_7164 (NP_828340), Streptomyces avermitilis MA-4680 73/83 334 11064..12065
8 Ornithine cyclodeaminase SAV_7163 (NP_828339), Streptomyces avermitilis MA-4680 67/75 319 12065..13021
9 Transporter SAV_1418 (NP_822593), Streptomyces avermitilis MA-4680 83/90 746 13484..15721
10 Hypothetical protein SAV_1419 (NP_822594), Streptomyces avermitilis MA-4680 75/81 739 15773..17989
11 3-hydroxybutyrate dehydrogenase SAV_1420 (NP_822595), Streptomyces avermitilis MA-4680 80/86 292 17923..18798
12 Mut-like protein SCO1013 (NP_625309), Streptomyces coelicolor A3(2) 71/82 159 18857..19333
13 Secreted protein SCO1016 (NP_625312), Streptomyces coelicolor A3(2) 52/57 327 19753..20733
14 GntR transcriptional regulator Sare_2660 (YP_001537488), Salinispora arenicola CNS-205 60/75 452 20720..22075
15 FMN-dependent α-hydroxy acid dehydrogenase 
Strop_2478 (YP_001159302), Salinispora tropica 
CNB-440 58/72 393 22075..23253
16 p-hydroxymandelate synthase NocF (AAT09803), Nocardia uniformis subsp. tsuyamanensis 52/63 373 23253..24371
17 L-threonine synthase Mbar_A3541 (YP_306990), Methanosarcina barkeri str. Fusaro 43/60 446 24451..25788
18 NRPS SCO3230 (NP_627443), Streptomyces coelicolor A3(2) 48/59 1282 25864..29709
19 NRPS Francci3_2461 (YP_481557), Frankia sp. CcI3 51/64 1344 29684..33715
 *aa = amino acids 
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Table 4.3 Summary of ORFs identified in cosmid 2/E12 
 
ORF Putative function Most similar homolog (protein, accession no., origin) Identities/ Positives (%) 
No. of 
aa* 
DNA 
coordinates 
1 NRPS snbDE (CAA67249), Streptomyces pristinaespiralis 70/81 181 2558..3100 
2 NRPS EndC  (ABD65958), Streptomyces fungicidus 69/78 159 4006..4482 
3 NRPS SnbDE (CAA72310), Streptomyces virginiae 58/70 613 4877..6715 
4 NRPS EndC  (ABD65958), Streptomyces fungicidus 60/72 242 7370..8095 
5 NRPS SACE_4288 (YP_001106482), Saccharopolyspora erythraea NRRL 2338 53/68 388 8201..9364 
6 NRPS SACE_4288 (YP_001106482), Saccharopolyspora erythraea NRRL 2338 51/59 553 10562..12220
7 NRPS SGR_3264 (YP_001824776), Streptomyces griseus NBRC 13350 43/61 167 12249..12749
8 NRPS  Francci3_2461 (YP_481557), Frankia sp. CcI3 45/58 3067 13300..22500
9 Thioesterase SAV_3639 (NP_824816), Streptomyces avermitilis MA-4680 49/66 228 22738..23421
10 ABC transporter SAV_5680 (NP_826857), Streptomyces avermitilis MA-4680 76/86 645 23508..25442
11 SyrP-like protein SAV_3638 (NP_824815), Streptomyces avermitilis MA-4680 69/80 213 25482..26120
12 Acyl carrier protein SGR_3255 (YP_001824767), Streptomyces griseus NBRC 13350 41/68 213 26386..27384
13 3-oxoacyl-ACP synthase II SGR_3254 (YP_001824766), Streptomyces griseus NBRC 13350 65/80 324 27442..28413
14 3-oxoacyl-ACP synthase I SGR_3249 (YP_001824761), Streptomyces griseus NBRC 13350 46/59 433 28287..29585
15 Dihydroxybenzoate synthesis DhbF (NP_391076), Bacillus subtilis str. 168 38/59 256 30324..31091
16 NRPS SACE_1305 (YP_001103553), Saccharopolyspora erythraea NRRL 2338 59/72 148 31365..31808
17 NRPS SnbDE (CAA67249), Streptomyces pristinaespiralis 58/71 460 33121..34500
18 NRPS PstC (CAM56770), Actinoplanes friuliensis 54/64 560 35032..36711
19 NRPS SACE_4288 (YP_001106482), Saccharopolyspora erythraea NRRL 2338 69/81 262 36835..37620
20 NRPS SACE_4288 (YP_001106482), Saccharopolyspora erythraea NRRL 2338 51/59 524 37678..39249
21 NRPS SnbDE (CAA72310), Streptomyces virginiae 64/78 140 40296..40715
22 Dihydroxybenzoate synthesis DhbF (NP_391076), Bacillus subtilis str. 168 49/67 321 40675..41637
*aa = amino acids 
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Table 4.4 Derived substrate signature sequences for NRPS adenylation domains 
 
Cosmid ORF Substrate recognition sequence 
Predicted amino 
acid 
Closest homolog 
(accession number) 
Identities/ Positives 
(%) 
 6 DIWQST- No hit --- --- 
1/C13 18 DITKIGHI Asp SrfAB-M2 (BAA08983) 75/100 
 19 DAYHLGVG Hpg CdaI-M6 (CAB38518) 71/85 
 4 DAYELGVG Ile Adp-M1 (CAC01606) 71/85 
 6 DILQVGCI Gly NosC-M2 (AAF17280) 75/87 
2/E12 8 DITKIASV No hit --- --- 
  DAYHLGVG Hpg Cda1-M6 (CAB38518) 71/85 
 18 DATKMGHV Asp SrfAB-M2 (BAA08983) 62/87 
 20 DILQVGCI Gly NosC-M2 (AAF17280) 75/87 
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4.2.3 PKS gene cluster from a genomic library (SPE10-1pWEB) of 
Saccharopolyspora cebuensis strain SPE 10-1T 
 
The strain Saccharopolyspora cebuensis SPE 10-1T was found to produce the novel 
polyketides named as cebulactam A1 and A2 (Pimentel-Elardo et al. 2008). The chemical 
structure of these compounds suggests that these are type I polyketides structurally 
related to ansamycins, compounds which utilize 3-amino-5-hydroxybenzoic acid synthase 
(AHBA) as a starter unit. In order to gain insight into the biosynthesis of these 
polyketides, a genomic library was thus constructed. A total of 1,152 clones were 
generated. Preliminary screening of the library using degenerated primers (K1 and M6R) 
that amplify the conserved ketosynthase domain for type I PKS revealed six PCR-positive 
clones. In order to target the specific polyketide synthase encoding for the cebulactam 
compounds, these clones were screened again using degenerated primers (degAH-F2 
and degAH-R2) that amplify the ansamycin starter unit, AHBA. PCR reaction yielded 
three PCR-positive clones namely, 1/J17, 2/I16 and 3/B3 which was further confirmed by 
subsequent sequencing of the PCR products. Restriction fragment length analysis of the 
cosmids revealed common bands (10 and 11 kb) indicating the presence of overlapping 
regions. These cosmids were subjected to shotgun library construction and complete 
sequence analysis by Macrogen (South Korea). However, only cosmid clone 3/B3 was 
successfully completely sequenced since trimmed sequences were found in 1/J17 and 
2/I16 and hence primer walking to assemble into final contig sequences was therefore not 
possible despite efforts on the reconstruction of the shotgun library (Macrogen, personal 
communication). 
 
Sequence analysis of the cosmid insert of 3/B3 (36355 bp) revealed the presence of 
several putative open reading frames (ORF) (Fig. 4.3A, Table 4.5) for polyketide 
synthase. The PKS analysis online tool (http://www.nii.res.in/searchall.html) was used to 
predict the domain organization in each of the putative PKS ORFs (Ansari et al. 2004).  
Only two ORFs were found to contain the essential PKS domains. ORF 1 was found to 
contain the acyl carrier protein (ACP) domain while ORF 5 contained the domains in the 
following order: ketoreductase (KR); acyl carrier protein (ACP); ketosynthase (KS); and 
acyltransferase (AT). The KR and ACP domains seem to belong to a separate module 
attached to another elongation module containing KS and AT domains. Closest homologs 
of these domains are as follows: KR domain with rapamycin-module 4 (Identities: 45%, 
Positives: 52%), ACP domain with ascomycin-loading module (Identities: 73%, Positives: 
81%), KS domain with rifamycin-module 3 (Identities: 74%, Positives: 85%) and AT 
domain with pimaricin-module 7 (Identities: 86%, Positives: 86%). The specificity of the 
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AT domain was predicted to be methylmalonyl-CoA with an active site motif 
QQGHSQGRSHTNV.  
  
 
 
 
 
 
 
 
 
 
 
 
            
            
            
         
     
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.3 Genetic organization (not drawn to scale) of the DNA regions isolated from the strain SPE 
10-1: (A) cosmid 3/B3 (36355 bp); (B) cosmid 1/J17 contigs: c11 (6797 bp), c10 (3718 bp), c7 
(2887 bp); (C) cosmid 2/I16 contigs: c22 (9331 bp), c13 (6650 bp), c20 (3136 bp), c12 (1061 bp), 
c16 (1054 bp), c18 (1721 bp). Genes putatively belonging to the PKS cluster are shaded in dark 
blue and PKS-related genes in light blue. Modules and domain organization are indicated above 
each ORF: ACP, acyl carrier protein; DH, dehydratase; KR, ketoreductase; KS, ketosynthase; AT, 
acyltransferase. 
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Other PKS-related genes are also found, namely those that are involved in the synthesis 
of 3-amino-5-hydroxybenzoic acid (AHBA) as seen in ORFs 7 to 11. This is not surprising 
since AHBA is the starter unit of the cebulactam polyketides and that analysis of the DNA 
regions surrounding the AHBA synthase gene also revealed the presence of other 
biosynthesis genes, confirming that indeed, the AHBA synthase gene is essential for 
cebulactam formation. 
 
Among the three contigs sequenced for cosmid 1/J17 (Fig. 4.3B, Table 4.6), only contig 
c11 bears five PKS ORFs. In particular, ORF 1 bears a module that contains DH, KR, 
ACP, KS domains.  Closest homologs of these domains are as follows: DH domain with 
amphotericin-module 3 (Identities: 47%, Positives: 59%); KR domain with ascomycin-
module 2 (Identities: 67%, Positives: 75%); ACP domain with ascomycin-module 2 
(Identities: 67%, Positives: 75%); KS domain with spinosad-module 7 (Identities: 71%, 
Positives: 83%). ORF 2 bears the AT domain with methylmalonate as predicted substrate 
and closest similarity with nystatin (Identities: 62%, Positives: 75%). ORFs 3-5 harbor the 
ketosynthase domain with following sequence similarities: amphotericin-module 1 
(Identities: 87%, Positives: 88%), rifamycin-module 3 (Identities: 72%, Positives: 84%) 
and avermectin-module 11 (Identities: 74%, Positives: 81%), respectively. ORF 5 of 
contig c7 bears a beta-ketoacyl synthase which is believed to be involved in polyketide 
synthesis but the sequence is disrupted at the end of this contig, thus a domain was not 
successfully predicted.  On the other hand, cosmid 2/I16 (Fig.4.3C, Table 4.7) contains 
only two contigs encoding for PKS-related genes. ORF 7 in contig c22 encodes for acyl 
CoA-transferase which is most probably involved in the loading or elongation module of 
the polyketide where CoA is transferred to a propionate unit into the growing ketide chain. 
ORFs 3 and 4 in contig c13 also encode for enzymes that are involved in the biosynthetic 
pathway of AHBA. Furthermore, other genes necessary for regulation and export could 
be identified as well. Export of the polyketide from the cell is likely to involve ORFs 16 and 
17 (3/B3) and ORF 1 (2/I16_c16) predicted to function as components of ABC 
transporters while regulation of antibiotic production is likely to involve ORFs 2 and 3 
(1/J17_c10).   
 
Overlapping regions with cosmid 3/B3 were found by comparing nucleotide sequence 
similarities (99-100 %) of both ends of the cosmid with each of the contigs in cosmid 
1/J17 and 2/I16.  Contigs c7 and c11 (1/J17) appear to overlap with the 5’-end of 3/B3 
while contig c13 (2/I16) overlaps with the 3’ end of 3/B3, thus confirming results from 
restriction fragment length analysis. Since only 3/B3 was fully sequenced, assembly of 
the three cosmids to identify the whole gene cluster was unfortunately not possible. 
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Table 4.5 Summary of ORFs identified in cosmid 3/B3 
 
ORF Putative function Most similar homolog (protein, accession no., origin) Identities/ Positives (%) 
No. of 
aa* 
DNA 
coordinates 
1 Beta-ketoacyl synthase  Strop_2768 (YP_001159588), Salinispora tropica CNB-440 58/72 234 181..882 
2 PKS LipPks2 (ABB05103), Streptomyces aureofaciens 48/56 191 1105..1677 
3 Beta-ketoacyl synthase 
Franean1_4838 (YP_001509110), Frankia sp. EAN1pec 
 47/55 161 1925..2407 
4 PKS CONC (AAZ94388), Streptomyces neyagawaensis  62/74 107 2957..3277 
5 PKS  SACE_2875 (YP_001105078), Saccharopolyspora erythraea NRRL 2338 59/68 1725 3453..8627 
6 Unknown function MbcB (ACF35444), Actinosynnema pretiosum subsp. pretiosum 38/45 293 8715..9593 
7 Aminohydroquinate synthase MbcO (ACF35443), Actinosynnema pretiosum subsp. pretiosum 76/86 165 9470..9964 
8 Phosphatase-like protein SACE_2872 (YP_001105075), Saccharopolyspora erythraea NRRL 2338 72/82 192 10682..11257
9 Oxidoreductase Francci3_0430 (YP_479546), Frankia sp. CcI3 64/71 454 11310..12671
10 AHBA synthase FRAAL0914 (YP_711176), Frankia alni ACN14a 77/88 464 12488..13879
11 RifN AHBA kinase SACE_3869 (YP_001105072), Saccharopolyspora erythraea NRRL 2338 64/71 292 14623..15498
12 LuxR transcriptional regulator SACE_2866 (YP_001105069), Saccharopolyspora erythraea NRRL 2338 65/76 947 16107..18947
13 MFS transporter  FRAAL0341 (YP_710628), Frankia sp. alni ACN14a 55/69 483 19218..20666
14 Monooxygenase Nfa23860 (YP_118597), Nocardia farcinica IFM 10152 48/62 347 20734..21774
15 Monooxygenase CMS_1261 (YP_001709999), Clavibacter michiganensis subsp. sepedonicus 44/56 432 21725..23020
16 ABC transporter Francci3_2764 (YP_481853), Frankia sp. CcI3 53/64 799 23096..25492
17 Membrane transporter Francci3_2766 (YP_481855), Frankia sp. CcI3 56/73 380 25482..26621
18 Extracellular solute-binding protein Francci3_2767 (YP_481856), Frankia sp. CcI3 50/66 437 26754..28064
19 SARP transcriptional regulator Franean1_4842 (YP_001509114), Frankia sp. EAN1pec 43/53 859 28788..31364
20 H+/citrate symporter SACE_1977 (YP_001104212), Saccharopolyspora erythraea NRRL 2338 80/87 701 31928..34030
21 Response regulator SACE_1975 (YP_001104210), Saccharopolyspora erythraea NRRL 2338 73/85 318 35062..36015
*aa = amino acids 
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Table 4.6 Summary of ORFs identified in contigs of cosmid 1/J17 
 
 
Contig ORF Putative function Most similar homolog (protein, accession no., origin) Identities/ Positives (%) 
No. of 
aa* 
DNA 
coordinates
 1 PKS SSAG_05828 (EDX26173), Streptomyces sp. MgI 52/63 1321 24..3986 
 2 PKS CONC (AAZ94388), Streptomyces neyagawaensis 60/69 107 4184..4504 
c11 3 PKS GelA (ABB86408), Streptomyces hygroscopicus 64/75 1176 4672..5847 
 4 PKS PKS1 (ABB88522), Streptomyces aculeolatus 76/84 122 5857..6222 
 5 PKS NemA3 (BAF85843), Streptomyces cyaneogriseus 74/82 109 6149..6475 
 1 H+/citrate symporter SACE_1977 (YP_001104212), Saccharopolyspora erythraea NRRL 2338 76/84 308 1..924 
 2 Two-component sensor kinase 
SACE_1976 (YP_001104211), Saccharopolyspora erythraea NRRL 
2338 71/83 566 1007..2704 
c10 3 Response regulator SACE_1975 (YP_001104210), Saccharopolyspora erythraea NRRL 2338 73/85 223 2704..3372 
 4 Transcriptional regulator SSAG_04054 (EDX24263), Streptomyces sp. MgI 47/62 92 3379..3654 
 1 HxIR transcriptional regulator Franean1_2255 (YP_001506596), Frankia sp. EAN1pec 69/80 128 122..505 
 2 SARP transcriptional regulator 
Franean1_4842 (YP_001509114), Frankia sp. EAN1pec 
 43/55 342 484..1509 
c7 3 Transcriptional activator Asm18 (AAM54096), Actinosynnema pretiosum 55/63 86 1660..1917 
 4 Transcriptional activator Asm18 (AAM54096), Actinosynnema pretiosum 57/65 111 1894..2226 
 5 Beta-ketoacyl synthase Franean1_4838 (YP_001509110), Frankia sp. EAN1pec 58/66 178 2197..2730 
*aa = amino acids 
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Table 4.7 Summary of ORFs identified in contigs of cosmid 2/I16 
 
Contig ORF Putative function Most similar homolog (protein, accession no., origin) Identities/ Positives (%) 
No. of 
aa* 
DNA 
coordinates
 1 Urease subunit Mpop_3208 (YP_001925895), Methylobacterium populi BJ001 56/71 236 233..940 
 2 Urease subunit UreC (YP_001851021), Mycobacterium marinum  65/76 472 1203..2618 
 3 Urease accessory UreF (NP_828283), Streptomyces avermitilis MA-4680 53/67 302 2609..3514 
c22 4 Urease accessory  UreG (YP_481754), Frankia sp. CcI3 74/83 407 3518..4738 
 5 Hypothetical protein BURPS1710b_1934 (YP_333333), Burkholderia pseudomallei 38/42 149 4757..5203 
 6 Transcriptional regulator 
SACE_3039 (YP_001105242), Saccharopolyspora erythraea NRRL 
2338 69/77 286 5381..6238 
 7 Acyl CoA-transferase SACE_3040 (YP_001105243), Saccharopolyspora erythraea NRRL 2338 77/86 675 6247..8271 
 8 Dicarboxylate carrier SACE_3042 (YP_001105245), Saccharopolyspora erythraea NRRL 2338 75/84 271 8445..9257 
 1 SARP transcriptional regulator 
Franean1_4842 (YP_001509114), Frankia sp. EAN1pec 
 45/56 675 166..2190 
c13 2 Extracellular solute-binding protein Francci3_2767 (YP_481856), Frankia sp. CcI3 46/62 648 2154..4097 
 3 Phosphatase RifM (AAC01721), Amycolatopsis mediterranei 78/88 146 4115..4552 
 4 3-Dehydroquinate synthase 
SACE_2686 (YP_001105071), Saccharopolyspora erythraea NRRL 
2338 75/83 636 4581..6488 
c20 1 Two-component sensor kinase 
SACE_1976 (YP_001104211), Saccharopolyspora erythraea NRRL 
2338 65/76 566 294..1991 
 2 H+/citrate symporter SACE_1977 (YP_001104212), Saccharopolyspora erythraea NRRL 2338 77/85 340 2074..3093 
c12 1 HxIR transcriptional regulator Franean1_2255 (YP_001506596), Frankia sp. EAN1pec 72/83 99..425 99..425 
 2 SARP Transcriptional regulator 
Franean1_4842 (YP_001509114), Frankia sp. EAN1pec 
 44/55 172 525..1040 
c16 1 Mannitol dehydrogenase 
SAMR1012 (CAJ88721), Streptomyces ambofaciens ATCC 23877 
 57/65 110 163..492 
 1 Membrane transport SAMR1013 (CAJ88722), Streptomyces ambofaciens ATCC 23877 73/84 164 48..539 
c18 2 L-idonate 5-dehydrogenase SAMR1014 (CAJ88723), Streptomyces ambofaciens ATCC 23877 74/82 358 634..1707 
*aa = amino acids 
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4.3 Discussion 
The majority of bioactive secondary metabolites produced by bacteria appear to be 
structurally biosynthesized by nonribosomal peptide synthetases (NRPS) and polyketide 
synthases (PKS). PCR primers designed for screening NRPS and PKS systems in 
actinomycetes have been used to identify isolates with metabolic potential (Ayuso-Sacido 
and Genilloud 2005; Ayuso et al. 2005).  Several actinomycete strains cultivated in this 
Ph.D. study showed the presence of NRPS and PKS systems clearly indicating the 
potential of these isolates to produce peptides and/or polyketides provided that these are 
cultivated under appropriate conditions that allows expression of their respective 
biosynthetic genes. Despite the fact that majority of the strains cultivated in this study are 
taxonomically known actinomycetes, these strains still hold great potential in producing 
peptides and/or polyketides with novel chemistry and significant biological activities. 
 
Interestingly, the biosynthesis of peptides and polyketides by enzymes are organized in a 
modular fashion utilizing specific domains to sequentially catalyze the condensation of 
simple carboxylic acids for PKS systems or amino acid building blocks for NRPS systems 
into a growing chain. Nonribosomal peptide synthetase systems, for example consists of 
a minimal chain elongation module with three essential domains: adenylation, thiolation 
and condensation.  The adenylation domain (A) selects a specific amino acid activating it 
as an amino acyl adenylate which is then transferred to the phosphopantethiene group of 
the post-translationally modified peptidyl carrier protein (PCP) or thiolation domain (T). 
The condensation domain (C) catalyzes the peptide bond formation between amino acids 
in adjacent modules. The chain is elongated successively and released finally by an 
integrated thioesterase (TE) domain or a separate TE producing either a linear or cyclic 
peptide. Additional structural diversity is introduced by modification of the growing chain 
catalyzed by various auxiliary domains such as epimerization (E), N-methylation (MT), 
cyclization (Cy) and oxidoreductase (Ox) domains (Stachelhaus and Marahiel 1995; 
Marahiel et al. 1997; Konz and Marahiel 1999; Mootz et al. 2002; Challis and Naismith 
2004; Salomon et al. 2004) (Fig. 4.4A).   
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A.  NRPS assembly system 
 
 
B.  PKS assembly system 
 
 
 
 
 
 
 
Furthermore, polyketides are also synthesized on multi-modular enzymes called 
polyketide synthases. Each PKS module is responsible for the incorporation of one 
acetate or propionate unit into the growing ketide chain (Schwarzer and Marahiel 2001). 
The initiation module starts with the selection of the acyltransferase domain (AT) of an 
activated acyl-CoA monomer which then transfers the acyl-CoA to the adjacent acyl 
carrier protein (ACP). This chain is transferred from the ACP to the upstream 
ketosynthase domain (KS) required for catalyzing the decarboxylation of the carboxyclic 
acid and subsequent Claisen condensation between the growing chain and the 
downstream ACP extender unit. Structural diversity is introduced by optional reductive 
domains such as: keto-reductase (KR) reducing the carbonyl to hydroxyl group; 
dehydratase (DH) dehydrating alcohol to form a form a double bond; and enoyl reductase 
(ER) reducing the double bond to a fully saturated methylene. Other unusual starter 
molecule such as amino acids and fatty acid derivatives are also incorporated to produce 
diverse polyketide structures. Additional auxiliary domains include methyl transferase 
Fig. 4.4 Domain organization and mechanisms for modular biosynthetic pathway systems (A)
Nonribosomal peptide synthetase (NRPS) and (B) Polyketide synthase (PKS). C, condensation;
A, adenylation; PCP, peptidyl carrier protein; E, epimerase; Cy, cyclization; Ox, oxidoreductase; 
KS, ketosynthase; AT, acyl transferase; ACP, acyl carrier protein; DH, dehydratase; KR,
ketoreductase; ER, enoyl reductase; TE, thioesterase; MT, methyl transferase. (Salomon et al. 
2004) 
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(MT). The complete elongated and functionalized chain is often transferred to a final 
thioesterase domain (TE) capable of catalyzing the hydrolytic release of a linear 
compound or a hydrolytic release coupled with cyclization to generate a macrolactone 
structure (Hopwood 1997; Rawlings 1997; Hutchinson 1999; Salomon et al. 2004; 
Sherman and Smith 2006; Ridley et al. 2008) (Fig. 4.4B). There are three major classes 
of PKS systems (type I, II and III) according to their mode of synthesis and structural type 
of product. Type I PKSs in bacteria are multi-enzyme complexes organized into individual 
linear modules responsible for a single, specific chain elongation process and β-carbonyl 
post condensation modification. Type II, or aromatic PKSs are complexes of mono-
functional proteins characterized by their iterative use of a single set of distinct enzymes 
to construct polyketide chains which are then cyclized to produce small molecules with 
aromatic ring systems. The third type belongs to the chalcone and stilbene synthase 
family of enzymes from plants and unlike the Type I and II systems, contain one protein, a 
single domain and active site to carry out the three essential mechanisms of chain 
initiation, elongation and cyclization (Salomon et al. 2004). 
 
NRPS system of Streptomyces sp. strain Aer003 
An interesting type of NRPS system was detected and identified in Streptomyces sp. 
strain Aer003 and was found to be widely distributed in different sponge samples, an 
ascidian as well as from seawater as supported by phylogenetic analysis of their 
adenylation domains. These results also indicate that the peptide encoded by this 
biosynthetic cluster is of actinobacterial origin and that this could be produced by 
actinomycetes associated with the invertebrate samples that are presumably not of 
symbiont nature since the same NRPS system was found in seawater. Notably, the 
overlap between PCR-based, culture-independent identification of a widely distributed 
seawater and sponge-associated bacteria and successful isolation of a corresponding 
strain is extremely rare. So far, this is the first report of a widely distributed NRPS system 
present in a cultivated actinomycete strain as well as in different sponge species.   
 
Since an entire biosynthetic cluster could not be constructed from the sequence data of 
the two cosmids, prediction of the peptide product is therefore not possible. The only 
speculations that can be drawn from the individual modules are the amino acids that are 
incorporated into the peptide chain. In most NRPS systems, the organization of the 
modules maps in a 1:1 manner to the amino acid sequence of the peptide products 
following the co-linearity principle and therefore allowing the possibility of assigning a 
specific amino acid activation function to each module (Challis et al. 2000). From the 
partial cluster flanked by the NRPS regions in cosmid 1/C13, 4-hydroxy-phenylglycine, 
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aspartic acid and an unknown modified amino acid constitute the peptide product, without 
any modification after release of the product.  On the other hand, the peptide product of 
the 2/E12 NRPS cluster consists also of 4-hydroxy-phenylglycine and an unknown 
modified amino acid.  Additionally, the thioester-bound amino acid to 4’-
phosphopantetheine co-factor in the thiolation domain is converted from the L- into the D- 
configuration as evidenced by the presence of the additional epimerization domain in both 
modules found in this cosmid. Whether the peptide has additional amino acids 
incorporated still remains to be elucidated by finding the preceding modules that make up 
the entire cluster. It also remains unclear whether the peptide is structurally related to 
enduracidin as previously shown by phylogenetic analysis of the A domains with that of 
Streptomyces fungicidus. It can be speculated further that the cosmids are part of 
different NRPS gene clusters and that these probably encode a large peptide molecule.  
 
In a previous study, the crude ethyl acetate extract obtained from Streptomyces sp. strain 
Aer003 exhibited antibacterial activity against Staphylococcus aureus (Scheuermayer 
2006).  It is therefore interesting to pursue the chemical analysis of the metabolite to 
identify the compound responsible for the biological activity. The NRPS gene cluster 
identified in this particular strain provides a valuable hint that the bioactive compound 
could possibly be the same peptide encoded by the said cluster.  Identification of the 
entire biosynthetic cluster is beyond the scope of this Ph.D. study but nevertheless 
warrants further investigation.  Primers flanking the ends of the two NRPS-bearing 
cosmids can be designed to screen the genomic library to find overlapping cosmids to 
assemble the rest of the NRPS cluster.  Prediction of the chemical structure and 
biosynthetic pathway of the encoded peptide will therefore be possible having the 
sequence of a complete biosynthetic cluster and the isolation of such peptide from the 
strain will be a worthwhile task. 
 
PKS system of Saccharopolyspora cebuensis SPE 10-1T 
The second actinomycete strain where the biosynthetic gene cluster was investigated in 
detail is Saccharopolyspora cebuensis SPE 10-1. A type I PKS system was detected in 
this isolate.  Furthermore, the strain has also been found to produce the macrolactam 
polyketides, cebulactams A1 and A2 (Pimentel-Elardo et al. 2008). Since the entire PKS 
cluster was not completely sequenced, the ASMPKS (Analysis System for Modular 
Polyketide Synthesis) (Tae et al. 2007) online tool 
(http://gate.smallsoft.co.kr:8008/~hstae/asmpks/index.html) was used to predict the PKS 
domain organization and biosynthetic pathway for these polyketides and then compared 
with identified PKS genes in the sequenced cosmids.  As is typical of all ansamycins, the 
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carbon skeleton of cebulactams from S. cebuensis strain SPE 10-1T is assembled from 
the 3-amino-5-hydroxybenzoic acid (AHBA) starter unit (Kim et al. 1998) followed by 
successive condensation of two-carbon building blocks in four chain-elongation steps 
each utilizing methylmalonyl extender units (Fig. 4.5). Each module loads one 
methylmalonyl unit into the growing ketide chain. The involvement of this particular 
extender unit is further confirmed by the identification of two methylmalonate-specific AT 
domains in the sequenced cosmids.  In this proposed pathway, the activated form 
methylmalonyl-CoA is added to the following carbon skeletons: C2 (module 1), C4 
(module 2), C6 (module 3) and C8 (module 4). Modification of the ketide chain appears to 
involve the reduction of the β-keto function (modules 1-3) by the auxiliary KR domain as 
well as dehydratization of the β-hydroxyl group (module 3) by the DH domain in the 
polyketide assembly. The involvement of these domains is confirmed by their presence in 
the sequenced cosmids such as ORF 5 (3/B3) bearing KR-ACP-KS-AT either flanking 
modules 1 and 2 or modules 2. Furthermore, ORFs 1 and 2 (1/J17_c11) bearing DH-KR-
ACP-KS-AT can be found in modules 3 and 4 (Fig. 4.5). Final product release is made 
possible by the TE or thiosterase domain.  As with all ansamycins, the C-terminus of the 
assembled polyketide eventually forms an amide linkage to the amino group of the AHBA 
moiety to close the macrolactam ring (Kim et al. 1998).  An additional PKS tailoring 
maybe involved in the oxidation of the aromatic system and cyclization as well as an 
isomerase enzyme to account for the production of the two constitutionally identical 
cebulactam polyketides by Saccharopolyspora cebuensis. Although not all predicted 
modules are found in the sequenced cosmids, these domains displayed close homologies 
with biosynthetic gene clusters such as the archetype ansamycin, rifamycin produced by 
Amycolatopsis mediterranei (August et al. 1998) and structurally striking similarities with 
the benzoquinone ansamycins  geldanamycin (Rascher et al. 2003) and herbimycin 
(Rascher et al. 2005) both produced by Streptomyces hygroscopicus. Only one set of 
AHBA synthesis genes was found in the cosmids indicating that there is a single PKS 
cluster involved in the synthesis of the cebulactams. The same set of AHBA synthesis 
genes can also be found clustered together in the rifamycin biosynthetic cluster (August 
et al. 1998).  
 
Identification of the whole biosynthetic cluster encoding for the cebulactams is indeed 
worthwhile pursuing.  Additional primers can be designed to find cosmid clones that 
harbor overlapping regions with the current cosmid sequences to complete the missing 
domains in the different modules. With the complete PKS gene cluster, the proposed PKS 
assembly as well as the cebulactam biosynthetic pathway described here can thus be 
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confirmed.  Furthermore, gene disruption studies can be carried out to prove the identity 
of the cluster and its involvement in the biosynthesis of cebulactams or other polyketides, 
if any, that this organism may be capable of producing.   
 
. 
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Chapter 5 
General discussion and outlook 
 
5.1 Secondary metabolite recovery by cultivation 
Marine actinomycetes are abundant in various ocean sediments (Grein and Meyers 1958; 
Mincer et al. 2002; Fiedler et al. 2005; Jensen et al. 2005; Maldonado et al. 2005; 
Bredholdt et al. 2007), with an estimated >13,000 different actinobacterial taxonomic 
units, a great proportion of which are predicted to represent novel species and genera 
(Stach and Bull 2005). Actinomycetes, or members of the phylum Actinobacteria have 
also been derived from marine sponges using cultivation-dependent and cultivation-
independent approaches (Webster and Hill 2001; Webster et al. 2001; Hentschel et al. 
2002; Kim et al. 2005; Montalvo et al. 2005; Zhang et al. 2006; Jiang et al. 2007; Xin et al. 
2008). The strains cultivated in this Ph.D. study have not been isolated from sponges 
before. Their absence in the sponge-derived 16S rRNA gene libraries suggests that the 
strains are probably not sponge symbionts but rather transient bacteria that were 
incidentally present during the collection of the sponge samples.  It is also highly likely 
that these strains are present in the surrounding seawater or sediments and that there is 
a given probability of re-isolating the same strains. 
 
The isolation strategy used in this study has yielded six diverse actinomycete genera 
comparable to those isolated from previous cultivation-dependent studies (Webster et al. 
2001; Montalvo et al. 2005; Zhang et al. 2006; Jiang et al. 2007). Several known 
actinomycete species were cultivated, the majority of which belonged to the ubiquitous 
genus Streptomyces. Interestingly, two novel actinomycete taxa were isolated, namely  
Saccharopolyspora cebuensis (Pimentel-Elardo et al. 2008c), the first obligate marine 
strain of this genus and Streptomyces axinellae (Pimentel-Elardo et al. 2008b). There are 
however, other cultivation media and pretreatments that can be employed aside from 
those used in this Ph.D. study to isolate taxonomically novel and rare actinomycetes. For 
example, the use of low-nutrient media (Santavy and Colwell 1990; Olson et al. 2000) can 
be used to selectively isolate for oligotrophic bacteria that have the competitive 
advantage to reproduce even with the minimal concentrations of organic substances in 
the medium (Kuznetsov et al. 1979). The use of humic acid-vitamin agar medium 
facilitates the efficient recovery of actinomycetes and promotes sporulation while 
restricting the growth of non-filamentous bacterial colonies. Humic acids are 
heterogenous cross-linked polymers that are generally resistant to biological 
decomposition and are utilized by actinomycetes as sources of carbon and nitrogen in the 
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medium  (Hayakawa 2008). Furthermore, the use of pretreatments such as UV irradiation 
and high frequency radiations have been shown to effectively stimulate the germination 
and outgrowth of spores of rare actinomycete genera (Bredholdt et al. 2007).  The 
chemotactic method using xylose and γ-collidine has also been proven to be effective for 
isolating motile and novel actinomycetes (Takahashi and Omura 2003; Hayakawa 2008). 
The cultivation media can also be supplemented with other antibiotics such as 
novobiocin, rifampicin and chlortetracycline and gellan gum can be used instead of agar 
as solidifying agent to select for specific actinomycete genera (Takahashi and Omura 
2003). 
 
The cultivation of Saccharopolyspora cebuensis and Streptomyces axinellae, producing 
cebulactams (Pimentel-Elardo et al. 2008a) and tetromycin derivatives, respectively 
further underlines the potential of taxonomically novel actinomycetes to produce new 
secondary metabolites. This can be explained by the premise that novel species will most 
probably contain unique compounds and that the evolution of novel secondary 
metabolites acts as the driving force for bacterial speciation (Czaran et al. 2002; Bull and 
Stach 2007). It is a given fact that actinomycetes are known to produce bioactive 
secondary metabolites, particularly antibiotics. The genus Streptomyces produces 80% of 
currently characterized actinomycete natural products with a predicted diversity 
exceeding 100,000 (Watve et al. 2001) and with other smaller contributions from genera 
such as Saccharopolyspora, Amycolatopsis, Micromonospora and Actinoplanes (Challis 
and Hopwood 2003). Secondary metabolites are non-essential for the growth of the 
producing organism and the metabolic pathways are only activated during particular 
stages of growth or during periods of stress caused by nutritional limitation or microbial 
attack (Mann 1987). Furthermore, the biosynthetic pathways for secondary metabolite 
production are usually activated in the late logarithmic to the stationary phase of the 
growth period, after cell division and biomass accumulation have ceased (Yarbrough et 
al. 1993). For example, Streptomyces antibiotics are typically produced in small amounts 
at the transition phase when the growth of the vegetative mycelium is slowing as a result 
of nutrient exhaustion while the aerial mycelium starts to develop at the expense of the 
nutrients released by the breakdown of the vegetative hyphae (Miguelez et al. 2000; 
Challis and Hopwood 2003). These antibiotics have been proposed to defend the food 
source from competing microorganisms that are attracted to the amino acids, sugars and 
other small molecules arising from the degraded vegetative mycelium (Shi and Zusman 
1993; Challis and Hopwood 2003).  
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Given the metabolic diversity of actinomycetes, it is highly probable that the strains 
cultivated in this Ph.D. study are capable of producing several additional compounds. The 
use of a starch-based M1 medium (Mincer et al. 2002) has been shown to be effective for 
cultivating marine actinomycetes and promote secondary metabolite production in this 
study as well as in other previous studies (Mincer et al. 2002; Soria-Mercado et al. 2005; 
Kwon et al. 2006). Nevertheless, the culture media and other growth conditions can also 
be manipulated not only to cultivate novel taxa such as the alternative methods previously 
mentioned, but also to fully exploit the metabolic potential of actinomycetes. Strain 
optimization for secondary metabolite production was not the major aim of this study, yet 
this endeavor is worthwhile to pursue. In fact, it has been shown that a single strain has 
the potential to produce various compounds when grown under different culture 
conditions. The so-called OSMAC (‘one strain-many compounds’) approach has yielded 
more than 100 compounds belonging to more than 25 different structural classes from 
only six different microorganisms (Bode et al. 2002). Metabolite diversity and production 
are functions of the biosynthetic capabilities of the organism and thus, fermentation 
parameters can be manipulated to encourage the production of diverse secondary 
metabolites (Yarbrough et al. 1993).  Previous studies have also shown that even small 
changes in the cultivation conditions can completely shift the metabolic profile of various 
microorganisms, including actinomycetes (Bode et al. 2002). The organism should be first 
grown in a seed medium that has been optimized to promote cell growth and once the 
organism has grown, these can be transferred to multiple production media, varying for 
example in carbon and nitrogen sources and other cultivation parameters (i.e. CaCO3 or 
Al2O3 and pH alteration) to promote the production of different metabolites. However, this 
approach poses practical limitations particularly when handling numerous strains.  For 
example, a limited number of growth conditions can only be applied to each strain. 
Therefore, there is a need for a high throughput screening that allows the exhaustive 
analyses of the effects of fermentation on secondary metabolite production of numerous 
strains. The application of HPLC for the selection of production media for actinomycetes 
based on their metabolite profiles provides a useful tool for identifying growth conditions 
that support the synthesis of secondary metabolites (Tormo et al. 2003). Tormo and co-
workers (2003) have shown that each strain can be grown in a panel of ten media or 
different culture conditions in a small-volume format and the metabolite profiles of each 
extract can be analyzed by high pressure liquid chromatography coupled with photodiode 
array detection (HPLC-DAD) in a semi-automated fashion. The media or growth 
conditions with the most diverse and least overlapping chemical profiles can then be 
selected and scaled-up to the appropriate volumes required for secondary metabolite 
isolation. The use of mass spectrometry (i.e. direct infusion electrospray) can be used to 
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complement this method to guide the development of improved conditions for expression 
of secondary metabolites from actinomycetes (Higgs et al. 2001; Zahn et al. 2001). 
Efficient dereplication protocols including access to current natural products databases 
should also be designed to minimize re-isolation of previously identified compounds 
(VanMiddlesworth and Cannell 1998). Another consideration is finding the optimal 
method to capture the secondary metabolites for bioactivity screening. The metabolites of 
interest may include intracellular molecules and/or those that are secreted into the 
fermentation media. In this Ph.D. study, both types of metabolites were extracted by lysis 
of the cells with methanol to release intracellular components followed by organic solvent 
partitioning of the whole broth or in the case of solid cultures, direct extraction of the 
mycelial mass with ethyl acetate. Methanol has been shown to dissolve most natural 
products at the same time enhancing their release from the cellular matrix or cell surface 
by permeabilizing the physical barrier of the cell walls (Cannell 1998) and the bulk of the 
insoluble material was then removed by filtration. There are however, alternative methods 
to capture and concentrate as many diverse metabolites as possible with the general 
consideration that the method should not interfere with succeeding bioassays. One 
alternative is filtration of the broth supernatant through a high molecular weight exclusion 
filter with subsequent freeze-drying of the filtrate. Another method involves mixing of the 
whole broth with polystyrene resin followed by washing with water and eluting the bound 
materials using methanol or acetone (Yarbrough et al. 1993; Fiedler et al. 2005; Soria-
Mercado et al. 2005; Kwon et al. 2006). The latter method has been utilized in this Ph.D. 
study to isolate the cebulactams from the strain S. cebuensis (data not shown). The use 
of Amberlite XAD-7 adsorbent resin (Sigma) and elution with methanol produced low 
yields of the compounds as compared to solvent partitioning with ethyl acetate which 
proved to be a more effective extraction method. Therefore, each strategy has its own 
advantages as well as limitations and metabolite properties vary among strains. Factors 
such as efficiency in optimum isolation of the metabolites, assay compatibility and cost 
should thus be considered. 
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5.2 Secondary metabolite recovery by cultivation-independent techniques 
Genome sequencing of actinomycetes and other microorganisms has revealed several 
biosynthetic enzymes unrelated to known metabolites, indicating that natural products are 
still underexplored (Van Lanen and Shen 2006). Actinomycetes producing NRPS and 
PKS-derived compounds have multiple biosynthetic gene clusters, consisting of an 
average of 12 clusters per genome (Farent and Zazopoulos 2005; Bull and Stach 2007). 
Furthermore, actinomycetes with large genomes devote 5-10% of their coding capacity to 
secondary metabolism (Bentley et al. 2002; Ikeda et al. 2003; Oliynyk et al. 2007; Udwary 
et al. 2007; Baltz 2008). The field of genomics has also paved the way for the discovery 
of orphan biosynthetic gene clusters that are phenotypically silent but capable of 
activation by fermentation and/or genetic manipulation (Bull and Stach 2007). For 
instance, when 60 actinomycete species were screened by traditional fermentation 
procedures, these were found to produce 65 natural products which is in contrast to the 
results obtained from genome scanning of the same species revealing ∼700 natural 
product biosynthetic gene clusters including those found by fermentation (Farent and 
Zazopoulos 2005). 
 
Sponge microbiota
Identification of 
producing microbe
Genomic library 
construction
Biosynthetic gene 
cluster identification
Optimization of 
culture conditions
Fermentation and 
compound production
Cloning and heterologous
expression
Novel anti-infectives
A B
Fig. 5.1 Culture-dependent (A) and culture-independent (B) strategies to access the 
biosynthetic potential of sponge-associated microorganisms 
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It is therefore not surprising that NRPS and PKS systems were detected in all of the 
actinomycete strains cultivated in this Ph.D. study. In particular, an interesting NRPS 
system found in Streptomyces sp. strain Aer003 was also detected in several sponge 
samples, in an ascidian and in seawater revealing the wide distribution of such system. 
These results also indicate that the NRPS system is of actinobacterial origin, thus 
pointing out the possible involvement of actinomycetes in the secondary metabolism of 
these marine invertebrates. Sequencing results of the NRPS-bearing cosmids from the 
genomic library of the strain indicated the involvement of different gene clusters encoding 
for a large peptide molecule.  However, identification of the entire biosynthetic cluster as 
well as prediction of the encoded peptide were beyond the scope of this PhD study but 
nevertheless warrants further investigation. On the other hand, the polyketide gene 
cluster of Saccharopolyspora cebuensis strain SPE 10-1T was investigated.  Sequencing 
results of the PKS-bearing cosmids from the genomic library of this strain pointed out the 
involvement of 3-amino-5-hydroxybenzoic acid (AHBA) as the starter unit of the 
polyketide. This is further supported by the isolation of the novel polyketides, cebulactam 
A1 and cebulactam A2 (Pimentel-Elardo et al. 2008a) produced by the strain. Moreover, 
prediction of the cebulactam biosynthetic pathway also revealed the involvement of AHBA 
synthase in its initiation module followed by the successive condensation in a series of 
chain-elongation steps each utilizing methylmalonyl extender units. The involvement of 
auxiliary domains and other PKS tailoring enzymes is also predicted to be responsible for 
the novelty of the compound structures.  Biosynthetic feeding studies or gene disruption 
work should be carried out to provide actual insights into the polyketide biosynthetic 
pathway and eventually prove the identity of the gene cluster present in this novel 
actinomycete strain. 
 
There are different strategies involved in developing an integrated biosynthetic study that 
can be used to fully exploit the secondary metabolite potential of sponge-associated 
microorganisms (Fig. 5.1). Using the cultivation-independent approach, gene cluster 
sequences can be probed from metagenomic libraries constructed for example, from the 
microbial consortia of marine sponges. The cluster sequences can be compared with 
those found in online databases to identify related genes and their source organisms. The 
compound-specific genes combined with 16S rRNA probes can be used to identify and 
localize the source of the cluster (Salomon et al. 2004). The identification of the likely 
microbial producer can direct efforts to better replicate appropriate conditions to obtain 
the producing microorganism in culture using the cultivation-dependent approach. 
Moreover, identification of the gene cluster will provide valuable information about the 
secondary metabolite. A major step in identifying specific gene clusters is predicting the 
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biosynthetic pathway of the encoded secondary metabolites. This is crucial for the 
identification of specific key enzymes that can be used as molecular probes to screen 
genomic libraries (Salomon et al. 2004).  Furthermore, heterologous expression of the 
gene clusters in suitable hosts for compound production poses a major hurdle.  The 
implementation of a genetically similar host strain should maximize the potential for 
productive transcription, translation and finally, metabolite production (Fortman and 
Sherman 2005). Heterologous expression has been achieved from entire biosynthetic 
clusters of actinomycetes (Martinez et al. 2004) and circumvents the need for numerous 
fermentations to obtain the compound of interest. More importantly, this valuable 
technique offers a sustainable supply of important bioactive metabolites.  
 
In summary, this Ph.D. study has clearly shown that diverse actinomycete genera are 
associated with marine sponges, highlighting the cultivation of two new actinomycete 
species. Although their functions in sponges are not known, it is evident that these 
actinomycetes play an important role in secondary metabolite production. The strains 
produced diverse chemical structures including new (cebulactams A1 and A2, tetromycin 
derivatives) and known (valinomycin, staurosporine, cycloisoleucylprolyl, butenolide) 
compounds with interesting anti-infective properties, underscoring the potential of the 
novel actinomycete taxa to produce novel compounds. Lastly, the presence of 
biosynthetic gene clusters identified in this study substantiates the biosynthetic potential 
of actinomycetes to produce exploitable natural products and hopefully provide a 
sustainable supply of anti-infective compounds. 
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ANNEX 
 
I. Abbreviations and Acronyms 
δC   chemical shift (ppm), 13C NMR 
δH   chemical shift (ppm), 1H NMR 
°C   degree Celsius  
ASW  artificial seawater 
ATP   adenosine triphosphate 
BLAST  basic local alignment search tool 
bp   base pair 
br (NMR)  broad 
ca.   approximately 
13C NMR  correlation spectroscopy 
COSY  carbon nuclear magnetic resonance 
d (NMR)  doublet 
dd (NMR)  double doublet 
dq (NMR)  double quartet 
DNA  deoxyribonucleic acid 
dNTP  deoxynucleotide triphosphate 
EtOH  ethanol 
EtOAc  ethyl acetate 
g   gram   
h   hour 
H2Od  distilled water 
H2Odd  double distilled water 
HMBC  heteronuclear multiple bond correlation 
1H NMR  proton nuclear magnetic resonance 
HPLC  high performance liquid chromatography 
HSQC  heteronuclear single quantum coherence 
Hz   hertz 
IC50  concentration required for 50% inhibition 
J   coupling constant 
kb   kilobase 
L   liter 
M   molar  
m (NMR)  multiplet 
MHz  megaherz 
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MeOH  methanol 
mg   milligram 
MIC  minimum inhibitory concentration 
min  minute 
ml   milliliter 
mM  millimolar 
MS   mass spectrometry 
mult  multiplicity 
NMR  nuclear magnetic resonance 
NRPS  nonribosomal peptide synthetase 
OD   optical density 
ORF  open reading frame 
PCR  polymerase chain reaction 
PKS  polyketide synthase 
ppm  parts per million 
RFLP  restriction fragment length polymorphism 
rDNA  ribosomal DNA 
rRNA  ribosomal RNA  
RNA  ribonucleic acid 
rpm  revolutions per minute 
Rt   retention time 
RT   room temperature 
s   second 
s (NMR)  singlet 
sp.   species 
strainT  type strain 
t (NMR)  triplet 
TFA  trifluoroacetic acid 
U   enzyme units 
μg   microgram 
μl   microliter 
μM   micromolar 
V   volt 
       w/v   weight per volume 
      vol/vol  volume per volume  
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II. Buffers, Solutions and Media 
The following were sterilized by autoclaving at 121°C for 30 min. Antibiotics and other 
solutions, when specified are added to the media at hand warm temperature following 
sterilization. Media containing agar were aseptically poured into sterile disposable Petri 
dishes and allowed to solidify at room temperature. 
 
A. Buffers and Solutions 
1. Artificial seawater 
  NaCl 234.70 g 
  Na2SO4  39.20 g 
  MgCl2.6H2O 106.40 g 
  CaCl2 11.00 g 
  NaHCO3 1.92 g 
  KCl 6.64 g 
  KBr 0.96 g 
  H3BO3 0.26 g 
  SrCl2 0.24 g 
  NaF 0.03 g 
H2Odd    ad      10.00 L 
 
2. EDTA (ethylenediamine tetraacetic acid) (0.5 M, pH 8.0) 
Na2EDTA.2H2O     93.05 g 
NaOH (10 M)  ca.    25.00 ml 
H2Odd              ad    500 ml 
The pH of the solution was adjusted to 8.0 with NaOH since EDTA does 
not go dissolve until the pH reaches 7.0. Water was added to make a final 
volume of 500 ml. 
 
3. Gel-loading buffer (5x) 
Bromphenol blue     25.0 mg 
Xylene cyanol      25.0 mg 
Ficoll (type 400)     1.5 g 
H2Odd   ad    10.0 ml 
4. IPTG  (Isopropyl-β-D-thiogalactopyranoside) (1 M) 
IPTG       2.38 g 
H2Odd   ad    10.00 ml 
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5. MgSO4 (1 M) 
MgSO4.7H2O    24.6 g 
H2Odd   ad  100.0 ml 
6. NaCl (5 M) 
NaCl     292.2 g 
H2Odd   ad  100.0 ml 
7. Phage dilution buffer 
NaCl (1 M)    1.0 ml 
MgCl2 (1 M)    0.1 ml 
Tris-Cl (1 M, pH 8.3)   0.1 ml 
H2Odd   ad  10.0 ml  
8. Plasmid mini-prep buffers 
Buffer P1 
 Tris-Cl (1 M, pH 7.5)   5.0 ml 
 EDTA (0.5 M, pH 8.0)   2.0 ml 
 RNAse A (10 mg/ml)   1.0 ml 
H2Odd   ad  100.0 ml 
Buffer P2 
   NaOH (2 M)    5.0 ml 
   SDS (10%)    10.0 ml 
H2Odd   ad  100.0 ml     
Buffer P3 
 Potassium acetate   29.4 g 
 Glacial acetic acid  ca.  11.5 ml 
 H2Odd   ad  100.0 ml 
The pH of the solution was adjusted to pH to 5.5 using glacial acetic acid 
and water was added to make a final volume of 100 ml. 
 
9. SDS (sodium dodecyl sulfate) solution (10% w/v) 
SDS     10.0 g 
H2Odd   ad  100.0 ml  
SDS was first dissolved in 80 ml water, with warming at 50°C to accelerate 
dissolution. The pH of the solution was adjusted to 7.0 by adding several 
drops of concentrated HCl and water was added to make a final volume of 
100 ml. 
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10. SET buffer 
NaCl (1 M)    750 μl 
EDTA (0.5 M, pH 8.0)   500 μl 
Tris-Cl (1M, pH 7.5)   200 μl 
H2Odd   ad  10.0 ml   
11. Sodium acetate (3 M) 
Sodium acetate.3H2O   40.8 g 
H2Odd   ad         100.0 ml 
12. TAE buffer (5x) 
Tris base    242.00 g 
Sodium acetate.3H2O   136.12 g 
Na2EDTA.2H2O   19.00 g 
H2Odd   ad         1.00  L 
Dissolve the above reagents in 700 ml water and adjust the pH to 7.2 with 
acetic acid. Add water to make a final volume of 1 L.  
 
13. TE buffer 
Tris-Cl (2 M, pH 7.4)   0.5 ml 
EDTA (0.5 M, pH 8.0)   20.0 μl 
H2Odd   ad         100.0 ml 
14. Tris-Cl (2 M, pH 7.4) 
Tris     242.2 g 
H2Odd   ad         1.0  L 
The pH of the solution was adjusted to 7.4 by adding about 140 ml 
concentrated HCl and water was added to make a final volume of 1 L.  
 
15. X-gal (5-bromo-4-chloro-3-indolyl-β-D-galactoside) (5% w/v) 
X-gal     0.5 g 
Dimethylformamide     ad  10.0 ml 
B. Media 
1. Czapek medium 
NaNO3     3.0 g 
K2HPO4    1.0 g 
MgSO4 .7H2O    0.5 g 
KCl     0.5 g 
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FeSO4.7H2O    10.0 mg 
Saccharose    30.0 g 
Agar     18.0 g 
H2Od   ad  1.0 L 
2. ISP 2  
Yeast extract    4.0 g 
Malt extract    10.0 g 
Glucose    4.0 g 
Agar     18.0 g 
H2Od   ad  1.0 L 
3. ISP 3  
Oatmeal    20.0 g 
Agar     18.0 g 
H2Od   ad  1.0 L 
4. ISP 4  
Soluble starch    10.0 g 
K2HPO4    1.0 g 
MgSO4    1.0 g 
NaCl     1.0 g 
(NH4)2SO4    2.0 g 
CaCO3     2.0 g 
FeSO4.7H2O    1.0 mg 
MnCl2.4H2O    1.0 mg 
ZnSO4.7H2O    1.0 mg 
Agar     18.0 g 
H2Od   ad  1.0 L  
5. ISP 5 
Glycerol    10.0 g 
Asparagine    1.0 g 
K2HPO4    1.0 g 
Trace element solution  1.0 ml 
H2Od   ad  1.0 L   
6. ISP 6 
Peptone    15.0 g 
Proteose peptone   5.0 g 
K2HPO4    1.0 g 
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Yeast extract     1.0 g 
Ferric ammonium citrate   0.5 g 
   Sodium thiosulfate    0.08 g 
   Agar      18.0 g 
H2Od   ad   1.0 L 
7. ISP 7 
L-tyrosine     1.0 g 
Agar      18.0 g 
H2Od   ad   1.0 L 
8. LB (Luria-Bertani) agar 
Peptone     10.0 g 
Yeast extract     5.0 g 
NaCl      5.0 g 
Agar      18.0 g 
H2Od   ad   1.0 L 
9. LB/amp 
LB agar     1.0 L 
   Ampicillin (100 mg/ml)              1.0 ml 
Filter-sterilized ampicillin (100 μg/ml) was added to LB agar after 
autoclaving. 
 
10. LB/amp/IPTG/X-gal  
LB agar      1.0 L 
Ampicillin (100 mg/ml)               1.0 ml 
IPTG (1 M)      0.4 ml 
X-gal (5%)      1.6 ml 
  Filter-sterilized ampicillin (100 μg/ml), IPTG (0.5 mM) and X-gal (80  
  μg/ml) were added to LB agar after autoclaving. 
 
11. M1 
Soluble starch      10.0 g 
Yeast extract      4.0 g 
Peptone      2.0 g 
Agar       18.0 g       
Artificial seawater ad    1.0 L 
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12. M2 
Glycerin (100%)    6.0 ml 
Arginine     1.0 g 
K2HPO4     1.0 g 
MgSO4                0.5 g 
Agar      18.0 g 
Artificial seawater ad   1.0 L 
13. M7 
Peptone     2.0 g 
Asparagine                 0.1 g 
Sodium propionate    4.0 g 
K2HPO4     1.0 g 
MgSO4                0.1 g 
FeSO4      0.001 g 
Glycerol     5.0 g 
NaCl      20.0 g 
Agar      18.0 g 
Artificial seawater ad   1.0 L 
14. MS  
Mannitol     20.0 g 
Soybean flour     20.0 g 
Agar      18.0 g 
H2Od   ad   1.0 L 
15. NaSt21Cx 
Solution A 
K2HPO4     1.0 g 
Agar      18.0 g 
Artificial seawater               750.0 ml 
  Solution B 
   KNO3      1.0 g 
   MgSO4     1.0 g 
   CaCl2.2H2O     1.0 g 
   FeCl3      0.2 g 
   MnSO4.7H2O     0.1 g  
Artificial seawater               250.0 ml 
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Solutions A and B were autoclaved separately and subsequently 
combined. Trace element solution (1 ml) was added to the final solution. 
 
  Trace element solution 
   ZnSO4.7H2O     0.1 g 
   FeSO4.7H2O     0.1 g 
   MnCl2.4H2O     0.1 g 
   CaCl2.6H2O     0.1 g 
   NaCl      0.1 g 
   Distilled H2O   ad   1.0 L  
16. SOC medium 
Tryptone     20.0 g 
Yeast extract     5.0 g 
NaCl (1 M)     10.0 ml 
KCl (1 M)     2.5 ml 
MgCl2 (1 M)     10.0 ml 
MgSO4 (1 M)     10.0 ml 
Glucose (2 M)     10.0 ml 
H2Od   ad   1.0 L 
Tryptone (2%), yeast extract (0.5%), NaCl (10 mM) and KCl (10 mM) were 
added to 970 ml distilled water prior to autoclaving. The following filter-
sterilized solutions: MgCl2 (10 mM), MgSO4 (10 mM) and glucose (20 mM) 
were subsequently added to the medium after autoclaving. 
   
17. YPD medium 
Yeast extract     10.0 g 
Peptone     20.0 g 
Glucose     20.0 g 
H2Od   ad   1.0 L 
18. Zobell medium 
Yeast extract     1.0 g 
Peptone       5.0 g 
Artificial seawater               750.0 ml 
H2Od   ad   1.0 L 
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III. Chemicals  
Chemical name Manufacturer 
Acetic acid AppliChem 
Acetonitrile Sigma 
Agar, granulated Difco 
Agarose, ultrapure Gibco 
Ammonium sulfate [(NH4)2SO4] AppliChem 
Ampicillin  AppliChem 
Arginine Sigma 
Asparagine Sigma 
Boric acid (H3BO3) AppliChem 
5-bromo-4-chloro-3-indolyl-β-D-galactoside (X-Gal) Sigma 
Bromphenol blue Merck 
Calcium carbonate (CaCO3) AppliChem 
Calcium chloride (CaCl2) AppliChem 
Chloramphenicol Sigma 
Chloroform Roth 
Cycloheximide Sigma 
Diaion HP-20ss Mitsubishi 
Dipotassium hydrogen phosphate (K2HPO4) Roth 
Dimethylformamide AppliChem 
Dimethylsulfoxide Sigma 
Ethanol absolute (EtOH) Merck 
Ethanol denatured (EtOH) Roth 
Ethidium bromide (1% solution)  Roth 
Ethyl acetate Roth 
Ethylenediamine tetraacetic acid dihydrate 
(Na2EDTA.2H2O) 
Serva 
Ferric ammonium citrate AppliChem 
Ferrous sulfate heptahydrate (FeSO4 .7H2O) Fluka 
Gentamicin Sigma 
Glucose  AppliChem 
Glutaraldehyde Sigma 
Glycerin/ Glycerol  Roth 
Hydrochloric acid (HCl) AppliChem 
Isopropanol  Roth 
Isopropyl-β-D-1-thiogalactopyranoside (IPTG) Sigma 
Kanamycin Merck 
Lincomycin Sigma 
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Chemical name Manufacturer 
Malt extract AppliChem 
Magnesium chloride hexahydrate (MgCl2.6H2O) AppliChem 
Manganous chloride tetrahydrate (MnCl2. 4H2O) AppliChem 
Magnesium sulfate heptahydrate (MgSO4.7H2O) AppliChem 
Mannitol AppliChem 
Methanol Sigma, Roth 
Nalidixic acid Sigma 
Nystatin Sigma 
Oatmeal Gesitz Haferflockenfabrik 
Osmium tetroxide Sigma 
Oxacillin Sigma 
Penicillin Sigma 
Peptone Roth 
Phenol  AppliChem 
Phytagel Sigma 
Potassium acetate  AppliChem 
Potassium bromide (KBr) AppliChem 
Potassium chloride (KCl) Fluka 
Potassium nitrate (KNO3) AppliChem 
Propylene oxide Roth 
Rifampin Sigma 
Saccharose Roth 
Sodium acetate trihydrate  AppliChem 
Sodium bicarbonate (NaHCO3) Merck 
Sodium chloride (NaCl) Roth 
Sodium dodecyl sulfate (SDS) AppliChem 
Sodium fluoride (NaF) Fluka 
Sodium hydroxide (NaOH) AppliChem 
Sodium nitrate (NaNO3) Merck 
Sodium propionate (C3H5NaO2) AppliChem 
Sodium sulfate (Na2SO4) Merck 
Sodium thiosulfate (Na2S2O3) AppliChem 
Soybean flour Neuform 
Starch Roth 
Streptomycin Sigma 
Strontium chloride (SrCl2) Fluka 
Tetracycline Sigma 
Trifluoroacetic acid (TFA) Sigma 
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Chemical name Manufacturer 
Tris (hydroxymethyl) aminomethane hydrochloride Sigma 
Tryptone Roth 
Tyrosine Sigma 
Uranyl acetate Sigma 
Vancomycin Sigma 
Xylene cyanol AppliChem 
Yeast extract Gibco 
Zinc sulfate heptahydrate (ZnSO4.7H2O) Sigma 
 
IV. Computer Programs 
Software Application Reference 
Align sequence alignment and editing Hepperle 2002 
AntiMarin database 
 
marine natural products 
database 
University of Canterbury, New Zealand 
ARB phylogenetic tree construction http://www.arb-home.de/ 
ASMPKS 
 
analysis and prediction of 
modular PKS systems 
 
http://gate.smallsoft.co.kr:8008/~hstae/ 
asmpks/index.html 
BLAST sequence comparison/alignment http://www.ncbi.nlm.nih.gov/BLAST/ 
 
ChemDraw Ultra 8.0 
 
Chem Office 2004 
 
Chem Office 2004 
ClustalX 
 
alignment of nucleotide and 
amino acid sequences 
http://www-igbmc.u- strasbg.fr/BioInfo/ 
ClustalX/Top.html 
Dictionary of Natural 
Products 
online database of natural 
products 
http://www.chemnetbase.com 
Multi Analyst 1.1 documentation of agarose gel BioRad 
NRPSpredictor NRPS adenylation analysis http://www.tigr.org/jravel/nrps/ 
UpSol NMR Prediction prediction of NMR shifts Pretsch et al. 2000 
Phylip phylogenetic tree construction http://evolution.genetics.washington.edu /phylip/getme.html 
PKS analysis tool prediction of PKS domains http://www.nii.res.in/searchall.html 
Primer3 designing of PCR primers http://frodo.wi.mit.edu/ 
SciFinder Scholar natural products access tool  http://www.cas.org/scifinder/scholar/ 
Treeview visualization of phylogenetic trees 
http://taxonomy.zoology.gla.ac.uk/rod 
/treeview.html 
Vector NTI  AdvanceTM 
10 
ORF identification and sequence 
annotation 
https://catalog.invitrogen.com/index.cfm?
fuseaction=userGroup.downloadCenter 
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V. Enzymes and Kits 
Name of Enzyme/ Kit Manufacturer 
ABI PrismTM Big Dye TM terminator cycle 
sequencing ready reaction kit Applied Biosystems  
API kits Biomerieux 
Biolog SF-P2 Biolog 
FastDNA® spin kit for soil Q-Biogene          
Lysozyme Sigma 
Proteinase K Sigma 
pGEM-Teasy vector system   Promega 
pWEBTM cosmid cloning kit Epicentre 
QIAquick PCR purification kit  Qiagen 
REDTaq® ReadyMixTM PCR reaction mix Sigma 
Restriction endonucleases and buffers New England Biolabs  
RNase  Roche 
Taq DNA polymerase and buffer Qiagen 
T4 DNA ligase and buffer New England Biolabs 
Molecular weight markers   
          GeneRulerTM 1kb DNA ladder Fermentas 
          GeneRulerTM 100bp DNA ladder Fermentas 
          FastRulerTM DNA Ladder, high range Fermentas 
          GeneRulerTM DNA Ladder, hrRange Fermentas 
 
 
VI. Equipment and Supplies 
Equipment/ Supplies Manufacturer Specifications 
Autoclave 
Fedegari 
H+P Labortechnik 
Tec 120, 9191E, FV 3.3 
Varioklav 500, 135S 
Benchtop centrifuge Hereaus Instruments Biofuge Frasco 
Distilling apparatus for H2Odd GFL Bi-Dest 2304 
Disposable cuvette Plastibrand halbmikro 1,5 ml 
Electroporator EquiBio Easyject PRIMA 
Electroporation cuvette EquiBio EPC 102 
ELISA plate reader Thermo Electron  Multiskan Ascent 
Filter disks Becton Dickinson - 
Filter membranes Millipore Millex-GS 0.22 μm 
Gel documentation BioRad Gel Doc 2000 
Gel electrophoresis chamber BioRad - 
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Equipment/ Supplies Manufacturer Specifications 
Heat block Laboratory Devices Digi-Block Jr. 
HPLC Agilent Agilent 1100 
HPLC columns Phenomenex RP18 
Ice maker Scotsman AF-20 
Incubator 
Heraeus 
Memmert 
Kelvitron®t 
TV 40b 
Magnetic stirrer Labinco L32 
Micropipettes 
 
Microlab 
Microlab 
Microlab 
Microlab 
MicroOne 0,5-10 μl 
MicroOne 2-20µl 
MicroOne 20-200µl 
MicroOne 100-1000µl 
Microfuge tubes  
  
Sarstedt   
Abgene 
Abgene 
Greiner 
1,5 ml; 2,0 ml 
0,5 ml Thermo tubes 
0,2 ml Thermo Stripes 
15 ml, 50 ml Bio-one 
CELLSTAR® 
Microplates Nalgene NunclonTM 
Microwave 
AEG 
Privileg 
Micromat 
8020 
NMR 
Varian 
Bruker 
Varian Inova 400, 500, 600 MHz 
Avance 400 MHz 
MS Waters, Bruker  Micromass Q-TOF, MicroTOF 
PCR cycler Biometra T3-Thermocycler 
Petri dishes, round Greiner - 
Petri dishes, square Nalgene NunclonTM 
pH Meter  WTW MultiLine P4, SenTix 41 
Pin replicator Nalgen Nunc International 384 pin replicator 
Quartz cuvette Hellma Suprasil 
Refrigerator Privileg Superöko 
Rotary evaporator Heidolph Laborota 4010 
Scanning electron microscope Zeiss DSM 962 
Sequencer ABI Prism ABI 377XL 
Spectrophotometer 
Pharmacia Biotech 
PeqLab 
Ultraspec 3000 
NanoDrop ND1000 
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Equipment/ Supplies Manufacturer Specifications 
Speedvac concentrator Thermo Scientific Savant 
Shakers 
Braun 
Edmund Bühler 
Eppendorf 
Infors 
Certomat U 
SM-30 
Rotationsmischer 3300 
HT 
Transmission electron 
microscope Zeiss 
EM 10 
 
 
VII. Microorganisms 
Microorganism Application 
Staphylococcus aureus NCTC 8325 Bioactivity testing 
Staphylococcus epidermidis RP62A Bioactivity testing 
Enterococcus faecalis JH212 Bioactivity testing 
Enterococcus faecium 6413 Bioactivity testing 
Escherichia coli 536  Cloning 
Escherichia coli XL1-Blue Bioactivity testing 
Escherichia coli EPI100-T1R Cloning 
Pseudomonas aeruginosa  Bioactivity testing 
Yersinia pseudotuberculosis 252 01A Bioactivity testing 
Yersinia pestis KUMA Bioactivity testing 
Candida albicans 5314 (ATCC 90028) Bioactivity testing 
Trypanosoma brucei brucei 221  Bioactivity testing 
Leishmania major Bioactivity testing 
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VIII. Oligonucleotides 
Oligonucleotide Sequence 5’ – 3’ Annealing (°C) Reference Specificity 
 
27f 
1492r 
 
GAGTTTGATCCTGGCTCA 
TACGGCTACCTTGTTACGACTT 
56 Lane 1991 bacterial 16S rRNA gene (universal) 
 
540f 
1100r 
 
GGITGCACSTCIGGIMTSGAC 
CCGATSGCICCSAGIGAGTG 
64 Wawrik et al. 2005 type II PKS 
 
A7R 
A3 
 
SASGTCVCCSGTSCGGTAS 
GCSTACSYSATSTACACSTCSGG 
59 
 
Ayuso and 
Genilloud 2003 
NRPS adenylation domain 
 
degAH-F2 
degAH-R2 
 
ATCATGCCSGTSCAYATGGCSGG 
CKRTGRTGSARCCASTKRCART 
52 Rascher et al. 2003 AHBA synthase 
 
K1 
M6R 
 
TSAAGTCSAACATCGGBCA 
CGCAGGTTSCSGTACCAGTA 
55 
Ayuso and 
Genilloud 2005 
type I PKS 
 
KS α 
KS β 
 
TSGRCTACRTCAACGGSCACGG 
TACSAGTCSWTCGCCTGGTTC 
58 Ayuso et al. 2005 type II PKS 
 
KS 1 
KS 2 
 
TSGCSTGCTTCGAYGCSATC 
TGGAANCCGCCGAABCCGTC 
58 Metsa-Ketela et al. 
1999 
type II PKS 
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Oligonucleotide Sequence 5’ – 3’ Annealing (°C) Reference Specificity 
 
PKS III Fwd 
PKS III Rev 
 
TCGCTSCTSTCGAACGGCCTSTT  
CGGCGACGCSCTSTCGGC 
CTCSGCGGTGATSCCGGGSCCG  
AAGCCSGCGATSAGGC 
58 Cortes et al. 2002 type III PKS 
 
S-C-Act-0878-A-19 
S-C-Act-0235-a-S-20 
 
CCGTACTCCCCAGGCGGGG 
CGCGGCCTATCAGCTTGTTG 
60 Stach et al. 2003 Actinobacteria 16S rRNA gene 
 
sebNRPS-1 
sebNRPS-2 
 
GGCAGGCTGGTTGACGTAG 
GTGTGGTGGAGCTGGCTTT 
59 Proksch 2008 NRPS adenylation domain 
 
SP6 
T7 
 
ATTTAGGTGACACTATAG 
GTAATACGACTCACTATAGGG 
45 Promega pGEM-T easy cloning vector 
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Pimentel-Elardo S, Scheuermayer M, Kozitska S, Hentschel U (2008) Streptomyces 
axinellae sp. nov., a novel actinomycete isolated from the Mediterranean sponge, Axinella 
polypoides (Porifera). Int J Syst Evol Microbiol: In Press. 
 
Pimentel-Elardo S, Gulder TAM, Hentschel U, Bringmann G (2008) Cebulactams A1 and 
A2, new macrolactams isolated from Saccharopolyspora cebuensis, the first obligate-
marine strain of the genus Saccharopolyspora. Tetrahedron Lett 49: 6889-6892. 
 
Pimentel-Elardo S, Tiro LP, Grozdanov L, Hentschel U (2008) Saccharopolyspora 
cebuensis sp. nov., a novel actinomycete isolated from a Philippine sponge (Porifera). Int 
J Syst Evol Microbiol 58: 628-632. 
 
Sertan-de Guzman AA, Predicala RZ, Bernardo EB, Neilan BA, Elardo SP, Mangalindan 
GC, Tasdemir D, Ireland CM, Barraquio WL, Concepcion GP (2007) Pseudovibrio 
denitrificans strain Z143-1, a heptylprodigiosin-producing bacterium isolated from a 
Philippine tunicate. FEMS Microbiol Lett 277: 188-196. 
 
Scheuermayer M, Pimentel-Elardo S, Fieseler L, Grozdanov L, Hentschel U (2006) 
Microorganisms of sponges: phylogenetic diversity and biotechnological potential. In: 
Proksch P, Müller W (eds) Frontiers in Marine Biotechnology. Horizon Bioscience, 
Norwich, pp 289-312. 
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Symposia, Workshops and Field Work 
 
 
“Presenting Talks in Academic English”, workshop organized by the Graduate School of 
Life Sciences (Würzburg, June 12-13, 2008) 
 
“Catalogue and Database Research”, workshop organized by the Graduate School of Life 
Sciences (Würzburg, May 15, 2008) 
 
“Scientific Writing Course", workshop organized by the the Graduate School of Life 
Sciences (Würzburg, November 14-16, 2007) 
 
“VIth US-Japan Symposium: Frontiers in Marine Natural Products Research”, organized 
by the University of Utah (Park City, Utah, July 1-6, 2007) 
 
“3rd International Symposium”, organized by the International Graduate School 
(Würzburg, October 8, 2007). 
 
“Young Investigator Symposium on Infection Biology”, organized by ZINF; Poster 
presentation (Würzburg, March 2-3, 2007). 
 
Field work: sponge collection and cultivation of actinomycetes (Cebu City, Philippines, 
December 2006). 
 
“New Trends in Infectious Disease Research”, symposium organized by the SFB 630 and 
SFB 544; Oral presentation (Heidelberg, November 2006). 
 
“2nd International Symposium: Molecular Approaches for Novel Therapies”; organized by 
the International Graduate School (Würzburg, October 2006) 
 
“Summer School on Sponges” organized by the Biotecmarin (Rovinj, Croatia, August 
2006). 
 
“1st International Symposium: Novel Agents against Infectious Diseases - an 
Interdisciplinary Approach”, organized by the SFB 630; Poster presentation (Würzburg, 
February 2006). 
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